<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" media="screen" href="/~d/styles/atom10full.xsl"?><?xml-stylesheet type="text/css" media="screen" href="http://feeds.feedburner.com/~d/styles/itemcontent.css"?><feed xmlns="http://www.w3.org/2005/Atom" xmlns:openSearch="http://a9.com/-/spec/opensearchrss/1.0/" xmlns:georss="http://www.georss.org/georss" xmlns:gd="http://schemas.google.com/g/2005" xmlns:thr="http://purl.org/syndication/thread/1.0" xmlns:feedburner="http://rssnamespace.org/feedburner/ext/1.0"><id>tag:blogger.com,1999:blog-9029913</id><updated>2012-02-26T22:28:12.466-05:00</updated><category term="physician blog" /><category term="spanish" /><category term="cindy owens" /><category term="drug" /><category term="high grade serous" /><category term="keyhole surgery" /><category term="journal of medicine and the person" /><category term="Kaiser Permanente" /><category term="China" /><category term="resistant cancers" /><category term="forecasting" /><category term="flu patch" /><category term="newly diagnosed" /><category term="waist hip ration" /><category term="patient preferences" /><category term="honest" /><category term="sebaceus carcinoma" /><category term="nras" /><category term="care" /><category term="Nanotax" /><category term="postmenopausal hormone therapy" /><category term="Brussels" /><category term="word on cancer" /><category term="investigation" /><category term="Peutz–Jeghers syndrome" /><category term="surgical menopause" /><category term="anxiety" /><category term="regime" /><category term="genetic testing" /><category term="cell therapeutics" /><category term="endoscopist" /><category term="work hours" /><category term="extracolonic tumors" /><category term="metaplasia" /><category term="gallbladder" /><category term="variant" /><category term="p53" /><category term="PMH" /><category term="gairdner" /><category term="postoperative" /><category term="UICC" /><category term="TMI" /><category term="carcinosarcoma" /><category term="followup" /><category term="phase2" /><category term="penetrant genes" /><category term="lung cancer risk" /><category term="Poly C12U" /><category term="posting" /><category term="followupcommunication" /><category term="septated" /><category term="fibromyalgia syndrome" /><category term="BIG 00-01 trial" /><category term="genetic" /><category term="reality" /><category term="IL-17" /><category term="antibodies" /><category term="pregnant" /><category term="gene expression" /><category term="PAI-1" /><category term="top 5 blog" /><category term="pollack" /><category term="alternative medicine" /><category term="home hospice" /><category term="knowledge translation" /><category term="homecare" /><category term="papillary serous ovarian" /><category term="Livestrong" /><category term="networking" /><category term="nerve-sparing surgery" /><category term="prognostic variable" /><category term="solid tumors" /><category term="enterocolitis" /><category term="annual meeting" /><category term="genetic information" /><category term="websites" /><category term="postmenopause" /><category term="ethnicity" /><category term="nonrandomized trials" /><category term="drug development" /><category term="wrong symptoms ovarian cancer" /><category term="family healthware impact trial" /><category term="drug safety" /><category term="qigong exercise" /><category term="intraoperative electron beam radiation therapy" /><category term="NCCN" /><category term="Nodular Histiocytic Aggregates" /><category term="PET" /><category term="Columbia" /><category term="BNC105" /><category term="TGen" /><category term="molecular biology" /><category term="short duration" /><category term="homeopathy" /><category term="fleming" /><category term="oncology nurse" /><category term="post adjuvant therapy" /><category term="fruit" /><category term="PREMM model" /><category term="introduction" /><category term="medical teaching" /><category term="venous thromboembolism" /><category term="venlafaxine" /><category term="saskatoon" /><category term="cutaneous squamous cell carcinomas" /><category term="Cabozantinib" /><category term="application" /><category term="protein CRD-BP" /><category term="gynecologic oncology" /><category term="dendritic cells" /><category term="gene testing" /><category term="RNA.treatment" /><category term="dialogue" /><category term="longterm followup" /><category term="physician owned centers" /><category term="heated chemo" /><category term="evaluation" /><category term="systems" /><category term="asia oncology" /><category term="orientation" /><category term="NCCS" /><category term="liposomal doxorubicin" /><category term="cancer patients genetics breast colorectal ovarian health" /><category term="perfusion CT" /><category term="patient advisory committee" /><category term="attitude" /><category term="variants unknown significance" /><category term="B1 2536" /><category term="polaneczky" /><category term="BRCA 2" /><category term="caboplatin" /><category term="unique" /><category term="exam" /><category term="Ontario Institute Cancer Research" /><category term="patent trial australia" /><category term="surgery  gastrointestinal" /><category term="genetic risk" /><category term="visual loss" /><category term="Oncolytic biotech" /><category term="micropapillary" /><category term="recent progress" /><category term="failure to diagose" /><category term="pituitary" /><category term="genetic risk assessment" /><category term="photoacoustic imaging" /><category term="osteopathy" /><category term="urinary markers" /><category term="ePrognosis" /><category term="bowel prep" /><category term="Target Ovarian Cancer" /><category term="doxorubicin" /><category term="compassion" /><category term="Varian Medical System" /><category term="annual conference" /><category term="hours of work" /><category term="karen mason" /><category term="miR-428" /><category term="Cary Vera Garcia" /><category term="Lovenox" /><category term="BRCA 1" /><category term="copay" /><category term="time interval" /><category term="cancer in pets" /><category term="genetic records" /><category term="eof" /><category term="MK-0457" /><category term="regional differences" /><category term="index" /><category term="Prediction" /><category term="vaccines" /><category term="ALCL" /><category term="canadian research" /><category term="low grade serous" /><category term="oncogene" /><category term="gene cards" /><category term="medical tourism" /><category term="neuropathy" /><category term="polo like" /><category term="monk debates" /><category term="individualized therapy" /><category term="Professional-patient relations; recurrence" /><category term="RT. benefit" /><category term="courses" /><category term="toxic chemicals" /><category term="finance" /><category term="teal" /><category term="gonadotropin" /><category term="dancing with N.E.D." /><category term="triple negative" /><category term="predictions" /><category term="France" /><category term="osteopontin" /><category term="drug monographs" /><category term="OCRA" /><category term="patient advocacy organizations" /><category term="lurker" /><category term="how" /><category term="rare disease clinical trials" /><category term="IL-2" /><category term="AVX901" /><category term="miR-429" /><category term="cardiology" /><category term="postmenopausal cysts" /><category term="pshyological impact" /><category term="chocolate" /><category term="japanese" /><category term="Docetaxel; Abdominal radiation; Chemosensitizer; low dose radiation" /><category term="compassionate allowances" /><category term="primary care providers" /><category term="acute abdominal venous thrombosis" /><category term="Healthlinx" /><category term="mesenteric infarction" /><category term="genetic analysis" /><category term="cutaneous" /><category term="Mayo" /><category term="cancer progress timeline" /><category term="tranquilizers" /><category term="hvo" /><category term="cardiac" /><category term="department of defense" /><category term="cancer.. ovarian" /><category term="systematic reviews" /><category term="phase 1 clinical trials" /><category term="GPX3" /><category term="research programs" /><category term="social aspect" /><category term="hype hope reality gap cancer" /><category term="high mortality rate cancers" /><category term="flavonoid" /><category term="ovarian stem cells" /><category term="robotic" /><category term="non-serous" /><category term="multiresistant" /><category term="serous; mutations" /><category term="radiologists" /><category term="pharmactist" /><category term="RMI" /><category term="second primary cancer" /><category term="bankruptcy" /><category term="advanced stage borderline" /><category term="Oncotech" /><category term="cancer in pregnancy" /><category term="regulation" /><category term="online health information" /><category term="diverticulosis" /><category term="worldwide clinical trials" /><category term="restless leg syndrome" /><category term="estimates" /><category term="ccr" /><category term="international male breast cancer program" /><category term="interviews" /><category term="internet drug purchases" /><category term="chemotherapy" /><category term="whole brain radiation" /><category term="simple cysts" /><category term="restaging" /><category term="initial" /><category term="familial pancreatic syndrome" /><category term="IL-1" /><category term="Li-Fraumeni syndrome" /><category term="ileus" /><category term="eva trial" /><category term="international genome consortium" /><category term="IL-18" /><category term="NIH clinical trials" /><category term="2011" /><category term="Imipramine" /><category term="detroit" /><category term="DiaTech" /><category term="osteopathic physicians" /><category term="imedex" /><category term="platelets" /><category term="Correlogic" /><category term="FIGO" /><category term="blood" /><category term="ROCA" /><category term="unknown clinical significance" /><category term="shorter" /><category term="fundraising" /><category term="chemotherapeutic errors" /><category term="Winnipeg" /><category term="empowerment" /><category term="pelvic inflammatory disease" /><category term="Seattle" /><category term="cochrane consumers" /><category term="brca clinical trial" /><category term="private clinics" /><category term="meonpause" /><category term="flu" /><category term="Owareness" /><category term="nursing guidelines" /><category term="CT scans" /><category term="cardiac catherterization" /><category term="empathy" /><category term="corporations" /><category term="quinine sulfate" /><category term="fatal" /><category term="markman" /><category term="infusion pumps" /><category term="brain tumors" /><category term="slogans" /><category term="politicans" /><category term="complementary therapies" /><category term="bone mets" /><category term="checklists" /><category term="ebulletin" /><category term="videos" /><category term="susan g. komen" /><category term="2010" /><category term="ExAblate" /><category term="staging system" /><category term="IOM" /><category term="smells" /><category term="5-FU" /><category term="non mutation carriers" /><category term="breast cancer incident rates" /><category term="sedatives" /><category term="appendiceal" /><category term="clinical trial reporting" /><category term="mcgill university" /><category term="epigenetics" /><category term="preclinical" /><category term="U.S. colonoscopy" /><category term="wsj" /><category term="cancer costs" /><category term="retreat" /><category term="breast cancer genes" /><category term="pancreas" /><category term="nurses" /><category term="weekly" /><category term="KRAS" /><category term="Calypso trial" /><category term="Bethesda" /><category term="keratoacanthomas" /><category term="diagnosis" /><category term="aspirin" /><category term="to err is human" /><category term="unnecessary surgeries" /><category term="gravy train" /><category term="U.S." /><category term="2009" /><category term="central lines" /><category term="survivorship advocate program" /><category term="arguments" /><category term="misinterpretation" /><category term="pharmacy" /><category term="books" /><category term="collaboration" /><category term="asymptomtic" /><category term="self reported" /><category term="editorial" /><category term="death" /><category term="terry fox" /><category term="Quebec" /><category term="9p22.s" /><category term="RNA" /><category term="nci clinical trials cooperative group" /><category term="leydig" /><category term="consumer health" /><category term="support groups" /><category term="pacilitaxel" /><category term="masses" /><category term="hMSH2" /><category term="effective health care program" /><category term="IAPO" /><category term="intenational" /><category term="acute pain" /><category term="Capecitabine" /><category term="hormone" /><category term="FAP" /><category term="lymph node" /><category term="latitude" /><category term="outcomes research" /><category term="HGG" /><category term="cancer education" /><category term="adolescents" /><category term="HER2" /><category term="open access" /><category term="Myriad" /><category term="patient accrual" /><category term="foreign trained" /><category term="montage" /><category term="policy makers" /><category term="Lee" /><category term="benign disease" /><category term="north american breast cancer group" /><category term="adverse drug events" /><category term="times" /><category term="anaesthesia" /><category term="Canada presentation" /><category term="genetics" /><category term="irinotecan" /><category term="alternative complimentary" /><category term="oncimmune" /><category term="lymphadenectomy" /><category term="herbal remedies" /><category term="hereditary risk recall" /><category term="2007" /><category term="american institute for cancer research" /><category term="interative" /><category term="computers" /><category term="text" /><category term="BIBF 1120" /><category term="warfarin" /><category term="patient advocate foundation" /><category term="HER3" /><category term="opinion" /><category term="prostate" /><category term="million women study" /><category term="caregivers" /><category term="stand up to cancer" /><category term="2006" /><category term="disease" /><category term="expert opininon journal" /><category term="ama" /><category term="swallowing" /><category term="Technorati Tags: ca125" /><category term="hypertermia" /><category term="intensity modulated whole abdominal radiotherapy" /><category term="BRACAnalysis" /><category term="consumer" /><category term="skills" /><category term="Edmonton" /><category term="variants of uncertain signifcants" /><category term="canadian health care crisis" /><category term="deandra trevino salem" /><category term="reference book" /><category term="IP chemotherapy" /><category term="advertising" /><category term="CHEK1" /><category term="Ovarian steroid cell tumor" /><category term="London" /><category term="anemia" /><category term="ovarian sex cord tumor" /><category term="low level CA125" /><category term="surgery" /><category term="canadian institute of health research" /><category term="breakthrough" /><category term="physician awareness" /><category term="splenectomy" /><category term="Dee" /><category term="EGF" /><category term="barrier" /><category term="Ki-67" /><category term="survival rates cancer" /><category term="medical homes" /><category term="health care systems" /><category term="dove project" /><category term="contraceptive pill" /><category term="mayo clinic" /><category term="whole abdominal radiation therapy" /><category term="endometrial" /><category term="social status" /><category term="CHEK2" /><category term="voice" /><category term="uncertain clinical significance" /><category term="prognostics" /><category term="tumorigenesis" /><category term="misdiagnose" /><category term="Cancer Australia" /><category term="steven lewis" /><category term="CHUM" /><category term="world cancer day" /><category term="Peutz-Jeghers" /><category term="biologic" /><category term="herbs" /><category term="activist" /><category term="nucleic acids" /><category term="kimberly-clark" /><category term="share" /><category term="recovery" /><category term="robert wood johnson foundation" /><category term="cancer prevention" /><category term="frozen section" /><category term="election" /><category term="population" /><category term="ovarian cancer survivours" /><category term="pre existing condition insurance plans" /><category term="ebm" /><category term="colo-rectal" /><category term="angiotensin receptor blockers" /><category term="antiemetic" /><category term="lesion" /><category term="terminal prognosis" /><category term="clinical trial toronto" /><category term="hromone prevention" /><category term="vitamin b6" /><category term="fears" /><category term="symptom clusters" /><category term="CA125 Antigen; CA-125" /><category term="residual" /><category term="t cells" /><category term="CA125; Surveillance; CA-125" /><category term="MCL1" /><category term="smoking" /><category term="interventions" /><category term="Gynecologic Oncologists" /><category term="opiods" /><category term="D.C." /><category term="well being" /><category term="androgens" /><category term="inequality" /><category term="bone metastases" /><category term="tumor types" /><category term="erythropoiesis-stimulating agents" /><category term="risks" /><category term="autoantibodies" /><category term="P27 gene" /><category term="bottlenecks" /><category term="sex-cord stromal" /><category term="cleveland clinic" /><category term="ovarian genome" /><category term="Epogen" /><category term="cancer" /><category term="gene patents" /><category term="single agent pegylated liposomal doxorubicin" /><category term="Quality of life; Symptom Index" /><category term="cancer survivors" /><category term="leg cramps" /><category term="young adults" /><category term="breast surgery" /><category term="male breast cancer" /><category term="negative trials" /><category term="serous ovarian" /><category term="loss" /><category term="oral contraceptive" /><category term="adenocarcinoma" /><category term="chemotherapy related hair loss" /><category term="Washington Times" /><category term="risk second primary breast" /><category term="bilateral prophylactic mastectomy" /><category term="parents with children" /><category term="familial colorectal cancer type X" /><category term="oral nutrition" /><category term="psychiatrist" /><category term="multinational study" /><category term="Princess Margaret Hospital" /><category term="FOXL2" /><category term="interactive map" /><category term="herpes zoster virus" /><category term="firefox" /><category term="legs" /><category term="extracolonic cancers" /><category term="the art of oncology" /><category term="performance measures" /><category term="circulating cells" /><category term="same day surgery" /><category term="combination drugs" /><category term="blood clots" /><category term="lhin" /><category term="Alzheimer" /><category term="octreotide" /><category term="Ganoderma lucidum" /><category term="PCORI" /><category term="CA 125" /><category term="childhood cancers" /><category term="treatment failure" /><category term="Lotocki" /><category term="reports" /><category term="SIK2 gene" /><category term="FDG-PET/CT" /><category term="primary peritoneal" /><category term="pyridoxine" /><category term="mortality" /><category term="surgical mesh" /><category term="tinnitus" /><category term="approval" /><category term="malignant colonic obstruction" /><category term="end of life care" /><category term="cycles" /><category term="comprehension" /><category term="premm" /><category term="ASCO" /><category term="laughter" /><category term="single agent" /><category term="oxycarbazepine" /><category term="Phytochemicals" /><category term="Bioidentical" /><category term="Argentina" /><category term="asia-pacific" /><category term="intensity modulated WAR" /><category term="gynecologic foundation" /><category term="fear of death" /><category term="doxetaxel" /><category term="VTE" /><category term="BPA" /><category term="markers" /><category term="stats" /><category term="womens college hospital" /><category term="prognosis" /><category term="turquoise" /><category term="request" /><category term="ABCC2" /><category term="personalized medicine coalition" /><category term="interprofessional care" /><category term="influence" /><category term="immune therapy" /><category term="CYP2C19" /><category term="media" /><category term="nagourney" /><category term="self-pay" /><category term="allele" /><category term="Fenretinide" /><category term="physician assistant" /><category term="ovarian cancer canada" /><category term="forums" /><category term="older patients" /><category term="ipad" /><category term="barbie" /><category term="public engagement" /><category term="environment" /><category term="conference" /><category term="hospital rooms" /><category term="considerations" /><category term="middle income" /><category term="life beyond cancer foundation" /><category term="grieving" /><category term="patient access" /><category term="dna methylation" /><category term="surprise question" /><category term="Andre Picard" /><category term="advanced breast cancer" /><category term="sex cord-stromal" /><category term="post traumatic stress disorder" /><category term="activism" /><category term="acupuntcure" /><category term="pap" /><category term="weeks" /><category term="psychostimulants" /><category term="not optimal" /><category term="global leader" /><category term="desprate" /><category term="after cancer" /><category term="matching service" /><category term="premature ovarian failure" /><category term="menopause international" /><category term="cancer related" /><category term="guidelines conference" /><category term="hereditary breast and ovarian" /><category term="return to work" /><category term="Barb" /><category term="biomed journal" /><category term="death at home" /><category term="Benivegna" /><category term="residual disease" /><category term="carcinosarcomas" /><category term="women of teal" /><category term="connections" /><category term="psycho-oncology" /><category term="ear damage" /><category term="politics" /><category term="urothelial" /><category term="etoposide" /><category term="mushrooms" /><category term="anticoagulation" /><category term="endometriod" /><category term="hand-foot reactions" /><category term="canadian patient safety" /><category term="healthcare organization" /><category term="webinars" /><category term="oral etoposide" /><category term="Iran" /><category term="mammograms" /><category term="ovarian cancer surgery" /><category term="Immunovaccine" /><category term="art of oncology series" /><category term="physicians" /><category term="FORCE" /><category term="calcium and magnesium" /><category term="shark cartilage" /><category term="healthy eating" /><category term="healthcare" /><category term="Linus Pauling Institute" /><category term="borderline tumors" /><category term="dacogen" /><category term="popular" /><category term="critique" /><category term="MGH" /><category term="CMAJ" /><category term="Environmental exposures" /><category term="BRCAx" /><category term="listserv" /><category term="oral chemotherapy" /><category term="high dose" /><category term="risk factors" /><category term="david haas" /><category term="nerve damage" /><category term="cure magazine" /><category term="contrast enhanced ultrasound" /><category term="uninsured patients" /><category term="gene variants" /><category term="medical genomics" /><category term="webcasts" /><category term="histologic" /><category term="debate" /><category term="surveillance" /><category term="RLS" /><category term="reduction" /><category term="AEZS-108" /><category term="bladder" /><category term="Cetuximab" /><category term="drug costs" /><category term="hypothyroidism" /><category term="unexpected deaths" /><category term="treatment cycles" /><category term="acute" /><category term="cardio-renal-anaemia syndrome" /><category term="email" /><category term="oral" /><category term="maternal" /><category term="body mass index" /><category term="patient power" /><category term="risk reduction" /><category term="Laurie Singer Sievers" /><category term="complicatons" /><category term="quality care" /><category term="aetna" /><category term="fast track" /><category term="Pemetrexed" /><category term="chemoradiation therapy" /><category term="plos blog" /><category term="questionnaires" /><category term="rs1649942" /><category term="PFPS" /><category term="policy canada" /><category term="uterus" /><category term="anaesethesia" /><category term="webinar" /><category term="divisions" /><category term="progressive disease" /><category term="clinical obstetrics and gynecology journal" /><category term="free clinic" /><category term="best practices" /><category term="bereavement" /><category term="supportive care" /><category term="screening tests misuse" /><category term="advocate" /><category term="monoclonal antibody" /><category term="Sublingual administration" /><category term="asthma" /><category term="juvenile granulosa" /><category term="autonomy" /><category term="health policy" /><category term="methylation" /><category term="BAF250a" /><category term="chelation" /><category term="new drugs" /><category term="ovarian remnants" /><category term="newreel" /><category term="anti cancer" /><category term="bile duct" /><category term="tumor samples" /><category term="gene tests" /><category term="clincial trials mailing list healthcare professionals" /><category term="British Columbia" /><category term="?" /><category term="cancer control measurements" /><category term="comparitive effectiveness research" /><category term="smart" /><category term="James Lind Alliance" /><category term="quote" /><category term="Austria" /><category term="C-reactive protein" /><category term="kennedy" /><category term="Gadovist" /><category term="wounds" /><category term="preclinical studies" /><category term="chronic illness" /><category term="hopenet" /><category term="Scotland" /><category term="international cancer benchmarking" /><category term="tumour spread" /><category term="pleuropulmonary blastoma" /><category term="tumor rupture" /><category term="define" /><category term="paternalism" /><category term="facing our risk" /><category term="PACE study" /><category term="SNPs" /><category term="maintenance" /><category term="nocc" /><category term="heptibiliary" /><category term="cancer screening" /><category term="Interferon" /><category term="age of onsetLynch Syndrome" /><category term="da Vinci" /><category term="antiproliferation" /><category term="teaching" /><category term="self seeding cancer cells" /><category term="centralization" /><category term="Oklahoma" /><category term="minor allele" /><category term="charts" /><category term="pharmacology" /><category term="national patient stakeholder dialogue" /><category term="educate" /><category term="apology" /><category term="INNO-206" /><category term="insured patients" /><category term="peritoneal" /><category term="progesterone receptor" /><category term="peritoneum" /><category term="NY-ESO-1" /><category term="mesothelial" /><category term="lesbians" /><category term="epithelial ovarian cancer" /><category term="selumetinib" /><category term="older adults" /><category term="late recurrences" /><category term="ghostwriting" /><category term="metabolism" /><category term="stresses" /><category term="bone mineral density" /><category term="eating" /><category term="Sorafenib" /><category term="U.S. cost cancer 2010" /><category term="interpreting" /><category term="doctor's notes" /><category term="compliance" /><category term="Li Fraumeni" /><category term="characteristics" /><category term="colony-stimulating factor" /><category term="early phase" /><category term="tea" /><category term="uroepithelial tract" /><category term="pledge" /><category term="Eyelea" /><category term="Sunesis" /><category term="microsatellite" /><category term="management" /><category term="predicitive" /><category term="job posting" /><category term="primary care" /><category term="signet ring cell" /><category term="mucinous ovarian cancer" /><category term="melanoma of genital tract" /><category term="clinician rights" /><category term="constipation" /><category term="u.s. annual cancer report" /><category term="overuse" /><category term="don berwick" /><category term="web" /><category term="rights" /><category term="kidney" /><category term="Trastuzumab" /><category term="side effects" /><category term="hospice" /><category term="controversy" /><category term="histopathology" /><category term="chemotherapy induced" /><category term="Womens Oncology Research and Dialogue" /><category term="orphan drugs" /><category term="intensity-modulated radiation therapy" /><category term="BRAF mutation" /><category term="colorectal cancer syndromes" /><category term="upgrading" /><category term="altruism" /><category term="GCT" /><category term="Lipodox" /><category term="magic mushrooms" /><category term="quackery" /><category term="endometrial cancer" /><category term="inappropriate tests" /><category term="diagnostics; Urine; HE4" /><category term="credit" /><category term="secrecy" /><category term="low volume hospitals" /><category term="patient records" /><category term="paternalsim" /><category term="Vorinostat" /><category term="abandoned" /><category term="AZD2281) cochrane" /><category term="drug companies" /><category term="single chain variable fragments" /><category term="world trade center" /><category term="clinical trials canada" /><category term="cancer mortality" /><category term="First Canary Foundation" /><category term="Low grade histopathology; BRCA1; BRCA2; Risk assessment; Hereditary breast and ovarian cancer" /><category term="depression" /><category term="contamination" /><category term="psychotherapy" /><category term="multivitamins" /><category term="TNM" /><category term="flaxseed" /><category term="reproductive age group" /><category term="nonepithelial ovarian cancer" /><category term="suicide" /><category term="rare ovarian cancer" /><category term="ERT" /><category term="oncolink" /><category term="chronic pain" /><category term="Prof Calvert" /><category term="familial colorectal cancer" /><category term="ovarian cancers" /><category term="caelyx" /><category term="ACRIN" /><category term="tumor diameter" /><category term="health insurance" /><category term="survivorship care plans" /><category term="patient groups" /><category term="patients safety" /><category term="metformin" /><category term="family health" /><category term="CT" /><category term="absolute risk" /><category term="lancet" /><category term="copyrighting" /><category term="anti-angiogenesis" /><category term="primary surgery" /><category term="supplements" /><category term="aging" /><category term="Susan" /><category term="IP/IV" /><category term="grey literature" /><category term="Elesclomol" /><category term="broken heart syndrome" /><category term="scFvs" /><category term="genetic test results" /><category term="radiation oncology guidelines" /><category term="genetic risk prediction studies" /><category term="best countries" /><category term="contralateral breast cancer" /><category term="representatives" /><category term="laptops" /><category term="centralized care" /><category term="Kentucky" /><category term="birth defects" /><category term="tumor suppressor genes" /><category term="CO-338" /><category term="Mesothelium" /><category term="patient" /><category term="dabigatran" /><category term="cam. complimentary and alternative medicine" /><category term="radioisotopes" /><category term="owhn" /><category term="GCS" /><category term="nausea" /><category term="e-records" /><category term="California" /><category term="views" /><category term="fred hutchinson research" /><category term="assays" /><category term="reunion" /><category term="msi-h" /><category term="Lapatinib" /><category term="molecular profiling clinical trial" /><category term="Hematology" /><category term="relevant therapy" /><category term="petition" /><category term="student" /><category term="stockings" /><category term="Breakaway from Cancer" /><category term="Texas" /><category term="Herod" /><category term="economics" /><category term="brca survival rates" /><category term="research works act" /><category term="surgical pathology" /><category term="long term survivors" /><category term="malignancy" /><category term="history" /><category term="ototoxicity" /><category term="caution" /><category term="FDG PET-CT" /><category term="hpv" /><category term="2012 conference" /><category term="pipa" /><category term="clinical trial" /><category term="never-event" /><category term="vitmain d" /><category term="Topotecan" /><category term="overdose" /><category term="university of health network toronto" /><category term="miRNA" /><category term="patient views" /><category term="medical notes" /><category term="north american native" /><category term="GDC-0449" /><category term="treatment related mortality" /><category term="DPX-0907" /><category term="WAR" /><category term="aspiring" /><category term="ERK" /><category term="abdomen" /><category term="MiSS" /><category term="neoplasia" /><category term="genome" /><category term="angiogenesis inhibitors" /><category term="WiT" /><category term="pre-menpausal" /><category term="antimicrobiotics" /><category term="radiation. self medicating" /><category term="estrogen" /><category term="mastectomies" /><category term="intergroup" /><category term="two step" /><category term="search site" /><category term="unknown significance" /><category term="personalized treatments" /><category term="video" /><category term="cytogenetics" /><category term="germany" /><category term="priority" /><category term="surgeons" /><category term="symptom tracking" /><category term="GnRH agonist treatment" /><category term="dasatinib" /><category term="reassessment" /><category term="ovarian cancer epidemiology" /><category term="WHI" /><category term="ovarian carcinoid tumor" /><category term="cancer cachexia" /><category term="saskatchewan" /><category term="thermography" /><category term="blog stats" /><category term="tumors" /><category term="definition" /><category term="legally binding" /><category term="infant tylenol recall" /><category term="hormonal contraception" /><category term="international" /><category term="breast cancer screening" /><category term="vitmains" /><category term="urothelial carcinoma" /><category term="MSH2" /><category term="infographic" /><category term="combination therapy" /><category term="GCIG" /><category term="Roche" /><category term="Angiotensin 1-7" /><category term="Keywords: CASP8; Epithelial ovarian cancer; Polymorphism; Genetic association" /><category term="recurrent ovarian cancer" /><category term="Oxaliplatin" /><category term="new doctors" /><category term="facts" /><category term="nominations" /><category term="primary ovarian trabecular carcinoid" /><category term="DTA-H19" /><category term="high grade" /><category term="gastrointestinal perforation" /><category term="ifosfamide" /><category term="vermillion" /><category term="race" /><category term="distinct" /><category term="MSH1" /><category term="laymen terms" /><category term="England" /><category term="Libby" /><category term="ovarian cancer risk" /><category term="interleukin research" /><category term="breast density" /><category term="patient centered care" /><category term="Perioperative infection" /><category term="2011 asco" /><category term="cancer registry" /><category term="top doctors" /><category term="integrated care" /><category term="benign" /><category term="protocols" /><category term="high platelets" /><category term="EPB41L3" /><category term="speakerlink" /><category term="minimally invasive surgery" /><category term="mutations" /><category term="oza" /><category term="biology" /><category term="informed decision making" /><category term="breast cancer detection" /><category term="grapefruit" /><category term="underdiagnosis" /><category term="caBIG" /><category term="AMG386" /><category term="access" /><category term="vido" /><category term="cancer subtypes" /><category term="metachronous" /><category term="guidelines international network conference" /><category term="Margaret Railton" /><category term="realistic" /><category term="liability" /><category term="ERRC1" /><category term="Rosiglitazone" /><category term="psychedlic" /><category term="Avian; Gene expresion; animal models" /><category term="desparate" /><category term="mutation prevalence" /><category term="Cyclophosphamide" /><category term="nursing" /><category term="pbs" /><category term="neuromotor" /><category term="family planning" /><category term="Hawaii" /><category term="fallopian tube" /><category term="Clarke-Pearson" /><category term="post menopausal" /><category term="healthcare policy" /><category term="discrimination" /><category term="Nepal" /><category term="income" /><category term="red tape" /><category term="carcinoma" /><category term="mademoiselle" /><category term="Docetaxel; Abdominal radiation; Chemosensitizer; ovarian cancer" /><category term="msi MLH1" /><category term="DOD" /><category term="disclosure" /><category term="stomach cancer" /><category term="ovarian cancer search engine" /><category term="media release" /><category term="genetic syndromes" /><category term="immune system" /><category term="gender" /><category term="cancer causes" /><category term="Trastuzamab" /><category term="lynch syndrome associated cancers" /><category term="attitudes" /><category term="molecular diagnostics" /><category term="colorectal cancer metastases to ovary" /><category term="vergote" /><category term="synthroid" /><category term="late stage" /><category term="PEM" /><category term="CAM" /><category term="cancerprogress. net" /><category term="surgical education" /><category term="supportive care needs" /><category term="first primary" /><category term="cell types" /><category term="gerson" /><category term="ultrasounds" /><category term="human spirit" /><category term="Decitabine" /><category term="screening" /><category term="multinodular goiter" /><category term="challenges" /><category term="MSH6" /><category term="webcast" /><category term="Symptoms; Assessment;  intensity" /><category term="body size" /><category term="second line therapy statistics" /><category term="lupus" /><category term="Transmucosal" /><category term="lactase" /><category term="radioembolization" /><category term="Giede" /><category term="miR-410" /><category term="nanotechnology" /><category term="JCO" /><category term="black box" /><category term="young" /><category term="notes" /><category term="san diego" /><category term="future" /><category term="FIT protocol.Forsythe" /><category term="ovarian cancer symptoms" /><category term="SCT" /><category term="med students" /><category term="NCCAM" /><category term="phosphate" /><category term="vasectomy" /><category term="serotonin" /><category term="Leslie Worthington" /><category term="XRT" /><category term="older" /><category term="grief" /><category term="IN-CAM" /><category term="war on cancer" /><category term="sopa" /><category term="cervical" /><category term="controversies" /><category term="germline mutations" /><category term="editor" /><category term="Azacitidine" /><category term="doctors and patients" /><category term="Stanford" /><category term="Rucaparib" /><category term="MD Anderson" /><category term="oral anticoagulation" /><category term="clinical trials finder" /><category term="Picoplatin" /><category term="non profits" /><category term="ovarian cancer and us blog" /><category term="ovarian cancer alliance Ohio" /><category term="authorship" /><category term="WHO" /><category term="small bowel" /><category term="sugar" /><category term="crisis" /><category term="work hour" /><category term="PLD" /><category term="incidential findings" /><category term="WBRT" /><category term="FCCTX" /><category term="CYP3A4" /><category term="delays" /><category term="fighting spirit" /><category term="therapeutic advances" /><category term="accountable" /><category term="cochrane review" /><category term="word of hope" /><category term="prestige" /><category term="rebuttal" /><category term="hyperestrogenism" /><category term="asco abstracts 2011" /><category term="colorectal" /><category term="HDAC" /><category term="erythropoietin" /><category term="breast colorectal ovarian" /><category term="non familial colorectal cancer" /><category term="gigascience" /><category term="cancer type" /><category term="mind body medicine" /><category term="Time Magazine" /><category term="seeman" /><category term="erthropoiesis-stimulating agents" /><category term="adhesions" /><category term="ovarian small-cell" /><category term="setting" /><category term="risk malignancy index" /><category term="Carolyn" /><category term="lawsuit" /><category term="simultaneous" /><category term="scandals" /><category term="VT" /><category term="W5" /><category term="ovarian cancer rare" /><category term="Glutathione peroxidase 3" /><category term="GOG-0262" /><category term="SCAR project" /><category term="handouts" /><category term="allergy" /><category term="feline" /><category term="duty" /><category term="johns hopkins kimmel cancer center" /><category term="Paxil" /><category term="Opaxio" /><category term="Gefitinib" /><category term="positive thinking" /><category term="employees" /><category term="thecoma" /><category term="first cycle chemotherapy" /><category term="pipeline" /><category term="IBC" /><category term="goff" /><category term="concerns" /><category term="targeted therapies" /><category term="book" /><category term="antioxidant" /><category term="chemosuppressant" /><category term="emerging drugs" /><category term="top women" /><category term="parents" /><category term="passion" /><category term="natural history" /><category term="breast implants" /><category term="Australia Canada" /><category term="noncurative" /><category term="Paclitaxel" /><category term="patient participation" /><category term="participants" /><category term="alchohol" /><category term="chemoprevention" /><category term="strangers" /><category term="mira Dx" /><category term="polyps" /><category term="patient data" /><category term="OCAN" /><category term="hMLH1" /><category term="money" /><category term="endo of life care" /><category term="prediagnostic" /><category term="infection" /><category term="contrast agents" /><category term="news" /><category term="MK4827" /><category term="gilbert" /><category term="protein MCPH1" /><category term="ascites" /><category term="twins" /><category term="gynaecologic" /><category term="sandy rollman" /><category term="uncertainty" /><category term="staging manual" /><category term="SARS" /><category term="criteria" /><category term="awards voice spirit cancer survivor ovarian" /><category term="genome web" /><category term="RECIST" /><category term="AI" /><category term="Armstrong" /><category term="low malignant potential" /><category term="uterine serous papillary carcinoma.HER-2 neu" /><category term="anthropometric" /><category term="symptom research" /><category term="pets" /><category term="nuclear survivin expression" /><category term="bone loss" /><category term="line" /><category term="probability" /><category term="genetic data" /><category term="first line therapy" /><category term="self referrals" /><category term="gastroenterology" /><category term="IMC-3G3" /><category term="RAD51D" /><category term="contradicitons" /><category term="altruisic" /><category term="patient navigation" /><category term="thrombocytopenia" /><category term="vus" /><category term="practical consideration" /><category term="evolutin" /><category term="Lovastatin" /><category term="clinical data" /><category term="instability" /><category term="Adelson" /><category term="duration" /><category term="bleomycin" /><category term="sterotactic radiosurgery" /><category term="shirley and sadie" /><category term="heart" /><category term="hours" /><category term="advocacy groups" /><category term="genomics research" /><category term="Oncologist" /><category term="Karolinska Institutet" /><category term="online" /><category term="NDP" /><category term="complex cyst" /><category term="nursing homes" /><category term="physical activity" /><category term="patient experience" /><category term="oncolytics biotech" /><category term="RAD51C" /><category term="heart failure" /><category term="clinical trials" /><category term="the underwear affair" /><category term="CA125; endometriosis" /><category term="breast cancer guidelines" /><category term="pelvic" /><category term="vitamin D" /><category term="antidiuretics" /><category term="founder muations" /><category term="conferences" /><category term="cancer research" /><category term="oral mucositis" /><category term="Arrayit" /><category term="cooking" /><category term="enrolment" /><category term="TGF-B" /><category term="European Journal of Medical Research" /><category term="awareness day" /><category term="treatment related malignancy" /><category term="precursor" /><category term="counselling" /><category term="DVT" /><category term="DCA" /><category term="medicare" /><category term="prevention" /><category term="diagnostics" /><category term="early discontinuation" /><category term="election canada" /><category term="BRIP1" /><category term="palliative surgery" /><category term="hope" /><category term="Malignant ascites; Paracentesis; Diuretics; Intraperitoneal chemotherapy; Bispecific antibodies; Antiangiogenetic agents; Biological therapies" /><category term="ear ringing" /><category term="HER2 gene" /><category term="talc" /><category term="NGR-hTNF" /><category term="colonic stents" /><category term="Hamilton" /><category term="genetic tests" /><category term="Meigs Syndrome" /><category term="postmenopausal. osteoporosis" /><category term="vitamin E" /><category term="AJCC" /><category term="patient-user involvement" /><category term="polymorphism" /><category term="Promestriene" /><category term="ihi" /><category term="abagovomab" /><category term="gyn cancer" /><category term="Rebecca Esparza" /><category term="time with patients" /><category term="peerage of science" /><category term="robotics" /><category term="death registry" /><category term="tailored cancer care" /><category term="thoracoscopy" /><category term="simple inclusion cysts" /><category term="asbestos" /><category term="spirtual care" /><category term="Hot flushes" /><category term="liver tumors" /><category term="decision-making" /><category term="mRNA" /><category term="optimist" /><category term="CMA" /><category term="R04929097" /><category term="canary foundation newsletter" /><category term="sex cord" /><category term="ovarian cancer national alliance" /><category term="curetoday" /><category term="ovarian" /><category term="headaches" /><category term="hypersenitivity" /><category term="ownership" /><category term="RCCA" /><category term="free trial" /><category term="dietary fiber" /><category term="standard of care" /><category term="immune compromised" /><category term="tears to transparency" /><category term="molecular characteristic" /><category term="uterine fibroids" /><category term="health" /><category term="postmenopausal" /><category term="debbie" /><category term="refractory" /><category term="serous cell type" /><category term="pictures" /><category term="origins ovarian cancer" /><category term="biomarkers" /><category term="antiaging" /><category term="ovarian metastasis to breast" /><category term="tumor markers" /><category term="blinded participants" /><category term="lymph node metastasis" /><category term="Yondelis" /><category term="emergencies" /><category term="cutaneous metastases" /><category term="medications" /><category term="relationships" /><category term="4th grade" /><category term="cancer genome" /><category term="Dr. Al-Hayki" /><category term="Iniparib" /><category term="gastrostomy tube placement" /><category term="medical records" /><category term="Goldman" /><category term="genomes" /><category term="social determinents" /><category term="MORAb-003" /><category term="chronic" /><category term="encryption" /><category term="young cancer patients" /><category term="Marjorie Williams" /><category term="breast cancer survivor" /><category term="circulating tumor cells" /><category term="COSA" /><category term="chemotherapy induced nausea" /><category term="defining" /><category term="community oncologists" /><category term="pancreatic" /><category term="hyperthermic intraoperative intraperitoneal chemotherapy" /><category term="performance" /><category term="memo" /><category term="cell type" /><category term="safeguards" /><category term="student research" /><category term="neurotoxicity" /><category term="story" /><category term="abstract" /><category term="antitumor effects" /><category term="young adults with cancer" /><category term="hormonal" /><category term="electronic health devices" /><category term="confidence" /><category term="KRAS mutation" /><category term="lynch syndrome screening" /><category term="immunoproteome" /><category term="histology" /><category term="immature ovarian teratoma" /><category term="CML" /><category term="gynecologists" /><category term="PAX8" /><category term="aromatase inhibitors" /><category term="gynaecologic cancer survivours" /><category term="universal pharmacare" /><category term="C6-ceramide" /><category term="biopsy" /><category term="patient conference" /><category term="correspondence breast cancer guidelines" /><category term="newsletter" /><category term="thermal imaging" /><category term="severity" /><category term="symptoms ovarian cancer wrong lancet" /><category term="differentiation" /><category term="exon 2" /><category term="education lynch syndrome" /><category term="DepoVax™" /><category term="betty" /><category term="users" /><category term="nurse" /><category term="ask" /><category term="dying at home" /><category term="protenuria" /><category term="gulf coast" /><category term="Levothyroxine" /><category term="Donna Trussell" /><category term="weight loss" /><category term="debulking" /><category term="CFS" /><category term="ovarian cancer clinical trials" /><category term="hormone receptor testing" /><category term="bilateral tumors" /><category term="genetic counselors" /><category term="Dr Henry Lynch" /><category term="beliefs" /><category term="help" /><category term="treatment response" /><category term="OHA" /><category term="courts" /><category term="racial" /><category term="monique" /><category term="targeted therapy" /><category term="FAMM" /><category term="fallopian tube masses" /><category term="peer review" /><category term="shingles" /><category term="patients stories" /><category term="Arava" /><category term="clinical trials search" /><category term="bioethics" /><category term="Anticancer therapy" /><category term="nasal perforation" /><category term="healthcare decisions" /><category term="genetic variations" /><category term="personal genomics" /><category term="zofran" /><category term="vaccine clinical trial" /><category term="old" /><category term="Gynecologic cancer; Symptoms; early detection" /><category term="killer t cells" /><category term="Anaphylactic reactions" /><category term="biomed" /><category term="drug naming" /><category term="patient safety oncology" /><category term="thyroid" /><category term="epimutations" /><category term="advanced directives" /><category term="herbal medicines" /><category term="family caregivers" /><category term="MLH1" /><category term="black women" /><category term="clear cell" /><category term="uterine cancer" /><category term="Nordic" /><category term="Effectiveness" /><category term="face" /><category term="PTK6" /><category term="copayments" /><category term="fda review" /><category term="cancer patients" /><category term="dollars" /><category term="stand up to cancer clinical trial search" /><category term="mortality statistics" /><category term="granulosa" /><category term="SRS" /><category term="colorectal  cancer" /><category term="failure" /><category term="MLH2" /><category term="chemosensitization" /><category term="family member" /><category term="compassion fatigue" /><category term="volunteers" /><category term="Octretide" /><category term="six figure salaries" /><category term="sonogram" /><category term="Sandi" /><category term="APC" /><category term="cancer fundamentals" /><category term="assessment" /><category term="preparing for surgery" /><category term="accountability" /><category term="penn" /><category term="moderate risk" /><category term="flower" /><category term="laparascopic institute" /><category term="patient information" /><category term="fraser institute" /><category term="targeted agents" /><category term="progesterone" /><category term="inheritance" /><category term="audio" /><category term="assistance" /><category term="underfunding" /><category term="generic descriptors" /><category term="Society" /><category term="stomach" /><category term="researchers" /><category term="borderline tumor;gastrointestinal type;malignant transformation; mature cystic teratoma; ovary" /><category term="warning.Lyrica" /><category term="testosterone" /><category term="system" /><category term="health news reviews" /><category term="ultra-low-molecular-weight heparin semuloparin" /><category term="first line chemotherapy" /><category term="bisphosphonates" /><category term="spread patterns" /><category term="ABT-767" /><category term="hypercalcemic type" /><category term="end-of-life" /><category term="liposomal encapsulated doxorubicin" /><category term="Dr Orr" /><category term="where" /><category term="hurricanes" /><category term="credibility" /><category term="whistleblower" /><category term="patient factor" /><category term="undifferentiated" /><category term="cancer world" /><category term="drug industry" /><category term="mouse models" /><category term="biospecimens" /><category term="industry" /><category term="tracy gorden" /><category term="drug shortages" /><category term="video-assisted thoracic surgery" /><category term="psychosexual" /><category term="tumeric" /><category term="Cediranib" /><category term="relocation" /><category term="gyneacologic" /><category term="OXiGENE" /><category term="c.difficile" /><category term="breast cancer prevention" /><category term="incomplete" /><category term="terms" /><category term="tweets" /><category term="e-health" /><category term="ovarian cancer information needs" /><category term="online poll" /><category term="neuropsychological" /><category term="nccn guidelines" /><category term="mmrpro" /><category term="network" /><category term="navigator" /><category term="estradiol" /><category term="survivor" /><category term="con side" /><category term="KLK" /><category term="chicken" /><category term="RAF inhibitors" /><category term="cancer unknown primary" /><category term="transportation industry impairment" /><category term="PD 407824" /><category term="PI3K Inhibitors" /><category term="founder mutation" /><category term="pregnancy" /><category term="mice offspring" /><category term="PDK" /><category term="sporadic ovarian cancer" /><category term="ultraradical" /><category term="support" /><category term="eye on dna" /><category term="ICON7" /><category term="clinical utility card" /><category term="acetaminiphen" /><category term="Trinova-1" /><category term="Target Ovarian Cancer Pathfinder study" /><category term="womens health initiative" /><category term="understanding" /><category term="advocacy" /><category term="self concept" /><category term="gray market drugs" /><category term="immunohistochemical" /><category term="paraneoplastic thrombocytosis" /><category term="DIM" /><category term="second breast cancer" /><category term="cancer treatment induced bone loss" /><category term="self monitoring" /><category term="Fentanyl" /><category term="ovarian cancer video" /><category term="prospero" /><category term="bleeds" /><category term="cancer. genetics  common cancers" /><category term="9/11" /><category term="GOG186H" /><category term="molecular events" /><category term="Farletuzumab" /><category term="e-patients" /><category term="vaccination" /><category term="realism" /><category term="CA-125" /><category term="2012 familial cancer conference" /><category term="gene" /><category term="BRCA" /><category term="ischemia" /><category term="strategies" /><category term="Lancet student" /><category term="neuroendocrine" /><category term="mychart" /><category term="Lynch Syndrome" /><category term="LOVD" /><category term="personalized" /><category term="Alberta" /><category term="haemopoietic growth factors" /><category term="mutation" /><category term="cancer surgeons" /><category term="low penetrance mutations" /><category term="LapOvCa-trial" /><category term="serum" /><category term="qatar" /><category term="chromsome" /><category term="stem cell markers" /><category term="men" /><category term="androgen" /><category term="emergency" /><category term="IMRT" /><category term="19p13.1" /><category term="disturbances" /><category term="ob gyns" /><category term="markets" /><category term="alternatives" /><category term="ocrf" /><category term="blood brain barrier" /><category term="MAB monoclonal antibodies" /><category term="hormone treatments" /><category term="pain medications" /><category term="patient reporting" /><category term="discussion" /><category term="blood tests" /><category term="obstruction" /><category term="Egypt" /><category term="first birth" /><category term="Erbitux" /><category term="recruiting" /><category term="chemoresistant" /><category term="palliative care training" /><category term="infectious disease" /><category term="american cancer society" /><category term="chemotherapy induced menopause" /><category term="12 cycles" /><category term="Manitoba" /><category term="smart pills" /><category term="it's our time" /><category term="bisphosphosphonates" /><category term="blogger stats" /><category term="junk dna" /><category term="kinase" /><category term="Ovature" /><category term="dietary. phytoestrogens" /><category term="hyperthermic intraperitoneal intraoperative chemotherapy" /><category term="microRNA" /><category term="conversations" /><category term="biobanking" /><category term="cancer predisposition" /><category term="province" /><category term="asco 2011 abstracts" /><category term="inequities" /><category term="volatile" /><category term="utilization of services" /><category term="physician as typist" /><category term="OGX-427" /><category term="cancer-related infertility" /><category term="platinum resistant" /><category term="mammogram screening" /><category term="carotenoids" /><category term="retroperitoneal" /><category term="INCTR" /><category term="response to treatment" /><category term="BCl-3" /><category term="tubal intra epithelial" /><category term="Symptoms; australia" /><category term="Bortezomib" /><category term="silence" /><category term="ice cream" /><category term="american association for cancer research" /><category term="dogs" /><category term="positron Emmission Mammography" /><category term="serbia" /><category term="breast cme" /><category term="models" /><category term="EGAPP recommendations" /><category term="groups" /><category term="frontiers magazine" /><category term="drug effectiveness" /><category term="african american" /><category term="Crispin" /><category term="ESR1" /><category term="ovarian primary peritoneal cancer risk side effects" /><category term="cancer pain" /><category term="IOERT" /><category term="sexual health" /><category term="non Ashkenazi" /><category term="emergency planning" /><category term="surrogate" /><category term="history of cancer" /><category term="early vs delayed" /><category term="mucositis" /><category term="impact" /><category term="VCAM-1" /><category term="health knowledge" /><category term="consumer involvement" /><category term="healthcare costs" /><category term="CIHI" /><category term="open books" /><category term="pedigree" /><category term="unknowns" /><category term="chronic fatigue syndrome" /><category term="Illumina" /><category term="wiki" /><category term="internet study" /><category term="personalized medicine" /><category term="protocol. eligibility" /><category term="medscape" /><category term="transdermal" /><category term="sponsorship" /><category term="canadian patient safety institute" /><category term="Flexishield" /><category term="premature birth" /><category term="Dr Urban" /><category term="variants" /><category term="pelvis" /><category term="quality cancer care" /><category term="glycoprotein" /><category term="CINV" /><category term="test results" /><category term="Cryotherapy" /><category term="early clinical trials" /><category term="breast cancer related genetic testing management" /><category term="myriad.prices" /><category term="10 year followup" /><category term="second opinions" /><category term="earthquake" /><category term="chemo brain" /><category term="PET-CT" /><category term="Holistic Health Research Foundation of Canada" /><category term="blood products" /><category term="approach" /><category term="endocrine" /><category term="failures" /><category term="issues" /><category term="pew research" /><category term="; Survival" /><category term="influenza" /><category term="height" /><category term="MammaPrint" /><category term="tumor freezing" /><category term="cancer-genetic testing" /><category term="prescriptions" /><category term="genome canada" /><category term="hapmap" /><category term="genetic mutations" /><category term="polymorphisms" /><category term="Tanzania" /><category term="enoxaparin" /><category term="science" /><category term="neurology" /><category term="prose database" /><category term="corporate sponsorship" /><category term="Brydon" /><category term="oral anticoagulants" /><category term="risk reducing surgery" /><category term="cancer chemprevention" /><category term="kidney disease" /><category term="Hyperthermic Intraperitoneal Chemotherapy HIPEC" /><category term="Gilles Frydman" /><category term="high risk" /><category term="clones" /><category term="national cost of cancer care" /><category term="cochrane reviews" /><category term="exemestane" /><category term="gynecologic cancers" /><category term="hematuria" /><category term="counterfeit drugs" /><category term="copy numbers" /><category term="endometrial carcinoma; ovarian carcinoma; intraepithelial" /><category term="shared decision making" /><category term="scans" /><category term="GOG-0252" /><category term="natural menopause" /><category term="cancer indicence" /><category term="participatory evidence" /><category term="colon" /><category term="leadership seminar" /><category term="Paul" /><category term="partners" /><category term="transgender" /><category term="oral contraceptives" /><category term="renal" /><category term="primar surgery" /><category term="world oncology" /><category term="dna repair pathways" /><category term="ACLU" /><category term="ontario cancer care" /><category term="trauma" /><category term="global pharmacy canada" /><category term="NSAID" /><category term="ultrasound" /><category term="ocean trial" /><category term="patient centered medicine" /><category term="measurement" /><category term="continuity of care" /><category term="healthcare seeking" /><category term="patients like me" /><category term="interruptions" /><category term="dying at home expenses" /><category term="outcomes" /><category term="call for participants" /><category term="blood thinners" /><category term="pathology review" /><category term="bee" /><category term="expectations" /><category term="second primary malignancy" /><category term="Catumaxomab" /><category term="comparisons" /><category term="anti-inflammatory agents" /><category term="serous uterine" /><category term="low dose" /><category term="Practice Guideline" /><category term="resources" /><category term="ovarian cancer diagnosis" /><category term="gas" /><category term="Gabapentin" /><category term="cadherins" /><category term="potassium iodide iodine" /><category term="family physician" /><category term="fellowships" /><category term="brain metastses" /><category term="small bowel perforation" /><category term="trial results" /><category term="false positives" /><category term="anorexia" /><category term="PRECEDENT" /><category term="stage borderline" /><category term="national patient safety" /><category term="Rustin" /><category term="erythropoietin; recombinant; ovarian neoplasms; anemia" /><category term="Prophylactic Oophorectomy" /><category term="Olaparib" /><category term="p53-AAb" /><category term="PS-341" /><category term="European Cancer Organisation" /><category term="moca" /><category term="screening Lynch Syndrome" /><category term="perioperative" /><category term="fasting" /><category term="uncertain significance" /><category term="IV" /><category term="United States" /><category term="charity intelligence canada" /><category term="Florida" /><category term="Pertuzumab" /><category term="subsequent primary" /><category term="ICGC" /><category term="soy" /><category term="diethyldithiocarbamate" /><category term="premenopausal" /><category term="pancreatic syndrome" /><category term="consolidation" /><category term="countries" /><category term="innovation" /><category term="maligancies" /><category term="life after cancer" /><category term="statistics" /><category term="post menopause" /><category term="endoscopy" /><category term="PJS" /><category term="ovarian masses" /><category term="rare disorders" /><category term="benefits" /><category term="slides" /><category term="risk variants" /><category term="do not resuscitate" /><category term="pre test" /><category term="early ovarian cancer" /><category term="dr monk" /><category term="intraperitoneal" /><category term="reporters" /><category term="primary ovarian neuroendocrine tumors" /><category term="end of life decisions" /><category term="audits" /><category term="blood donations" /><category term="annamarie" /><category term="documentary" /><category term="triple negative ovarian cancer" /><category term="thryoid cancer" /><category term="NVP-BEZ235" /><category term="zone" /><category term="world health report" /><category term="decision making.legislation" /><category term="Correlogic Systems" /><category term="wijnenlynch syndrome" /><category term="Lasofoxifene" /><category term="Sweden" /><category term="sedation" /><category term="silver" /><category term="response" /><category term="survey" /><category term="patient care" /><category term="participation" /><category term="chemobrain" /><category term="vitamin c" /><category term="ovarian cancer signs and symptoms" /><category term="Losartan" /><category term="Palonosetron" /><category term="adherence" /><category term="India" /><category term="cumulative risk" /><category term="Gynecologic cancer; Symptoms; assessment" /><category term="abdominal-pelvic radiotherapy" /><category term="early stage breast" /><category term="gay" /><category term="I.P." /><category term="coverage" /><category term="bone pain" /><category term="pelvic mass" /><category term="neglect" /><category term="understanding studies" /><category term="vascular" /><category term="stamp" /><category term="Polymorphism; Genetics" /><category term="hospital discharge" /><category term="factor" /><category term="cystic" /><category term="GOC" /><category term="medical harm" /><category term="cryopreserved" /><category term="canine" /><category term="pelvic radiation disease" /><category term="food-drug interactions" /><category term="colonoscopy" /><category term="POET/CT" /><category term="defining value" /><category term="stay" /><category term="patients rights" /><category term="genetic variation" /><category term="stem cell research" /><category term="robotic assisted surgery" /><category term="endometrial carcinoma; ovarian carcinoma; PPP2R1A; PP2A; high-grade serous;mutations" /><category term="sertoli-leydig" /><category term="lymphadenectomyy" /><category term="dose exposure" /><category term="Canfosfamide" /><category term="Brazil" /><category term="complications" /><category term="sentinel nodes" /><category term="aacr clinical trial finder" /><category term="socioeconomics" /><category term="research papers" /><category term="bilateral oophorectomy" /><category term="meida" /><category term="fear" /><category term="DSHEA" /><category term="preimplantation" /><category term="oligodendrogliomas" /><category term="micrometastases" /><category term="arth-forth" /><category term="infections" /><category term="gestational trophoblastic" /><category term="publications" /><category term="sFANCD2" /><category term="rare cancers" /><category term="hVps37A" /><category term="breaking bad news" /><category term="healthcare systems" /><category term="mucin" /><category term="chemicals" /><category term="professionals" /><category term="health canada" /><category term="geriatric oncology" /><category term="Herceptin" /><category term="art" /><category term="gyn oncologist" /><category term="older age" /><category term="abstracts" /><category term="TLE3" /><category term="OvPlex" /><category term="excedrin" /><category term="Sunnybrook" /><category term="psychological adjustments" /><category term="dna repair" /><category term="WAPRT" /><category term="PLOS" /><category term="journal" /><category term="ALK7" /><category term="family" /><category term="familial" /><category term="inherited mutations" /><category term="IP" /><category term="low grade" /><category term="cognitive function" /><category term="ethics informed consent" /><category term="heavy lifting" /><category term="statin cancer risk" /><category term="drain placement" /><category term="diabetes" /><category term="incidence rates" /><category term="simulation" /><category term="blood cell counts" /><category term="drug delivery" /><category term="meaning of life" /><category term="Belotecan" /><category term="act network" /><category term="anticancer" /><category term="gynaecologic cancers" /><category term="unclassified variants" /><category term="ENMD-2076" /><category term="gynecologic oncologist" /><category term="abdominal mass" /><category term="fracture" /><category term="inhibitor" /><category term="ruling" /><category term="unknown primary" /><category term="early stage ovarian" /><category term="retractions" /><category term="Brenner" /><category term="cytology" /><category term="longwoods" /><category term="IN" /><category term="surgery tips" /><category term="artificial hydration" /><category term="Benevigna" /><category term="breast cancer surgery" /><category term="hormone receptor positive" /><category term="concepts" /><category term="cancer advocacy coalition" /><category term="helen palmquist" /><category term="trait" /><category term="labs" /><category term="Mylan-Minocycline" /><category term="genitourinary" /><category term="GOG" /><category term="Wiley-Blackwell" /><category term="metastatic" /><category term="double mutations" /><category term="hospital" /><category term="TROP-2" /><category term="infection control" /><category term="visits" /><category term="Interleukins" /><category term="residents" /><category term="burnout" /><category term="MuGard" /><category term="sarcoma" /><category term="global health status" /><category term="sandi pniauskas" /><category term="ascities" /><category term="Greece" /><category term="hydroxychloroquine" /><category term="second cancers" /><category term="Ixabepilone" /><category term="social" /><category term="early treatment" /><category term="contraceptives" /><category term="journal of negative results" /><category term="media reporting" /><category term="metastasectomy" /><category term="canadian medical association journal" /><category term="delayed vomiting" /><category term="poultry" /><category term="financial" /><category term="Canada U.S." /><category term="social networking" /><category term="patient charter of rights" /><category term="anaemia" /><category term="physical well being" /><category term="patient assistance programs" /><category term="borderline ovarian" /><category term="asymptomatic ovarian" /><category term="community oncology alliance" /><category term="large bowel obstruction" /><category term="tracers" /><category term="resistant tumors" /><category term="ovarian cancer stem cells" /><category term="micrometastatic" /><category term="chromosomes" /><category term="recurrence rates" /><category term="prognostic factor" /><category term="diagnostic" /><category term="crca" /><category term="1930" /><category term="rxlist" /><category term="tool" /><category term="$$" /><category term="OvPlexT" /><category term="realites" /><category term="disorders" /><category term="origin" /><category term="endometrial carcinoma; ovarian carcinoma; PPP2R1A; PP2A; high-grade serous; mutations; uterine carcinoma" /><category term="SYK" /><category term="medical errors" /><category term="Kat" /><category term="aromatese inhibitors" /><category term="rate" /><category term="adverse effects" /><category term="aggressive" /><category term="trying to please" /><category term="GOG 218" /><category term="concentrated formula" /><category term="Danish" /><category term="conventional" /><category term="progestins" /><category term="international database" /><category term="lefunomide" /><category term="aggression" /><category term="cancer drugs" /><category term="references" /><category term="patient website" /><category term="herzog" /><category term="inflammatory" /><category term="rsearch methodology" /><category term="ADZ5363" /><category term="primary care doctorssurvivorship" /><category term="AZD6244" /><category term="OncoMap" /><category term="johns hopkins" /><category term="too much information" /><category term="Youtube" /><category term="miR-155" /><category term="recall" /><category term="inherited cancers" /><category term="who does what" /><category term="bmi" /><category term="uterine" /><category term="champions" /><category term="vitamin" /><category term="NICE;  UK" /><category term="hospital procedure" /><category term="antioxidants" /><category term="ureter" /><category term="overtreatment" /><category term="Randomized controlled trials; Recruitment; Patient information; Primary care; Research methods; Trial design" /><category term="operating time" /><category term="research access" /><category term="Hatlie" /><category term="cancer progression" /><category term="integrin inhibitors" /><category term="medical" /><category term="IUD" /><category term="taxanes" /><category term="herparin" /><category term="expenses" /><category term="study" /><category term="combinations" /><category term="booklet" /><category term="small intestine" /><category term="anesthesia" /><category term="executive director" /><category term="data collection" /><category term="african americans" /><category term="journal index" /><category term="high risk breast cancer" /><category term="sunitinib" /><category term="HE4" /><category term="canadian" /><category term="private practice" /><category term="studies" /><category term="canadian health care system" /><category term="increasing rates" /><category term="TYMS rs495139" /><category term="herbal mushrooms" /><category term="phase 11" /><category term="memory" /><category term="cyst" /><category term="native" /><category term="harvard" /><category term="employment" /><category term="pharma" /><category term="TrueBeam" /><category term="obese" /><category term="2012 eso conference" /><category term="immunohistochemical analysis" /><category term="subpopulations" /><category term="chemosensory alterations" /><category term="oophorectomy" /><category term="sunshine" /><category term="OCATS" /><category term="LMWH" /><category term="pathologic response" /><category term="magazine article" /><category term="surgical treatment" /><category term="spirtual" /><category term="lack of evidence" /><category term="oxygen" /><category term="brain tumor clinical trials" /><category term="stem cell. research" /><category term="cure" /><category term="underdiagnosed" /><category term="small bowel obstruction" /><category term="IGFBP-4" /><category term="HIPEC" /><category term="super-specialization" /><category term="minorities" /><category term="stem cell treatments" /><category term="Ted Okon" /><category term="challenge" /><category term="legal services" /><category term="cancer improvement act" /><category term="korea" /><category term="microscopic bubbles" /><category term="diffusion weighted imaging" /><category term="VATS" /><category term="intraperitoneal spillage" /><category term="excuses" /><category term="low dose enhanced CT" /><category term="wait times" /><category term="Norway" /><category term="robotic surgery" /><category term="movement" /><category term="alternative therapy" /><category term="LDL" /><category term="molecular classification" /><category term="new lesions" /><category term="Docetaxel" /><category term="community cancer centers" /><category term="QOL. clinical trials" /><category term="new cancer center" /><category term="pleasing" /><category term="results" /><category term="patient outcomes" /><category term="ismycancerdifferent?" /><category term="triage" /><category term="telomere" /><category term="differences" /><category term="advertisements" /><category term="PARP inhibitors" /><category term="ovarian cell types" /><category term="other" /><category term="FDA warning" /><category term="perspective" /><category term="California Teachers Study" /><category term="melanoma" /><category term="pharmacist" /><category term="genetic alterations" /><category term="BSB4uD" /><category term="protein inhibitor" /><category term="litigation" /><category term="Tamoxifen" /><category term="plymorphism" /><category term="medical school" /><category term="extracolonic" /><category term="tubal ligation" /><category term="fertility sparing surgery" /><category term="financial reimbursement" /><category term="PMS2" /><category term="thompson" /><category term="array testing" /><category term="non carriers" /><category term="pay per view" /><category term="skin" /><category term="congestive heart failure" /><category term="dignity" /><category term="access to information" /><category term="antioxidative" /><category term="shannon" /><category term="top blogs" /><category term="Scottish" /><category term="Caris" /><category term="PCP" /><category term="radiation oncology" /><category term="veliparib" /><category term="patient voices" /><category term="dna sequencing" /><category term="natural healing" /><category term="WRHA" /><category term="bone marrow" /><category term="abdominal" /><category term="Velcade" /><category term="world cancer congress" /><category term="cancer support" /><category term="lab tests" /><category term="Lowell" /><category term="inherited markers" /><category term="stem cell" /><category term="humanitarianism" /><category term="St Louis" /><category term="elastic compression" /><category term="university of health network" /><category term="borderline tumours" /><category term="registry" /><category term="needs assessment" /><category term="Ovarian neoplasms; CA125; Decision-making; Surveillance; HE4" /><category term="Halifax" /><category term="test" /><category term="assay" /><category term="psychology" /><category term="liver" /><category term="Indonesia" /><category term="ZD6474" /><category term="fertility sparing surger" /><category term="audo" /><category term="tips" /><category term="advances" /><category term="microenvironment research" /><category term="combined HRT" /><category term="sloca" /><category term="obsturctions" /><category term="Novartis" /><category term="polymer micell nanotechnology" /><category term="living" /><category term="Amifostine" /><category term="neoadjuvant chemotherapy" /><category term="asian americans" /><category term="inflammation" /><category term="survival rates" /><category term="SPORE grant" /><category term="ovarian cancer ascites" /><category term="trial" /><category term="reporting" /><category term="Michiana" /><category term="copy number" /><category term="benefit" /><category term="survivorship care" /><category term="afebrile neutropenia" /><category term="rectovaginal" /><category term="interns" /><category term="epatients" /><category term="osteoporosis" /><category term="observations" /><category term="cdc" /><category term="imaging results" /><category term="Ohio" /><category term="stem cell transplant" /><category term="radiation-induced" /><category term="palliation" /><category term="advanced cancer" /><category term="miR-335" /><category term="intestinal" /><category term="Ovarian cancer; Biomarker; Autoantibody; p53; CA125" /><category term="Ovacom" /><category term="streamlining" /><category term="Extraperitoneal metastases" /><category term="notch signaling pathway" /><category term="endocrine policy statement" /><category term="clear cell ovarian" /><category term="carcinomatosis" /><category term="spiritual care" /><category term="geography" /><category term="pericardiocentesis" /><category term="quality" /><category term="misclassification" /><category term="AUra" /><category term="mouth" /><category term="patient advocate" /><category term="reproductive factors" /><category term="informed consent" /><category term="seakers" /><category term="ovarian cancer; symptoms" /><category term="PARP" /><category term="antiangiogenic therapy" /><category term="genetic signature" /><category term="near death" /><category term="genetic profile" /><category term="patient pages asco" /><category term="individualized treatment of patients with advanced stage ovarian cancer" /><category term="Asia" /><category term="ecancer" /><category term="cancer survivorship" /><category term="webMD" /><category term="esgo" /><category term="i.p. chemotherapy" /><category term="USA" /><category term="ovarian cancer blogger" /><category term="company sponsored" /><category term="disability" /><category term="mothers" /><category term="medical record access" /><category term="Arab" /><category term="primary mucinous" /><category term="aranesp" /><category term="recalls" /><category term="upper gastro-intestinal" /><category term="type 2" /><category term="comparison" /><category term="c.5266dupC" /><category term="response shift" /><category term="high blood pressure" /><category term="internet" /><category term="colectomy" /><category term="CNS" /><category term="complimentary and alternative medicine" /><category term="family physicians" /><category term="medical research" /><category term="port" /><category term="subtype" /><category term="glaxosmithkline" /><category term="access  fda" /><category term="slow growing" /><category term="oral supplements" /><category term="biomarker" /><category term="brain metastases" /><category term="women" /><category term="placebo" /><category term="chinese herbal medicine" /><category term="human experiments" /><category term="OvaGene" /><category term="ARIDIA" /><category term="cancer control strategy" /><category term="law" /><category term="Wyllie Ohagan" /><category term="clinical trial older ovarian cancer women" /><category term="Tumor interstitial fluid" /><category term="DTC advertising" /><category term="pathways" /><category term="patient involvement" /><category term="intraperitoneal chemotherapy" /><category term="prophylactic vaginal dilators" /><category term="ribbon" /><category term="braf" /><category term="lucier" /><category term="recurrance" /><category term="omega-3" /><category term="Britain" /><category term="spleen" /><category term="Ovarian Cancer Action" /><category term="parenteral nutrition" /><category term="Percutaneous" /><category term="Folkman" /><category term="conflict of interest" /><category term="yeast" /><category term="optimism" /><category term="FTY720" /><category term="drug resistance" /><category term="religion" /><category term="vinblastine" /><category term="national healthcare" /><category term="COTI" /><category term="public policy" /><category term="loneliness" /><category term="Teal journal" /><category term="vancouver" /><category term="undertreatment" /><category term="warning" /><category term="chemoprotection" /><category term="mets" /><category term="emesis" /><category term="Toronto" /><category term="ovarian research canada" /><category term="e medical" /><category term="firefighters" /><category term="Symptoms;  monitoring" /><category term="persistent disease" /><category term="molecular testing" /><category term="Clare" /><category term="gene specific risk" /><category term="pain specialists" /><category term="physician training" /><category term="poll" /><category term="fertility preservation" /><category term="women diagnostics nothing healthcare cancer" /><category term="fallopian tube cancer" /><category term="skin testing" /><category term="medication errors" /><category term="clinical research" /><category term="drug shortages canada" /><category term="hyperthroidism" /><category term="presurgical" /><category term="lower extremity" /><category term="early detection test" /><category term="Heat Biologics" /><category term="primary peritoneal cancer" /><category term="registration" /><category term="governments" /><category term="diagnostic tool" /><category term="cognition" /><category term="fraud" /><category term="23 and me" /><category term="therapy" /><category term="New York" /><category term="colon cancer" /><category term="Methotrexate" /><category term="floxuridine" /><category term="longterm side effects" /><category term="policy" /><category term="genomic assay" /><category term="legal" /><category term="Filgrastim" /><category term="ideas" /><category term="literacy" /><category term="individualized care" /><category term="tumours" /><category term="adverse drug reactions" /><category term="capsule rupture" /><category term="interview" /><category term="clinicopathological" /><category term="practical" /><category term="new generation" /><category term="orphan" /><category term="primary treatment" /><category term="cognitive" /><category term="power" /><category term="dose selection" /><category term="HER2 VRP" /><category term="cancer related cachexia" /><category term="hospital errors" /><category term="OCNA" /><category term="subscriptions" /><category term="figure" /><category term="in-hospital mortality" /><category term="bloggers" /><category term="Maspin" /><category term="advisory" /><category term="surgical oncology" /><category term="FINAVAST" /><category term="somatic" /><category term="option" /><category term="Precision Therapeutics" /><category term="anthracyclines" /><category term="immunhistochemistry" /><category term="healhcare" /><category term="micronutriends" /><category term="reactions" /><category term="underweight" /><category term="incompetence" /><category term="dalteparin" /><category term="patient advocacy" /><category term="trailer" /><category term="spirit" /><category term="nurse led" /><category term="antibiotics" /><category term="integrated genomic based approach" /><category term="gastrointestinal complications" /><category term="podcasts" /><category term="complimentary" /><category term="granulosa cell tumor;  palliative therapy;  radiotherapy" /><category term="fatigue" /><category term="CVac" /><category term="molecular markers" /><category term="out of pocket" /><category term="health advocacy organizations" /><category term="failed" /><category term="Shanghai" /><category term="palliative" /><category term="Genentech" /><category term="malignant transformation" /><category term="Peutz-Jeghers Syndrome" /><category term="Marilyn" /><category term="concierge medicine" /><category term="willingness to pay" /><category term="inhome chemotherapy" /><category term="tracey gorden" /><category term="plants" /><category term="psychological" /><category term="platinum" /><category term="principles" /><category term="MAPK" /><category term="Teal Toes" /><category term="awareness" /><category term="menopause" /><category term="patterns of care" /><category term="MRR" /><category term="parking costs cancer centres" /><category term="Wistar Institute" /><category term="Yi" /><category term="siblings" /><category term="harper" /><category term="asco 2011" /><category term="BC Cancer Agency" /><category term="hallmarks of cancer" /><category term="ABT-888" /><category term="neoadjuvant" /><category term="PTEN" /><category term="Daunorubicin" /><category term="telemedicine" /><category term="blame" /><category term="Ignace Vergote" /><category term="social media" /><category term="geriatrics" /><category term="canadian scientists" /><category term="dysgerminoma" /><category term="Lynch Syndrome clinical trial" /><category term="genes" /><category term="biomedical research" /><category term="tp53" /><category term="knowledge genetics family history" /><category term="relevance" /><category term="calcium" /><category term="Carol" /><category term="survivorship planning" /><category term="radiation therapy" /><category term="unstudied" /><category term="vasilev" /><category term="interleukin-6" /><category term="false" /><category term="donate" /><category term="50+ years of age" /><category term="systemic" /><category term="carcinoid" /><category term="self care" /><category term="consequences" /><category term="HER2 and mucinous ovarian" /><category term="heparin" /><category term="ZNF365" /><category term="psychosocial" /><category term="warning letter" /><category term="Ovotax" /><category term="cardiotoxicity" /><category term="contrast-enhanced" /><category term="function" /><category term="mmr mutation carriers" /><category term="followup care" /><category term="sorry" /><category term="tv" /><category term="disparities" /><category term="arginine" /><category term="expert patients" /><category term="government grants" /><category term="rankings" /><category term="primary" /><category term="early breast cancer" /><category term="Vismodegib" /><category term="gabapentin enacarbil" /><category term="patient computer dialogue" /><category term="public health" /><category term="skinner" /><category term="health evidence network" /><category term="bisphenoal A" /><category term="Histone deacetylase (HDAC) inhibitors" /><category term="needs" /><category term="financial information" /><category term="undiagnosed diseases" /><category term="HDAC inhibitors" /><category term="assay testing" /><category term="p53 gene" /><category term="trials" /><category term="clusters" /><category term="universal healthcare system" /><category term="Pfizer" /><category term="GTA" /><category term="transparency" /><category term="Jewish" /><category term="radiology" /><category term="hereditary nonpolyposis colorectal cancer" /><category term="errors" /><category term="Maritimes" /><category term="spoptosis" /><category term="annual cancer statistics" /><category term="stories" /><category term="platinum sensitive" /><category term="changing the health care system" /><category term="journal club" /><category term="port placements" /><category term="health care delivery; informed consent; professional-patient relationship; right to health care" /><category term="trial methods" /><category term="progression" /><category term="journalism" /><category term="santa" /><category term="self management" /><category term="Methylphenidate" /><category term="cme" /><category term="burden" /><category term="Pertuzamab" /><category term="Amsterdam" /><category term="necrosis" /><category term="isolation" /><category term="CA125" /><category term="reputation" /><category term="CEA" /><category term="AICR" /><category term="letter to the editor" /><category term="charities" /><category term="treatment related secondary cancers" /><category term="PreOvar test" /><category term="follow-up" /><category term="AGR2" /><category term="cancer specific stress" /><category term="blood transfusions" /><category term="non invasive" /><category term="immune function" /><category term="amazon" /><category term="physician characteristics" /><category term="gilda's club" /><category term="borderline" /><category term="natural health products" /><category term="institituion" /><category term="the lab" /><category term="uncommon histology" /><category term="MRI" /><category term="simvastin" /><category term="Ferrandina" /><category term="Mimosa" /><category term="sex." /><category term="asian medicine" /><category term="presentations" /><category term="SWOG trial" /><category term="cardiovascular" /><category term="implants" /><category term="malignant cells" /><category term="faulty logic" /><category term="Gadavist" /><category term="history of ovarian cancer surgery" /><category term="politician" /><category term="goals" /><category term="no mutation" /><category term="enomics" /><category term="Berwick" /><category term="Dr Benivegan" /><category term="death rates" /><category term="monitoring" /><category term="website" /><category term="Avastin" /><category term="commentary" /><category term="OVAR-IMRT" /><category term="experiences" /><category term="high volume" /><category term="ras" /><category term="QCRF" /><category term="dr amit oza" /><category term="toxicities" /><category term="IGCS" /><category term="dna tests" /><category term="squamous cell ovarian cancer; endometriosis" /><category term="sporadic" /><category term="drug shortage" /><category term="Update" /><category term="ovatax" /><category term="dilemmas" /><category term="grading systems" /><category term="world report" /><category term="drainage tube" /><category term="Onko-Sure" /><category term="clinicopathology" /><category term="postage stamp" /><category term="dysphagia" /><category term="ethics" /><category term="accelerated approval" /><category term="guidelines" /><category term="Anxiety; Decision-making" /><category term="addiction" /><category term="understand" /><category term="prostate cancer" /><category term="spices" /><category term="self manage" /><category term="study design" /><category term="gog 262" /><category term="2012 cancer conference" /><category term="quest diagnostics" /><category term="cancer genetics" /><category term="quest pharma" /><category term="chemotherapy induced alopecia" /><category term="healthy lifestype" /><category term="amlodipine" /><category term="advanced ovarian cancer" /><category term="survivorship plans" /><category term="romanow commission" /><category term="2010 conference" /><category term="safety" /><category term="drug mishap" /><category term="health news review" /><category term="truth" /><category term="2012 WCIO conference" /><category term="toxicity" /><category term="inflammatory breast cancer" /><category term="ovarian cancer newsletter" /><category term="anthropometry" /><category term="canadian healthcare system myths" /><category term="prairie" /><category term="medical students; peer learning; surgical skills" /><category term="virtual" /><category term="survivours debate" /><category term="critical review" /><category term="correspondence" /><category term="adhesion barrier" /><category term="stem cells" /><category term="health evidence canada" /><category term="PAI" /><category term="sertoli" /><category term="techniques" /><category term="gas-x" /><category term="conflicts of interest" /><category term="Clomiphene" /><category term="pregnancy in cancer" /><category term="breast" /><category term="P1K3CA" /><category term="tumor progression" /><category term="rheumatoid arthritis" /><category term="regulations" /><category term="problems" /><category term="sleep disturbances" /><category term="granai" /><category term="gastric cancer" /><category term="cancers" /><category term="DARE" /><category term="Australasia" /><category term="clincial trials" /><category term="red meat" /><category term="Urban" /><category term="president" /><category term="ambiguous" /><category term="rnai" /><category term="content" /><category term="poverty" /><category term="ureteral" /><category term="Michelle Robinson" /><category term="clear cell uterine" /><category term="unfunded" /><category term="education" /><category term="universal health care" /><category term="packaging" /><category term="save the patient" /><category term="ovarian squamous" /><category term="Gould" /><category term="referral patterns" /><category term="loyalty" /><category term="serous" /><category term="interleukin-2" /><category term="pet registry" /><category term="cost effectiveness" /><category term="ports" /><category term="preferences" /><category term="prophylactic surgery" /><category term="pulmonary embolism" /><category term="underestimates" /><category term="TGFß1 mRNA" /><category term="lifestyle" /><category term="Ethyol" /><category term="sequential" /><category term="falsification" /><category term="sleep" /><category term="committee" /><category term="hypermethylation" /><category term="breast conserving surgery" /><category term="Chicago" /><category term="moderate" /><category term="pediatric" /><category term="lactolose" /><category term="proteins" /><category term="ALOX5" /><category term="investigators" /><category term="graves disease" /><category term="susan g komen" /><category term="unclassified" /><category term="OGX-011" /><category term="learning" /><category term="Eleftherios Diamandis" /><category term="U.S. healthcare" /><category term="ethical dilemma" /><category term="stakeholder" /><category term="neuropathic pain" /><category term="dextran" /><category term="lung cancer" /><category term="Laurie" /><category term="cancer of unknown primary" /><category term="Montreal" /><category term="CSF" /><category term="Taxotere" /><category term="fluid" /><category term="breast fellowship" /><category term="speaker" /><category term="fibre" /><category term="post" /><category term="indices" /><category term="ESMO. conference" /><category term="rectum" /><category term="pelvic veins" /><category term="costs" /><category term="clinical practice guidelines" /><category term="physical examinations" /><category term="readmissions" /><category term="aacr" /><category term="insomnia" /><category term="end points" /><category term="doctor patient communication" /><category term="harms" /><category term="cassandra experience" /><category term="awards" /><category term="miracle mineral solution" /><category term="bowel perforation" /><category term="ovarian cysts" /><category term="donations" /><category term="Org 2766" /><category term="ovarian cancer target therapies" /><category term="HNPCC" /><category term="calculator" /><category term="hereditary" /><category term="familial breast cancer" /><category term="familial non-syndromic" /><category term="chemotherapy resistance" /><category term="patient file" /><category term="CA125 Antigen; early detection" /><category term="hereditary breast ovarian" /><category term="quality of life" /><category term="CER" /><category term="apoptosis" /><category term="national cancer genomic medicine" /><category term="public documents" /><category term="LFS" /><category term="hens" /><category term="trends" /><category term="amalgamate" /><category term="concealment" /><category term="elderly cancer patients" /><category term="emotion" /><category term="biologics" /><category term="pain management" /><category term="educator" /><category term="Canada" /><category term="CA-19-9" /><category term="subtypes" /><category term="Akts" /><category term="cochrane" /><category term="bladder carcinoma" /><category term="Symptoms; assessment" /><category term="familial risk" /><category term="miR-645" /><category term="hope-ology" /><category term="disadvantage" /><category term="stem cell therapies" /><category term="clearity foundation" /><category term="patient decisions" /><category term="HER2/neu" /><category term="germline" /><category term="excercise" /><category term="UK Collaborative Trial Ovarian Cancer Screening" /><category term="cancer politics" /><category term="cancer. ovarian" /><category term="sequence" /><category term="decatumumab" /><category term="screeing" /><category term="Gynecologic cancer; Symptoms; Assessment; Ovarian cancer; Cervical cancer; Vulvar cancer" /><category term="DICER1" /><category term="cancer control" /><category term="kindred" /><category term="herbal use" /><category term="MSKCC" /><category term="labels" /><category term="canhelp" /><category term="patient seminar" /><category term="the oncologist free app" /><category term="target based" /><category term="L'Oreal" /><category term="wishes" /><category term="kidney cancer" /><category term="PPP2R1A" /><category term="VEGFR-2" /><category term="CUP" /><category term="heath" /><category term="TIF" /><category term="coping" /><category term="BNP1350" /><category term="premedication" /><category term="Pazopanib" /><category term="chapter 11" /><category term="neuroendocrine differentiation" /><category term="Voreloxin" /><category term="colonoscopies" /><category term="triple negative breast cancer" /><category term="interpret" /><category term="drug induced damage" /><category term="treatments" /><category term="; NICE; CA125" /><category term="ASGO" /><category term="Bevacizumab" /><category term="caucasian" /><category term="tungsten particles" /><category term="Surveillance; Follow-up; FIGO staging; CA-125" /><category term="Elaine" /><category term="tarceva" /><category term="cyst rupture" /><category term="zoledronic acid" /><category term="qigong" /><category term="anthracycline" /><category term="neuro-oncologists" /><category term="acrylamide" /><category term="endometriosis" /><category term="GOG 157" /><category term="saliva" /><category term="health inovation" /><category term="ovarian cancer mayo management genetics" /><category term="PRD" /><category term="feedback" /><category term="PARP inhibitor" /><category term="patients online" /><category term="bilary tract" /><category term="heated chemotherapy" /><category term="nci cancer bulletin" /><category term="registries" /><category term="interleukin-12" /><category term="integrative cancer therapies" /><category term="colorectal cancer" /><category term="ovarian cancer survivor" /><category term="bladder cancer" /><category term="agonists" /><category term="taste alterations" /><category term="breast cancer genetic management" /><category term="miR-200c" /><category term="online prescriptions" /><category term="recruitment" /><category term="google fast flip" /><category term="natural S-equol" /><category term="stage" /><category term="combination with cisplatin" /><category term="children" /><category term="FIPPA" /><category term="unpublished" /><category term="breach" /><category term="PAF" /><category term="cause" /><category term="research" /><category term="patients voice" /><category term="occult" /><category term="pelvic pain" /><category term="single port" /><category term="consumer driven genomics" /><category term="back to the future" /><category term="MuGuard" /><category term="doctors for medicare" /><category term="editors" /><category term="darbopoetin" /><category term="WT1" /><category term="Uruguay" /><category term="mice" /><category term="options" /><category term="prospective trial" /><category term="neoadjuvant therapy" /><category term="social support" /><category term="jobs" /><category term="perforations" /><category term="comparative effectiveness research" /><category term="glycoproteins" /><category term="clinicians" /><category term="dictionary" /><category term="internal malignancy" /><category term="weight changes" /><category term="cystotomy" /><category term="mutch" /><category term="free speech" /><category term="diagnostic testing" /><category term="progress" /><category term="erythropoietin-stimulating agents" /><category term="PLCO" /><category term="artifacts" /><category term="beneficent" /><category term="drugs" /><category term="sgo white paper" /><category term="metastasis" /><category term="distribution" /><category term="medicine" /><category term="patient activation" /><category term="pathologist" /><category term="medical devices" /><category term="hospital staff" /><category term="patient charters" /><category term="circulating miRNA biomarkers" /><category term="predictive factor" /><category term="salaries" /><category term="unmet needs" /><category term="skin cancers" /><category term="plain text summary" /><category term="wait lists" /><category term="PI3K/mTOR-pathway inhibitors" /><category term="difficult patient" /><category term="PET scans" /><category term="surgical adhesions" /><category term="older women" /><category term="fingerprint loss" /><category term="pathogenesis" /><category term="specialist" /><category term="NCI" /><category term="elderly" /><category term="deep vein thrombrosis" /><category term="las vegas" /><category term="platinum dna" /><category term="canadian medical association" /><category term="consumers" /><category term="ARBs" /><category term="dying" /><category term="assessments" /><category term="fistula" /><category term="peritoneal carcinomatosis" /><category term="asymptomatic" /><category term="continuous therapy" /><category term="simutation" /><category term="EGFR" /><category term="Intraperitoneal Radioimmunotherapy" /><category term="commercialization" /><category term="S. 1674" /><category term="long term care" /><category term="munk debates" /><category term="suppportive care" /><category term="hypersensitivy" /><category term="scalp cooling" /><category term="parking" /><category term="advocates" /><category term="Quest" /><category term="rare tumors" /><category term="ecco" /><category term="self reported health" /><category term="atlas" /><category term="protection" /><category term="life expectancy" /><category term="variables" /><category term="astrazeneca" /><category term="patch" /><category term="molecular" /><category term="cpsi" /><category term="heterogeneity" /><category term="compensation" /><category term="schedule" /><category term="granisetron" /><category term="The Eve Appeal" /><category term="cooperative" /><category term="pan-canadian" /><category term="enema" /><category term="government" /><category term="disease drug comparisons" /><category term="cats" /><category term="experimental drug" /><category term="symptoms menopause" /><category term="type D personality" /><category term="OPN" /><category term="ovarian cancer overview" /><category term="family practice" /><category term="patients notes" /><category term="mmr" /><category term="n-acetyl l-aspartate" /><category term="bad news" /><category term="platinum resistance" /><category term="systematic  reviews" /><category term="high stage" /><category term="secondary care" /><category term="nightshift" /><category term="NORD" /><category term="epidemiology" /><category term="diciplinarian action" /><category term="hysterectomy" /><category term="holistic medicine" /><category term="Susan Lowell Butler" /><category term="sleep deprivation" /><category term="ATE" /><category term="OvPlex . UK" /><category term="bureaucracy" /><category term="platinum-resistant" /><category term="communication imaging" /><category term="technology" /><category term="genetic test" /><category term="MUC1" /><category term="10 deadliest cancers" /><category term="RAF" /><category term="pools" /><category term="anastrozole" /><category term="glutathione" /><category term="dr oz show" /><category term="origins" /><category term="ginkgo biloba" /><category term="consent" /><category term="medication events chemotherapy" /><category term="tedmed" /><category term="1C" /><category term="botanical research" /><category term="gcf" /><category term="ovarian cancer cell types" /><category term="censorship" /><category term="Frydman" /><category term="vulvar" /><category term="conditional" /><category term="vascular disease" /><category term="recurrent" /><category term="decision making" /><category term="Becoming a Radiologist" /><category term="treatment outcomes" /><category term="gastrointestinal tract" /><category term="inherited" /><category term="water" /><category term="third chemotherapy" /><category term="salzburg global seminar" /><category term="chemotherapy and patient safety" /><category term="violations" /><category term="september" /><category term="BMJ" /><category term="BRCAPRO" /><category term="IL1A rs17561" /><category term="alaska" /><category term="radiation oncologist" /><category term="endocrinology" /><category term="last birth" /><category term="LMP" /><category term="childhood cancer survivors" /><category term="gathering" /><category term="ovarian cancer 2011" /><category term="abscess" /><category term="declaration" /><category term="omentum" /><category term="teal heart" /><category term="psychsocial" /><category term="pre menopausal" /><category term="goiter" /><category term="rational therapeutics" /><category term="health care services" /><category term="self diagnosis" /><category term="pic lines" /><category term="Colorado" /><category term="rural" /><category term="world health organization" /><category term="Reolysin" /><category term="stigmatism" /><category term="when" /><category term="cancerworld" /><category term="intimidation" /><category term="economics of cancer" /><category term="cancer bureaucracy" /><category term="adjuvant" /><category term="VDR rs2228570" /><category term="gadolinium" /><category term="twitter" /><category term="Radiologist" /><category term="virus" /><category term="hedgehog pathway" /><category term="mathematics" /><category term="malinda teel" /><category term="empowered patient" /><category term="standards" /><category term="green tea" /><category term="coffee" /><category term="treatment refusal" /><category term="cancergazing" /><category term="death certificates" /><category term="doctor-patient" /><category term="SG2000" /><category term="fda.genetic testing" /><category term="ovarian cancer management" /><category term="journals" /><category term="dose-dense" /><category term="continuity care" /><category term="magazine" /><category term="relationship" /><category term="imp;implications" /><category term="barriers" /><category term="Coumadin" /><category term="retraction" /><category term="radiation" /><category term="second cytoreductive surgery" /><category term="digital divide" /><category term="canadian government" /><category term="Carboplatin-PLD" /><category term="PET/CT" /><category term="GOG 0239 trial" /><category term="cachexia" /><category term="mental health" /><category term="MAb B43.13" /><category term="thromboembolism" /><category term="Carboplating" /><category term="Australia" /><category term="multidisciplinary care" /><category term="surviivorship" /><category term="standard" /><category term="risk reducing mastectomy" /><category term="world conference on interventional oncology" /><category term="chemotherapy advisor" /><category term="doctor-patient communication" /><category term="planner" /><category term="multicentre" /><category term="multiple serrated polyps" /><category term="injection" /><category term="50+ yr" /><category term="review" /><category term="Akt" /><category term="warnings" /><category term="doctor" /><category term="natural products" /><category term="fallopian tubes" /><category term="female" /><category term="patient rights" /><category term="longterm sde effects" /><category term="oncology" /><category term="2011 asco abstracts" /><category term="anatomy" /><category term="seminar" /><category term="aarp" /><category term="college" /><category term="minister of health" /><category term="dual primaries" /><category term="blog posts" /><category term="hsien-hsien lei" /><category term="front line therapy" /><category term="bullying" /><category term="FA-BRCA" /><category term="neurologic" /><category term="alcohol" /><category term="FIGO staging endometrial cancer" /><category term="cytotoxic drug errors" /><category term="oshawa" /><category term="dietary" /><category term="Ovacome" /><category term="vegetables" /><category term="self identified" /><category term="research centers" /><category term="Leiden Variation Database" /><category term="insurance denial" /><category term="adenoviruses" /><category term="endometrioid ovarian" /><category term="dosage" /><category term="Mabcure" /><category term="dna testing" /><category term="articles" /><category term="CA125 Antigen; Surveillance; nadir" /><category term="public" /><category term="Bisphosphonate" /><category term="postmarketing studies" /><category term="Early integration" /><category term="slovenia" /><category term="signoidoscopy" /><category term="patients" /><category term="Donna Stecker" /><category term="leukemia" /><category term="VEGF Trap" /><category term="photos" /><category term="ovarian tissue" /><category term="Cisplatin" /><category term="palliative homecare" /><category term="concurrent" /><category term="leiomyosarcoma" /><category term="Ketoconazole" /><category term="chinese women" /><category term="private health care canada" /><category term="dietary supplements" /><category term="analysis" /><category term="cancer spread" /><category term="womens health matter" /><category term="post surgery" /><category term="patrick dempsey" /><category term="patient participants" /><category term="self advocacy" /><category term="deficiency" /><category term="treatment related second primary" /><category term="psa" /><category term="consumer representation" /><category term="single cell" /><category term="brca genetic testing" /><category term="recommendations" /><category term="commonwealth fund" /><category term="local oestrogen" /><category term="Oral Mucosal" /><category term="psychiatry" /><category term="pediatrics" /><category term="MRSA" /><category term="gynecology" /><category term="biochemistry" /><category term="clear cell ovarian cancer" /><category term="symptoms" /><category term="IV  carboplatin" /><category term="cathy chapman" /><category term="radiation technology" /><category term="genetic instability" /><category term="2011 conference" /><category term="perspectives" /><category term="ontario doctor pay" /><category term="spirituality" /><category term="award" /><category term="partnership for patients" /><category term="ondansetron" /><category term="patient privacy" /><category term="Urogynocolgy" /><category term="epi procolon" /><category term="overweight" /><category term="workload" /><category term="new regimens" /><category term="clinical trials ovarian cancer" /><category term="medical error" /><category term="u.s. news" /><category term="taxane chemotherapy" /><category term="photodynamic therapy" /><category term="Cochrane Collaboration" /><category term="genetic variances" /><category term="search" /><category term="para-aortic" /><category term="e-care records" /><category term="specialists" /><category term="neuroendocrine cervical" /><category term="stroke" /><category term="teens" /><category term="pelvic exams" /><category term="patient safety canada" /><category term="merger" /><category term="subgroups" /><category term="lymphedema" /><category term="OvaCheck" /><category term="delayed treatment" /><category term="family doctors" /><category term="lungs" /><category term="transvaginal ultrasound" /><category term="scar tissue" /><category term="TP53 (gene)" /><category term="diaphram" /><category term="centralisation" /><category term="cancer survivorship health behaviours" /><category term="relatives" /><category term="updates" /><category term="nonprofit" /><category term="MYH associated polyposis" /><category term="recap" /><category term="clarity" /><category term="FDA" /><category term="Ottawa" /><category term="hematologic" /><category term="cleaning products" /><category term="pixantrone fda" /><category term="practice" /><category term="Muir-Torre Syndrome" /><category term="patient exploitation" /><category term="germline genetic variation" /><category term="lost in transition" /><category term="healthcare act" /><category term="survivor award" /><category term="patient perspective" /><category term="education campaign" /><category term="vegatables" /><category term="peritonei" /><category term="aspartame" /><category term="ginger" /><category term="Phenoxodiol" /><category term="work" /><category term="alternative" /><category term="peglylated liposomal doxorubicin" /><category term="DTC" /><category term="sponsors" /><category term="urothelial bladder cancer" /><category term="OPT-821" /><category term="p53;circulating" /><category term="non-brca" /><category term="life support" /><category term="oregovamab" /><category term="press release" /><category term="Symptom control" /><category term="information" /><category term="Recurrences" /><category term="american college of radiology" /><category term="anaplastic large cell lymphoma" /><category term="optimal" /><category term="gene signatures" /><category term="gi dna testing fecal biomarkers" /><category term="endogenous" /><category term="human genome" /><category term="monk" /><category term="stents" /><category term="approvals" /><category term="malignant ascites" /><category term="research misconduct" /><category term="ovarian cancer book" /><category term="tongue" /><category term="Gynaecology" /><category term="insurance" /><category term="contraindications" /><category term="pediatric cancer survivors" /><category term="Therapy-related myeloid leukemia" /><category term="tuberculous Peritonitis" /><category term="EUAS" /><category term="books for children" /><category term="melatonin" /><category term="chinese" /><category term="unnecessary healthcare" /><category term="feeds" /><category term="bone health" /><category term="rare genetic mutations" /><category term="sulfonylureas" /><category term="explanation" /><category term="RAD51" /><category term="cruciferous vegetables" /><category term="ovarian primary peritoneal cancer risk side effects DVT" /><category term="patients first" /><category term="wine" /><category term="fraser report" /><category term="population cancer screening" /><category term="critical illness" /><category term="hnppc" /><category term="comparative effectiveness trials" /><category term="international gynecologic cancer society" /><category term="Boston" /><category term="off label drug use" /><category term="planning" /><category term="ulceration" /><category term="continuity of patient care" /><category term="frontiers in oncology" /><category term="underserved" /><category term="responsibilites" /><category term="pharmaceutical industry" /><category term="Mendoza" /><category term="diagnostic errors" /><category term="23andme" /><category term="Ovarian Cancer Association Consortium" /><category term="bleach" /><category term="rehospitalization rates" /><category term="CTC" /><category term="comments" /><category term="ESMO" /><category term="high tech" /><category term="dose density" /><category term="Ashkenazi Jewish" /><category term="TRAIL" /><category term="second maligancies" /><category term="non hormonal therapies" /><category term="distress" /><category term="inadequate surgery" /><category term="hospital care" /><category term="grade" /><category term="patient decision aids" /><category term="healing journey" /><category term="genetic counseling" /><category term="no needless list" /><category term="treatment intervals" /><category term="powerful patients" /><category term="healthcare providers" /><category term="BEAT" /><category term="upper abdominal surgery" /><category term="oopherectomy" /><category term="Reovirus" /><category term="cellsearch" /><category term="shaared care model" /><category term="appetite" /><category term="opinions" /><category term="burger" /><category term="contrast enhanced" /><category term="public health genomics" /><category term="vitamins" /><category term="shared environment" /><category term="MRC" /><category term="herpes zoster vaccine" /><category term="ptsd" /><category term="BRCA2; SNP" /><category term="single-gene" /><category term="MicroRNA let-7a" /><category term="women's health" /><category term="molecular subtypes" /><category term="COTI-2" /><category term="Avemar" /><category term="questions" /><category term="A4" /><category term="Epoetin" /><category term="radiation induced cancer; radiotherapy; second cancer" /><category term="aurora-B protein" /><category term="laparoscopic" /><category term="immunization schedule" /><category term="illness" /><category term="hypocritical" /><category term="nevada cancer institute" /><category term="bio markers" /><category term="free access" /><category term="Darbepoetin" /><category term="tricyclic" /><category term="low penetrance" /><category term="alteratives" /><category term="doctors" /><category term="the oncologist" /><category term="Temsirolimus" /><category term="clinical care options" /><category term="caring" /><category term="human rights" /><category term="neovascular" /><category term="surgical practice" /><category term="pre counselling" /><category term="in vitro fertilization" /><category term="ages" /><category term="high-grade glioma" /><category term="cost" /><category term="heart attack" /><category term="end of life" /><category term="DPX-Suvivac" /><category term="VEGFR2" /><category term="fertility" /><category term="pilot program" /><category term="P13K" /><category term="institutional" /><category term="cancer systems canada" /><category term="surgical management" /><category term="ovarian cancer survival Europe" /><category term="suffering" /><category term="mismatch repair genes" /><category term="political oncology" /><category term="futility" /><category term="peripheral neuropathy" /><category term="bias" /><category term="decision aids" /><category term="overview" /><category term="SGO" /><category term="dna generational changes" /><category term="horse" /><category term="SEMS" /><category term="microbubble" /><category term="patient safety" /><category term="etiologic link" /><category term="antiangiogenic" /><category term="chromosomerisk" /><category term="McMaster" /><category term="European Cancer Resolution" /><category term="Gemcitabine" /><category term="closson" /><category term="skeptical" /><category term="Adhesiolysis" /><category term="integrated cancer care" /><category term="outcome research" /><category term="dr Ilana cass" /><category term="medicaid" /><category term="Conejo-Garcia" /><category term="diagnostic test" /><category term="uncommon" /><category term="poster session" /><category term="ovarian germ cell" /><category term="FDG" /><category term="Assisted reproductive technology" /><category term="genomic sequencing" /><category term="user involvement" /><category term="integrity" /><category term="proteinuria" /><category term="testing" /><category term="terry fox foundation" /><category term="nurse practitoners" /><category term="trabectedin" /><category term="NBOCC" /><category term="hansard" /><category term="ny times" /><category term="others" /><category term="humans" /><category term="Nektar" /><category term="healthcare politics" /><category term="consolidated radiotherapy" /><category term="clinical practice" /><category term="breast reconstruction" /><category term="WORD" /><category term="post-operative" /><category term="EDR" /><category term="online tools" /><category term="concensus" /><category term="keystone" /><category term="industrialized" /><category term="iphone app" /><category term="chinese-americans" /><category term="treatment responses" /><category term="AHRQ" /><category term="GINECO" /><category term="Commonweath Fund" /><category term="angiogenesis" /><category term="shame" /><category term="drug advertising" /><category term="reimplantation" /><category term="nomogram" /><category term="low stage" /><category term="lawsuit oncologist physician canada cancer ovarian gynecology" /><category term="human abuses" /><category term="measuring" /><category term="couples" /><category term="monotherapy" /><category term="mutation carriers" /><category term="SOX11" /><category term="SU2C" /><category term="Roxiane" /><category term="research results" /><category term="academic health science centres" /><category term="AMG 386" /><category term="moderated" /><category term="breast cancer risk" /><category term="ovarian cancer CANO presentation conference St John's" /><category term="GAP-107B8" /><category term="phase 1" /><category term="home care" /><category term="cancer stem cells" /><category term="telephone" /><category term="Peg Ford" /><category term="disgusted" /><category term="double brca" /><category term="breakthoughs" /><category term="catheters" /><category term="obesity" /><category term="office" /><category term="PI3K" /><category term="Curcumin" /><category term="AML" /><category term="P349L" /><category term="Anti-inflammatory" /><category term="venous thrombeombolism" /><category term="needless" /><category term="acquired" /><category term="hedgog pathway inhibitor" /><category term="lack of understanding" /><category term="screening colorectal cancer" /><category term="interpretation" /><category term="Avandia" /><category term="phase 2" /><category term="gastrointestinal" /><category term="yolk sac" /><category term="CHEMSAS" /><category term="risk assessment" /><category term="comparative effectiveness" /><category term="MYH gene" /><category term="access to care" /><category term="hours of service" /><category term="food" /><category term="vrca" /><category term="santa claus" /><category term="canadian partnership against cancer" /><category term="mimicking" /><category term="Norweigian Cancer Genomics Consortium" /><category term="guidance" /><category term="patient reported outcomes" /><category term="ehealth" /><category term="Tipper" /><category term="clinial trials" /><category term="in vitro chemosensitivity testing" /><category term="pancreatic cancer" /><category term="treatment related side effects" /><category term="MLN8237" /><category term="urine" /><category term="cancer journal" /><category term="health insurance canada prescriptions" /><category term="Zaida" /><category term="protocol" /><category term="faltering cancer trials" /><category term="hypertension" /><category term="NS" /><category term="non-hormonal" /><category term="multidisciplinary" /><category term="Nidogen-2" /><category term="world cancer research fund" /><category term="cognitive impairment" /><category term="platinum refractory" /><category term="identification" /><category term="medical tests" /><category term="gynecologist" /><category term="community" /><category term="adverse event" /><category term="9p22.2" /><category term="selenium" /><category term="overall survival" /><category term="low-risk women" /><category term="CCO" /><category term="freezing ovarian tissue" /><category term="atlas of genetics" /><category term="bladder injury" /><category term="your guide to taking control" /><category term="doxorubicinm" /><category term="secondary" /><category term="doxil" /><category term="stage 1 ovarian cancer" /><category term="cancer specific" /><category term="extreme drug resistance assays" /><category term="self reporting" /><category term="sand balloon" /><category term="red cross" /><category term="poradic ovarian cancer" /><category term="cancer care" /><category term="bone turnover" /><category term="research integrity" /><category term="workplace" /><category term="ADE" /><category term="Stimuvax" /><category term="morphine" /><category term="engagement" /><category term="obituary" /><category term="facebook" /><category term="open medicine" /><category term="kitten" /><category term="integrated optical coherence tomography" /><category term="survivorship" /><category term="chris carr" /><category term="sporadic breast cancer" /><category term="first relapse" /><category term="diagnostics; HE4" /><category term="MMS" /><category term="low penetrance genes" /><category term="breast cancer documentary" /><category term="thrombocytosis" /><category term="antiretrovirals" /><category term="donors" /><category term="at-risk" /><category term="samples" /><category term="Professor Quinn" /><category term="unconscious" /><category term="indianapolis" /><category term="diet" /><category term="ADC" /><category term="Brivanib" /><category term="neuroendocrine tumors" /><category term="risk reduction surgery" /><category term="professional practice" /><category term="prescription costs canada" /><category term="early stage ovarian cancer" /><category term="tumor dimension" /><category term="duodenal" /><category term="molecular profiling" /><category term="patient survey" /><category term="ATAC" /><category term="palliative care" /><category term="digital mammography" /><category term="nodules" /><category term="national organiztion rare disorders" /><category term="gynecologic surgery" /><category term="rct" /><category term="hypersensitivity" /><category term="early detection" /><category term="opportunities" /><category term="healthy volunteers" /><category term="randomised trials" /><category term="HIPPA" /><category term="male" /><category term="Patupilone" /><category term="cancer statistics" /><category term="Carolyn Benivegna" /><category term="EC145" /><category term="cancer diagnosis" /><category term="stromal cells" /><category term="imaging" /><category term="oral sodium phosphate" /><category term="HuGENet" /><category term="Latinos" /><category term="bowel" /><category term="adverse medical events" /><category term="limited" /><category term="weekly taxol" /><category term="granulocyte colone stimulating" /><category term="charity" /><category term="NAFC" /><category term="hormone contraceptive" /><category term="personality type d" /><category term="compare" /><category term="telethon" /><category term="report card" /><category term="precauctions" /><category term="patients' association of canada" /><category term="patient harm" /><category term="borderline ovarian cancer survival" /><category term="pills" /><category term="NIH" /><category term="nanoparticles" /><category term="ovarian cancer in chinese women" /><category term="EORTC" /><category term="astro" /><category term="system abuses" /><category term="6TG" /><category term="EGAPP" /><category term="brca muation testing" /><category term="diversity" /><category term="scale" /><category term="idiot" /><category term="ESO" /><category term="ovarian yolk sac" /><category term="inhibitorsmutations" /><category term="cancer.ovarian" /><category term="colorectal cancer screening" /><category term="laparoscopic surgery" /><category term="slide presentation" /><category term="invasive" /><category term="tai chi" /><category term="dna" /><category term="bahamas" /><category term="cancer clusters" /><category term="variances" /><category term="surgical safety" /><category term="AG-014699" /><category term="consultant" /><category term="stage 1V" /><category term="sdoh" /><category term="pay for performance" /><category term="foundation" /><category term="plant based" /><category term="bufferin" /><category term="information technology" /><category term="68Ga-DOTATATE" /><category term="reimbursement" /><category term="re-staging" /><category term="surgical costs" /><category term="risk of malignancy index" /><category term="uninformative" /><category term="negative study" /><category term="ovarian cancer research" /><category term="CA4P" /><category term="patients voice drug safety" /><category term="lack of action" /><category term="Women's Health Initatiave" /><category term="doxil." /><category term="Chronix Biomedical" /><category term="GALNT1 gene" /><category term="boards" /><category term="ovarian cancer surveillance" /><category term="amgen" /><category term="secondary surgery" /><category term="SNP" /><category term="plant for life" /><category term="invasive ovarian cancers" /><category term="immunostaining" /><category term="survival" /><category term="presentation" /><category term="NL" /><category term="ovarian cancer and us" /><category term="south jersey" /><category term="pegfilgrastim" /><category term="rare tumor types" /><category term="legislative" /><category term="gtube" /><category term="fractures" /><category term="breast cancer" /><category term="professional" /><category term="EGP-1" /><category term="weekly topotecan" /><category term="managed care" /><category term="Karen Klok Anderegg" /><category term="bryostatin" /><category term="health care changes" /><category term="Fox12" /><category term="diabetic" /><category term="H1N1" /><category term="krukenberg" /><category term="Primary peritoneal cancer; Low-grade serous carcinoma; Ovarian cancer" /><category term="VEGF" /><category term="subspeciality" /><category term="BMS-582664" /><category term="Elisa" /><category term="randomized trials" /><category term="Tetranectin" /><category term="experiments" /><category term="CHOP" /><category term="2nd surgery" /><category term="elsevier journals" /><category term="precancer" /><category term="nonsteroid anti-inflammatory" /><category term="sex cord stromal" /><category term="patients opinion" /><category term="contrast" /><category term="most popular posts" /><category term="spain" /><category term="darlene gray" /><category term="parents without children" /><category term="claims" /><category term="classifications" /><category term="global" /><category term="malnutrition" /><category term="ovarian cancer hope" /><category term="histotype" /><category term="sensory perception" /><category term="CA 125 patient survey" /><category term="first degree" /><category term="followup; Surveillance" /><category term="overdiagnosis" /><category term="unmeasurable" /><category term="2nd line therapy" /><category term="flowers" /><category term="Folate Binding Protein" /><category term="germ cell" /><category term="table of contents" /><category term="scc" /><category term="legislation" /><category term="Women's Health Initiative" /><category term="perceptions" /><category term="Breakthrough pain" /><category term="usual care" /><category term="invisible" /><category term="MYC" /><category term="paraneoplastic cerebellar degeneration" /><category term="Canary Foundation" /><category term="secondary cancers" /><category term="voices into action" /><category term="rare ovarian tumors" /><category term="critical thinking" /><category term="health centers" /><category term="disease clusters" /><category term="clinical" /><category term="performance status" /><category term="lesions" /><category term="assembly" /><category term="gray matter" /><category term="influences" /><category term="stage 1" /><category term="Primary tumourdebulking; Secondary tumourdebulking; Tumour dissemination; Tumour residuals; Outcome" /><category term="clinique" /><category term="sabotage" /><category term="serous; Survival" /><category term="ovarian primary peritoneal cancer" /><category term="postsurgical" /><category term="CPU" /><category term="dose dense" /><category term="sun exposure" /><category term="mortality rates" /><category term="serms" /><category term="plain language" /><category term="nations" /><category term="seeding trials" /><category term="patient safety day" /><category term="karenitecin" /><category term="age" /><category term="msh3" /><category term="teleconference" /><category term="september 2010" /><category term="stage 2" /><category term="prophylatic" /><category term="vomiting" /><category term="acetylcysteine" /><category term="Carboplatin" /><category term="platinum based chemotherapy" /><category term="Mount Sinai" /><category term="adnexal masses" /><category term="qualaquin" /><category term="sharing" /><category term="venous thrombosis" /><category term="Prealbumin; Transthyretin; CA 125; Ovarian neoplasms; Pelvic mass" /><category term="canada gastroenterology" /><category term="dermatology" /><category term="patterns" /><category term="ZYBRESTAT" /><category term="subspecialization" /><category term="host factors" /><category term="unrealistic optimism" /><category term="SEER" /><category term="geriatric" /><category term="adverse events" /><category term="peri menopause" /><category term="chart" /><category term="folllowup" /><category term="hereditary breast cancer" /><category term="modern doctor" /><category term="life" /><category term="trialcheck" /><category term="medical diseases" /><category term="Epimutation" /><category term="early stage" /><category term="patient education" /><category term="model" /><category term="delayed diagnosis" /><category term="myths" /><category term="miR-31" /><category term="ovarian cancer diet" /><category term="qualitative research" /><category term="distrupted lives" /><category term="peritoneal mesothelioma" /><category term="ecstacy" /><category term="non epithelial ovarian" /><category term="child" /><category term="tools" /><category term="erlotinib" /><category term="combination therapies" /><category term="informed decisions" /><category term="cancer oncology alternatives complimentary medicine Canada U.S." /><category term="insulin" /><category term="Israel" /><category term="online pharmacy" /><category term="lung" /><category term="abstracts 2011 asco" /><category term="hospital comparisons" /><category term="corporate" /><category term="cardio" /><category term="cytoreduction" /><category term="conflicts" /><category term="agreements" /><category term="huh" /><category term="telecare" /><category term="Liverpool" /><category term="hormone replacement therapy" /><category term="TheraPlas®" /><category term="wigs" /><category term="nasal" /><category term="ummunovaccine" /><category term="synchronous" /><category term="ACOR" /><category term="mammography" /><category term="arterial thrombosis" /><category term="training" /><category term="acanthosis nigricans" /><category term="cancer world declaration" /><category term="Kate Murphy" /><category term="inconclusive" /><category term="genetics colorectal" /><category term="deaths" /><category term="jama" /><category term="fda alert" /><category term="advanced stage" /><category term="family patient engagement" /><category term="magnesium" /><category term="urinary tract injury" /><category term="mistletoe" /><category term="cystic tumors" /><category term="patient's perspective" /><category term="brain" /><category term="genome research" /><category term="physician" /><category term="cancer medical oncologist" /><category term="family doctor" /><category term="vitamin D. less common" /><category term="cancer.genetics" /><category term="tumor spread" /><category term="Methylene blue" /><category term="bioscience" /><category term="survivors debate" /><category term="treatment resistance" /><category term="ACS" /><category term="ureteral injury" /><category term="contagious cancer" /><category term="unemployment" /><category term="pain" /><category term="IOTA" /><category term="TA-65" /><category term="febrile neutropenia" /><category term="marketing" /><category term="NHS" /><category term="stereotactic radiosurgery" /><category term="CT scan" /><category term="CA19.9" /><category term="abdominal aortic aneurysms" /><category term="ovarian cancer" /><category term="prognostic" /><category term="legal actions" /><category term="comment" /><category term="direct to consumers" /><category term="Dan McMorris" /><category term="dnr" /><category term="nutrition" /><category term="short" /><category term="2012 sgo conference" /><category term="low risk" /><category term="physicial" /><category term="taxane" /><category term="pseudoscience" /><category term="pathologists" /><category term="NICE" /><category term="reproduction" /><category term="libby's hope" /><category term="coercive" /><category term="treatment" /><category term="risk" /><category term="Aflibercept" /><category term="inspiration" /><category term="herbal products" /><category term="length" /><category term="Leape" /><category term="AIDS" /><category term="thank you" /><category term="individual tumor cells" /><category term="permetrexed" /><category term="hinder" /><category term="immunotherapeutic" /><category term="survivours" /><category term="Singapore" /><category term="impairments" /><category term="Ortiz" /><category term="2012 japanese medical oncology conference" /><category term="women over 50" /><category term="next generation sequencing" /><category term="2009 Italy" /><category term="nccn conference" /><category term="goodfellow" /><category term="flaherty" /><category term="hot flashes" /><category term="Enzastaurin" /><category term="cell lines" /><category term="NAA" /><category term="knowledge" /><category term="appreciative inquiry" /><category term="womens health initative" /><category term="thalidomide" /><category term="white light" /><category term="patient advocates" /><category term="Edinburgh" /><category term="artists" /><category term="automated" /><category term="statements" /><category term="Edmond" /><category term="cytoreductive surgery" /><category term="patient safety institute" /><category term="lunafest" /><category term="Taxol" /><category term="publishing" /><category term="oncogenetic counselling" /><category term="cystic mass" /><category term="saudi arabia" /><category term="misconduct" /><category term="placebos" /><category term="sequencing" /><category term="dissemination" /><category term="missing data" /><category term="Cathy" /><category term="outpatient" /><category term="radiotherapy" /><category term="physician assistants" /><category term="ESA" /><category term="Hirte" /><category term="acupuncture" /><category term="falsifying" /><category term="epithelial" /><category term="Oncotype DX test" /><category term="baggage" /><category term="targeted" /><category term="ontario womens health network" /><category term="organizations" /><category term="Gynecologic Oncologists of Canada" /><category term="alleles" /><category term="fish" /><category term="phase 11 clinical trial" /><category term="gynaecologic oncologist" /><category term="EHR" /><category term="PennMed" /><category term="elle" /><category term="funding" /><category term="poland" /><category term="dynamic  fmri" /><category term="BRCA1" /><category term="stimatization" /><category term="FBW7" /><category term="magnetic nanoparticles" /><category term="dynamic  constrast mri" /><category term="debate presentation" /><category term="Docetaxel; Abdominal radiation; Chemosensitizer; CT" /><category term="patient values" /><category term="internet strike" /><category term="rupture" /><category term="Tracy" /><category term="major complications" /><category term="naturopathy" /><category term="NEJM" /><category term="trial design" /><category term="advanced care planning" /><category term="ill" /><category term="extreme drug resistance" /><category term="arimidex" /><category term="neutropenia" /><category term="patient organizations" /><category term="lynch syndrome. colorectal adenomas" /><category term="veterinarians" /><category term="personhood" /><category term="institutions" /><category term="endometrioid" /><category term="grass roots" /><category term="statistical model" /><category term="patient portals" /><category term="mistakes" /><category term="fecal accult blood tests" /><category term="Coleman" /><category term="ceRNA" /><category term="generic drugs" /><category term="CT/PET" /><category term="game" /><category term="endometrial carcinoma; ovarian carcinoma; PPP2R1A; PP2A; high-grade serous; mutations; dual malignancies" /><category term="vegfr inhibitors" /><category term="movie" /><category term="cbc" /><category term="elsevier" /><category term="national" /><category term="book review" /><category term="non genital tract" /><category term="financial statements" /><category term="risk perceptions" /><category term="Li-Fraumeni" /><category term="non toxic" /><category term="computerized system patent" /><category term="antigens" /><category term="aspiration" /><category term="ovarian patients followup cancer" /><category term="breast cancer and system diseases" /><category term="Antiangiogenic Agents" /><category term="bilary" /><category term="Archexin" /><category term="patient centred care" /><category term="ductal carcinoma in situ" /><category term="newsweek" /><category term="primary health care" /><category term="ACOG" /><category term="genomes unzipped" /><category term="Intraperitoneal access ports" /><category term="dexamethasone" /><category term="Denmark" /><category term="intereactive" /><category term="Cyberchondria" /><category term="radical fimbriectomy" /><category term="MRE11" /><category term="evidence" /><category term="government of canada" /><category term="blood pressure" /><category term="appendix" /><category term="personal health records" /><category term="DepoVax" /><category term="organ transplant" /><category term="sub standard surgery" /><category term="minnesota" /><category term="vaccine" /><category term="pleural malignancy" /><category term="annual report" /><category term="science and healing" /><category term="breast cancer surgeons" /><category term="hype" /><category term="sex cord stromal tumors" /><category term="hospitals" /><category term="dna damage" /><category term="PF-01367338" /><category term="portuguese" /><category term="food effect" /><category term="BRCA2" /><category term="counseling" /><category term="health care utlilization and outcomes" /><category term="scleroderma" /><category term="public hospitals" /><category term="cognitive change" /><category term="lymphocyst" /><category term="science research" /><category term="national registry" /><category term="MEK" /><category term="stopping" /><category term="voluntary" /><category term="Gail model" /><category term="OTUB1" /><category term="pediatric ovarian cancer" /><category term="surviving" /><category term="GOG 0126-T" /><category term="rare genetic syndromes" /><category term="pretreatment" /><category term="tumor volume" /><category term="esophageal cancer" /><category term="life sustaining treatments" /><category term="conflict" /><category term="omega fatty acids" /><category term="non serous" /><category term="terminal" /><category term="spouses" /><category term="integrative medicine" /><category term="long distance" /><category term="mesothelin" /><category term="chronic disease" /><category term="US" /><category term="hernia" /><category term="data" /><category term="HUGO" /><category term="expert opinion" /><category term="drug-drug interactions" /><category term="fecal immunochemical testing" /><category term="damages" /><category term="cancer journals" /><category term="adnexal mass" /><category term="Surgical mortality" /><category term="upper GI" /><category term="Oregon" /><category term="privacy" /><category term="infectious" /><category term="septal" /><category term="bioidenticals" /><category term="patient safety. surgery" /><category term="screemomg" /><category term="progestin" /><category term="four biomarker panel" /><category term="hormone therapy" /><category term="Diindolylmethane" /><category term="authors" /><category term="Ovarian cancer; Endometriosis; Pathogenesis; Oxidative stress; Microarray; Clear cell carcinoma; Microenvironment" /><category term="detection" /><category term="Dr Lynch" /><category term="clincial trials mailing list healthcare" /><category term="personality" /><category term="patient input" /><category term="gynecologic cancer webinar" /><category term="patient issues" /><category term="useful information" /><category term="clinics" /><category term="patients association canada" /><category term="ROMA" /><category term="metastatectomy" /><category term="health states" /><category term="middletown" /><category term="lymph nodes" /><category term="doctors notes" /><category term="alice little" /><category term="renal cell carcinoma" /><category term="healing" /><category term="reforms" /><category term="ovarian stromal cancer" /><category term="thrombosis" /><category term="votrient" /><category term="drug interactions" /><category term="dense" /><category term="patiuents" /><category term="oral aromatase inhibitors" /><category term="L1CAM" /><category term="Claudins" /><category term="extraovarian" /><category term="procedure" /><category term="bleeding" /><category term="contralateral" /><category term="weighte" /><category term="plain english" /><category term="art of oncology" /><category term="reconstruction" /><category term="health records" /><category term="satisfaction" /><category term="UK" /><category term="direct to consumer" /><category term="patents" /><category term="Modern Healthcare" /><category term="exon" /><category term="early stage breast cancer" /><category term="right to know" /><category term="Spirtos" /><category term="cancer risk" /><category term="magazines" /><category term="choices" /><category term="late effects" /><category term="readers digest" /><category term="dietary fat" /><category term="immune" /><category term="Procrit" /><category term="Diamandis" /><category term="high-grade" /><category term="epigenomics" /><category term="RAD51 assay" /><category term="google" /><category term="Netherlands" /><category term="drug coverage" /><category term="young women" /><category term="Contralateral Prophylactic Mastectomy" /><category term="early onset" /><category term="podcast" /><category term="martin luther king jr" /><category term="Flit" /><category term="Dee Edwards memorial" /><category term="Halt Medical" /><category term="heart attack risk" /><category term="malnourished" /><category term="user fees" /><category term="New Zealand" /><category term="obstacles" /><category term="western medicine" /><category term="breast cancer recurrence" /><category term="students for medicare" /><category term="second look" /><category term="quality of care" /><category term="Ashkenazi Jew pancreatic" /><category term="personalised cancer" /><category term="farlow" /><category term="gene expression profile" /><category term="cancer genomics" /><category term="Steve Jobs" /><category term="canadian health policy" /><category term="romanow" /><category term="patient-reported outcomes" /><category term="lower leg" /><category term="soul" /><category term="Joan" /><category term="brain metastasis" /><category term="sleepiness" /><category term="cancer test" /><category term="sexuality" /><category term="curis" /><category term="burgers" /><category term="chat sessions" /><category term="CKD" /><category term="progression free survival" /><category term="cancer oncology" /><category term="Apoptotic dna blood test" /><category term="Washington" /><category term="determinants" /><category term="longevity" /><category term="citations" /><category term="histone deacetylase inhibitor" /><category term="6-thioguanine" /><category term="pleural effusion" /><category term="easy-to-use" /><category term="hRad17" /><category term="program" /><category term="brca2 c.156_157insAlu" /><category term="size" /><category term="belinostat" /><category term="stem cell biology" /><category term="OvaDx" /><category term="HRI" /><category term="Pniauskas" /><category term="breast screening" /><category term="oprah" /><category term="sofafenib" /><category term="words" /><category term="double gloved" /><category term="Syndromes" /><category term="cell damage" /><category term="Dr Yi Pan" /><category term="ARID1A" /><category term="communications" /><category term="pakistan" /><category term="Ashkenazi" /><category term="nodoz" /><category term="hormones" /><category term="Melbourne" /><category term="synergy" /><category term="purgatives" /><category term="squamous cell carcinoma" /><category term="arteriosclerosis" /><category term="nytimes" /><category term="elsevier open access" /><category term="canada healthcare system" /><category term="gynecologic conference" /><category term="cholesterol" /><category term="genetic testing registry" /><category term="dietary guidelines" /><category term="ostomy" /><category term="sickness certificates" /><category term="initial surgery" /><category term="MSI" /><category term="liposomal" /><category term="Palmar–plantar erythrodysesthesia" /><category term="Prealbumin; Transthyretin; CA 125;  Pelvic mass" /><category term="fiber" /><category term="negligence" /><category term="urogynecology" /><category term="blood test" /><category term="e-communication" /><category term="heart disease" /><category term="stage 11" /><category term="Mylan-Amlodipine" /><category term="womens health" /><category term="artist" /><category term="Australia; New South Wales; Ovarian neoplasms; CA125 Antigen; Anxiety; Decision-making; Surveillance; Medical gaze" /><category term="stable" /><category term="peritoneal fibrosis" /><category term="jeopardy" /><category term="Cowden Syndrome" /><category term="paracentesis" /><category term="resveratrol" /><category term="group dynamics" /><category term="mucinous" /><category term="Ocrelizumab" /><category term="non-natural menopause" /><category term="inquiries" /><category term="friend" /><category term="scientific" /><category term="RFI" /><category term="mastectomy" /><category term="pharmacogenomics" /><category term="cervical cancer screening" /><category term="herpes zoster" /><category term="carcinogens" /><category term="Regina" /><category term="wound complications" /><category term="OVA1" /><category term="microwave thermotherapy" /><category term="serous borderline" /><category term="fashion magazines" /><category term="cancer genetics risks" /><category term="animal models" /><category term="HRT" /><category term="research quality" /><category term="faceboo" /><category term="language" /><category term="nonadherence" /><category term="anticogulants" /><category term="vemurafenib" /><category term="lung metastases" /><category term="rare" /><category term="MK-4827" /><category term="decisions" /><category term="mTOR" /><category term="financial conflicts of interest" /><category term="limitations" /><category term="seniors" /><category term="amsterdame 11" /><category term="dimethylsphingosine" /><category term="malignant effusion" /><category term="Globe and Mail" /><category term="gynecologic cancer" /><category term="seth's blog" /><category term="dendritic" /><category term="cancer therapies" /><category term="health and illness" /><category term="icu" /><category term="Pat" /><category term="Clinical Oncological Society" /><category term="privitisation" /><category term="microarray" /><category term="brain metastases; Central nervous system metastases; Ovarian cancer; Survival" /><category term="Temisirolimus" /><category term="UHN" /><category term="trust" /><category term="nurses health study" /><category term="House of Commons" /><category term="empower her" /><category term="persuasion" /><category term="navigators" /><category term="choosing wisely" /><category term="treatment related secondary primary" /><category term="patients views" /><category term="electronic health records" /><category term="MiCK" /><category term="contaminants" /><category term="relapse" /><category term="paid" /><category term="lancet oncology" /><category term="neuroprotective" /><category term="CIPROFLOXACIN" /><category term="ovarian cancer blog" /><category term="QOL" /><category term="genomics" /><category term="happiness" /><category term="C6ORF97" /><category term="NanoKnife" /><category term="friends" /><category term="childhood cancer" /><category term="C6ORF96" /><category term="misinterpreted" /><category term="antibody drug conjugates" /><category term="pelvic floor prolapse" /><category term="internet explorer" /><category term="durhane wong-rieger" /><category term="culture" /><category term="national pharmacare" /><category term="non epithelial" /><category term="PFS" /><category term="gastric" /><category term="Gorden" /><category term="maintenance therapy" /><category term="misdiagnosis" /><category term="fecal incontinence" /><category term="admissions" /><category term="questionnaire" /><category term="physician survey" /><category term="signals" /><category term="dissection" /><category term="time" /><category term="chemo response" /><category term="small study" /><category term="minerals" /><category term="PND" /><category term="tests" /><category term="protein" /><category term="blogger" /><category term="pathology" /><category term="laparotomy" /><category term="pegylated liposomal doxorubicin" /><category term="hormone replace therapy" /><category term="EpCAM" /><category term="cochrane journal club" /><category term="genetic discrimination" /><category term="osteoporois" /><category term="genetic testing effects" /><category term="physician payments ontario" /><category term="CA125; surgery" /><category term="psychosocial oncology" /><category term="nurse practitioner" /><category term="immunohistochemistry" /><category term="recurrent venous thrombosis. transdermal oestrogens" /><category term="survivors" /><category term="Jerusalem" /><category term="health care system" /><category term="necrotic tissue" /><category term="lancet oncology ovarian cancer detection study" /><category term="risk-reducing oophorectomy" /><category term="cysts" /><category term="minor children" /><category term="adjuvant hormonal therapy" /><category term="immunology" /><category term="rare diseases" /><category term="FOXL2 c.402C G" /><category term="android app" /><category term="prospective study" /><category term="malignant bowel obstruction" /><category term="low income" /><category term="hospital volume" /><category term="NKTR-102" /><category term="second-line" /><category term="inhibitors" /><category term="randomization" /><category term="immunosuppression" /><category term="cancer theme issue" /><category term="meta-analysis" /><category term="glossary" /><category term="left sided colonic obstruction" /><category term="mother" /><category term="Munk" /><category term="patients for patient safety" /><category term="radiation resistant" /><category term="microRNAs" /><category term="guardians" /><category term="malignant" /><category term="cervical cancer" /><category term="perforation" /><category term="agenda" /><category term="co-pay" /><category term="primary care physicians" /><category term="collateral damage" /><category term="pregabalin" /><category term="resident physicians" /><category term="injury" /><category term="media critique" /><category term="Obstretricians and Gynaecologists" /><category term="ovariancancerandus" /><category term="platinum-resistance" /><category term="letter" /><category term="cochrane consumer network" /><category term="chemoresistance" /><category term="plasminogen activator inhibitor-1" /><category term="not flashes" /><category term="freezing" /><category term="health care" /><category term="pelvic ultrasound" /><category term="HAI" /><category term="GRIPS" /><category term="DMS" /><category term="physican" /><category term="restless leg" /><category term="treatment related" /><category term="DMRT1" /><category term="referrals" /><category term="endometrium" /><category term="weight" /><category term="mesothelin antibodies" /><category term="my sister's voice" /><category term="pink" /><category term="salpingo-oophorectomy" /><category term="citalopram" /><category term="European Congress" /><category term="efficiency" /><category term="patient-centered care" /><category term="laparoscopy" /><category term="centres" /><category term="research ethics" /><category term="HTX005" /><category term="OCRP" /><category term="matching services" /><category term="symptoms ovarian cancer" /><category term="navigation service" /><category term="recurrence" /><category term="play  playwright" /><category term="brain mets" /><category term="metastases" /><category term="CRF" /><category term="hypoxia" /><category term="ears" /><category term="polish" /><category term="NSAIDs" /><category term="family history" /><category term="epidemic" /><category term="socioeconomic status" /><category term="staging" /><category term="statement" /><category term="birrer" /><category term="Hispanic" /><category term="cancer progress" /><category term="international federation gynecology and obstetrics" /><category term="TRC105" /><category term="gynecologic cancer drug monograms" /><category term="hand hygiene" /><category term="Cameroon" /><category term="theory" /><category term="hyperthermic Intraperitoneal Chemotherapy" /><category term="Wyeth" /><category term="alleric reactions" /><category term="dollar a day" /><category term="double primaries" /><category term="partnership" /><category term="morbidity" /><category term="early menopause" /><category term="BluePrint" /><category term="remote" /><category term="p53; Ovarian cancer; Biomarker; Autoantibody; p53; CA125" /><category term="gynaecological cancers" /><category term="hand foot syndrome" /><category term="ego" /><category term="ovaries" /><category term="families" /><category term="doubling time" /><category term="women's college hospital" /><category term="rationing" /><category term="humanities" /><category term="gynecologic cancers in   pregnancy" /><category term="Switzerland" /><category term="canadian cancer society" /><category term="direct to consumer genetic testing" /><category term="health plans" /><category term="drug therapy;antineoplastic agents" /><category term="early diagnosis" /><category term="dichloroacetate" /><category term="paraneoplastic" /><category term="survivor ovarian" /><category term="tissue samples" /><category term="onko sure" /><category term="slideshow" /><category term="C6ORF211" /><category term="ancient times" /><category term="cash" /><category term="1970" /><category term="Coukos" /><category term="in situ" /><category term="lymphomas" /><category term="Europe" /><category term="ovarian cancer screening" /><category term="check list" /><category term="IL-12 gene" /><category term="borderline ovarian tumors" /><category term="antiestrogens" /><category term="L-Glutamine" /><category term="evidenced based medicine" /><category term="HBOC" /><category term="meat" /><category term="ACE inhibitors" /><category term="enacct" /><category term="suboptimal" /><category term="medical imaging" /><category term="easter bunny" /><category term="adult granulosa ovarian cell" /><category term="psychosocial factors" /><category term="second line treatment" /><category term="ECOG" /><category term="reproductive organs" /><category term="doctors 2.0" /><category term="phase 111" /><category term="genetic counselling" /><category term="womens magazines" /><category term="primare" /><category term="SSRI" /><category term="CRC" /><category term="GINA" /><category term="roles" /><category term="provinces" /><category term="Denise" /><category term="clinical trial results" /><category term="in research" /><category term="guideline" /><category term="early stage ovarian cancer survival" /><category term="never events" /><category term="exercise" /><category term="negative studies" /><category term="complex care" /><category term="ovarian cell" /><category term="oregovomab" /><category term="interactive" /><category term="business" /><category term="tHE ART of the Matter" /><category term="survivourship" /><category term="hereditary non polyposis colorectal cancer" /><category term="C. difficile" /><category term="LXS Oral Powder" /><category term="skin cancer" /><category term="therapies" /><category term="NHA" /><category term="miratazapine" /><category term="grades" /><category term="algorithm" /><category term="clinical cancer advances" /><category term="cloud" /><category term="LPA" /><category term="links" /><category term="patient safety surgical site infections" /><category term="molecular analysis" /><category term="agency" /><category term="Complementary and Alternative Medicine" /><category term="amino acids" /><category term="nordic countries" /><category term="video CME" /><category term="restreat" /><category term="social networks" /><category term="alpha-tocopherol" /><category term="immunotherapy" /><category term="stigma" /><category term="Japan" /><category term="dose" /><category term="acr appropriateness criteria" /><category term="human genetics" /><category term="EU" /><category term="microsatellite instability" /><category term="ColoMarker" /><category term="cancer related fatigue" /><category term="truth telling" /><category term="kreppner" /><category term="patient costs" /><category term="international group" /><category term="gynecologic" /><category term="participatory medicine" /><category term="diaphragmatic surgery" /><category term="medical care" /><category term="post WHI" /><category term="infertility" /><category term="antidepressants" /><category term="Latino" /><category term="phase11" /><category term="oncology massage" /><category term="dormancy" /><category term="undiagnosis" /><category term="evolution" /><category term="cryoablation" /><category term="drug responses" /><category term="etastasis" /><category term="stromal" /><category term="high dose vitamin c" /><category term="glucose" /><category term="Ontario" /><category term="bill gates" /><category term="orc oncology" /><category term="evidenced informed" /><category term="Nichol" /><category term="ChemoFx" /><category term="Genetic Alliance" /><category term="statins" /><category term="screening tests" /><category term="Nevada" /><category term="rectal" /><category term="database" /><category term="tweet cloud" /><category term="viscum album L" /><category term="Darbepoetin Alfa" /><category term="stress" /><category term="Antiandrogen" /><category term="call for abstracts" /><category term="luncheon" /><category term="maintenance chemotherapy" /><category term="adverse reaction" /><category term="bowel obstruction" /><category term="young age" /><category term="communication" /><category term="understanding your lab tests" /><category term="ontario hospital association. data sharing" /><category term="blog" /><category term="Wellcome Trust" /><category term="probiotic" /><category term="patient guide" /><category term="Supercentenarian" /><category term="ovarian cancer detection study" /><category term="estrogen receptor positive" /><category term="genomic data" /><category term="caregiving" /><category term="Ovary" /><category term="h lee moffitt" /><category term="ovarian stimulation" /><category term="subspecialty care" /><category term="MolMed" /><category term="turning up the volume" /><category term="fdurd" /><category term="Sandostatin" /><category term="BRCAness" /><category term="biosimilars" /><category term="commentaries" /><title type="text">OVARIAN CANCER and US</title><subtitle type="html">“We can't solve problems by using the same kind of thinking we used when we created them.”..........“Not everything that can be counted counts and not everything that counts can be counted.” 

Albert Einstein</subtitle><link rel="http://schemas.google.com/g/2005#feed" type="application/atom+xml" href="http://ovariancancerandus.blogspot.com/feeds/posts/default" /><link rel="alternate" type="text/html" href="http://ovariancancerandus.blogspot.com/" /><link rel="next" type="application/atom+xml" href="http://www.blogger.com/feeds/9029913/posts/default?start-index=26&amp;max-results=25" /><author><name>Sandi Pniauskas</name><uri>https://profiles.google.com/104150638679323605960</uri><email>noreply@blogger.com</email><gd:image rel="http://schemas.google.com/g/2005#thumbnail" width="32" height="32" src="//lh3.googleusercontent.com/-pXxp-HXKY6M/AAAAAAAAAAI/AAAAAAAAAek/8dBEqVT6p0I/s512-c/photo.jpg" /></author><generator version="7.00" uri="http://www.blogger.com">Blogger</generator><openSearch:totalResults>7835</openSearch:totalResults><openSearch:startIndex>1</openSearch:startIndex><openSearch:itemsPerPage>25</openSearch:itemsPerPage><atom10:link xmlns:atom10="http://www.w3.org/2005/Atom" rel="self" type="application/atom+xml" href="http://feeds.feedburner.com/OvarianCancerAndUs" /><feedburner:info uri="ovariancancerandus" /><atom10:link xmlns:atom10="http://www.w3.org/2005/Atom" rel="hub" href="http://pubsubhubbub.appspot.com/" /><link rel="license" type="text/html" href="http://creativecommons.org/licenses/by-nc-nd/3.0/" /><logo>http://creativecommons.org/images/public/somerights20.gif</logo><feedburner:emailServiceId>OvarianCancerAndUs</feedburner:emailServiceId><feedburner:feedburnerHostname>http://feedburner.google.com</feedburner:feedburnerHostname><entry><id>tag:blogger.com,1999:blog-9029913.post-4354784026780582659</id><published>2012-02-26T22:26:00.002-05:00</published><updated>2012-02-26T22:28:12.933-05:00</updated><category scheme="http://www.blogger.com/atom/ns#" term="ovarian stem cells" /><category scheme="http://www.blogger.com/atom/ns#" term="fertility" /><title type="text">WebMD - Future Fertility Fix? Egg-Producing Stem Cells Found in Human Ovaries</title><content type="html">"....Scientists say they have found a way to use ovarian stem cells to perhaps one day help infertile women get pregnant -- or add years to a woman’s reproductive cycle.     
In a study published in...&lt;br/&gt;
&lt;br/&gt;
Ovarian Cancer? What You Need to Know&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?a=LxzroBl-odw:Sewz2sLkh3Y:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?a=LxzroBl-odw:Sewz2sLkh3Y:63t7Ie-LG7Y"&gt;&lt;img src="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?d=63t7Ie-LG7Y" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?a=LxzroBl-odw:Sewz2sLkh3Y:4cEx4HpKnUU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?i=LxzroBl-odw:Sewz2sLkh3Y:4cEx4HpKnUU" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/OvarianCancerAndUs/~4/LxzroBl-odw" height="1" width="1"/&gt;</content><link rel="related" href="http://www.webmd.com/infertility-and-reproduction/news/20120226/future-fertility-fix-egg-producing-stem-cells-found-in-human-ovaries?src=RSS_PUBLIC" title="WebMD - Future Fertility Fix? Egg-Producing Stem Cells Found in Human Ovaries" /><link rel="replies" type="application/atom+xml" href="http://ovariancancerandus.blogspot.com/feeds/4354784026780582659/comments/default" title="Post Comments" /><link rel="replies" type="text/html" href="http://ovariancancerandus.blogspot.com/2012/02/webmd-future-fertility-fix-egg.html#comment-form" title="0 Comments" /><link rel="edit" type="application/atom+xml" href="http://www.blogger.com/feeds/9029913/posts/default/4354784026780582659" /><link rel="self" type="application/atom+xml" href="http://www.blogger.com/feeds/9029913/posts/default/4354784026780582659" /><link rel="alternate" type="text/html" href="http://feedproxy.google.com/~r/OvarianCancerAndUs/~3/LxzroBl-odw/webmd-future-fertility-fix-egg.html" title="WebMD - Future Fertility Fix? Egg-Producing Stem Cells Found in Human Ovaries" /><author><name>Sandi Pniauskas</name><uri>https://profiles.google.com/104150638679323605960</uri><email>noreply@blogger.com</email><gd:image rel="http://schemas.google.com/g/2005#thumbnail" width="32" height="32" src="//lh3.googleusercontent.com/-pXxp-HXKY6M/AAAAAAAAAAI/AAAAAAAAAek/8dBEqVT6p0I/s512-c/photo.jpg" /></author><thr:total>0</thr:total><feedburner:origLink>http://ovariancancerandus.blogspot.com/2012/02/webmd-future-fertility-fix-egg.html</feedburner:origLink></entry><entry><id>tag:blogger.com,1999:blog-9029913.post-5610183827071328116</id><published>2012-02-26T22:21:00.001-05:00</published><updated>2012-02-26T22:24:40.347-05:00</updated><category scheme="http://www.blogger.com/atom/ns#" term="Catumaxomab" /><category scheme="http://www.blogger.com/atom/ns#" term="paracentesis" /><category scheme="http://www.blogger.com/atom/ns#" term="ascites" /><title type="text">Humoral response to catumaxomab correlates with clinical outcome: Results of the pivotal phase II/III study in patients with malignant ascites. (compared to paracentesis)</title><content type="html">Humoral response to catumaxomab correlates with clinical outcome: Results of the pivotal phase II/III study in patients with malignant ascites.

The trifunctional antibody catumaxomab is a targeted...&lt;br/&gt;
&lt;br/&gt;
Ovarian Cancer? What You Need to Know&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?a=g1U-70HtExY:wwkZxC0qG-A:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?a=g1U-70HtExY:wwkZxC0qG-A:63t7Ie-LG7Y"&gt;&lt;img src="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?d=63t7Ie-LG7Y" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?a=g1U-70HtExY:wwkZxC0qG-A:4cEx4HpKnUU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?i=g1U-70HtExY:wwkZxC0qG-A:4cEx4HpKnUU" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/OvarianCancerAndUs/~4/g1U-70HtExY" height="1" width="1"/&gt;</content><link rel="related" href="http://ukpmc.ac.uk/abstract/MED/21702044?source=rss" title="Humoral response to catumaxomab correlates with clinical outcome: Results of the pivotal phase II/III study in patients with malignant ascites. (compared to paracentesis)" /><link rel="replies" type="application/atom+xml" href="http://ovariancancerandus.blogspot.com/feeds/5610183827071328116/comments/default" title="Post Comments" /><link rel="replies" type="text/html" href="http://ovariancancerandus.blogspot.com/2012/02/humoral-response-to-catumaxomab.html#comment-form" title="0 Comments" /><link rel="edit" type="application/atom+xml" href="http://www.blogger.com/feeds/9029913/posts/default/5610183827071328116" /><link rel="self" type="application/atom+xml" href="http://www.blogger.com/feeds/9029913/posts/default/5610183827071328116" /><link rel="alternate" type="text/html" href="http://feedproxy.google.com/~r/OvarianCancerAndUs/~3/g1U-70HtExY/humoral-response-to-catumaxomab.html" title="Humoral response to catumaxomab correlates with clinical outcome: Results of the pivotal phase II/III study in patients with malignant ascites. (compared to paracentesis)" /><author><name>Sandi Pniauskas</name><uri>https://profiles.google.com/104150638679323605960</uri><email>noreply@blogger.com</email><gd:image rel="http://schemas.google.com/g/2005#thumbnail" width="32" height="32" src="//lh3.googleusercontent.com/-pXxp-HXKY6M/AAAAAAAAAAI/AAAAAAAAAek/8dBEqVT6p0I/s512-c/photo.jpg" /></author><thr:total>0</thr:total><feedburner:origLink>http://ovariancancerandus.blogspot.com/2012/02/humoral-response-to-catumaxomab.html</feedburner:origLink></entry><entry><id>tag:blogger.com,1999:blog-9029913.post-830973116742855783</id><published>2012-02-26T22:18:00.001-05:00</published><updated>2012-02-26T22:18:48.374-05:00</updated><category scheme="http://www.blogger.com/atom/ns#" term="smoking" /><category scheme="http://www.blogger.com/atom/ns#" term="mucinous" /><title type="text">Cigarette smoking and risk of histological subtypes of epithelial ovarian cancer in the EPIC... - Abstract - UK PubMed Central</title><content type="html">"The results from the EPIC study add further evidence that smoking increases risk of mucinous ovarian cancer and support the notion that the effect of smoking varies according to histological...&lt;br/&gt;
&lt;br/&gt;
Ovarian Cancer? What You Need to Know&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?a=FOLSabDBbLo:PICnjQH1yGI:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?a=FOLSabDBbLo:PICnjQH1yGI:63t7Ie-LG7Y"&gt;&lt;img src="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?d=63t7Ie-LG7Y" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?a=FOLSabDBbLo:PICnjQH1yGI:4cEx4HpKnUU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?i=FOLSabDBbLo:PICnjQH1yGI:4cEx4HpKnUU" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/OvarianCancerAndUs/~4/FOLSabDBbLo" height="1" width="1"/&gt;</content><link rel="related" href="http://ukpmc.ac.uk/abstract/MED/21678398/reload=0;jsessionid=3h8nqVgy0deWAhUjbQhp.0" title="Cigarette smoking and risk of histological subtypes of epithelial ovarian cancer in the EPIC... - Abstract - UK PubMed Central" /><link rel="replies" type="application/atom+xml" href="http://ovariancancerandus.blogspot.com/feeds/830973116742855783/comments/default" title="Post Comments" /><link rel="replies" type="text/html" href="http://ovariancancerandus.blogspot.com/2012/02/cigarette-smoking-and-risk-of.html#comment-form" title="0 Comments" /><link rel="edit" type="application/atom+xml" href="http://www.blogger.com/feeds/9029913/posts/default/830973116742855783" /><link rel="self" type="application/atom+xml" href="http://www.blogger.com/feeds/9029913/posts/default/830973116742855783" /><link rel="alternate" type="text/html" href="http://feedproxy.google.com/~r/OvarianCancerAndUs/~3/FOLSabDBbLo/cigarette-smoking-and-risk-of.html" title="Cigarette smoking and risk of histological subtypes of epithelial ovarian cancer in the EPIC... - Abstract - UK PubMed Central" /><author><name>Sandi Pniauskas</name><uri>https://profiles.google.com/104150638679323605960</uri><email>noreply@blogger.com</email><gd:image rel="http://schemas.google.com/g/2005#thumbnail" width="32" height="32" src="//lh3.googleusercontent.com/-pXxp-HXKY6M/AAAAAAAAAAI/AAAAAAAAAek/8dBEqVT6p0I/s512-c/photo.jpg" /></author><thr:total>0</thr:total><feedburner:origLink>http://ovariancancerandus.blogspot.com/2012/02/cigarette-smoking-and-risk-of.html</feedburner:origLink></entry><entry><id>tag:blogger.com,1999:blog-9029913.post-4050205144882348925</id><published>2012-02-26T22:07:00.001-05:00</published><updated>2012-02-26T22:07:43.276-05:00</updated><category scheme="http://www.blogger.com/atom/ns#" term="stem cells" /><title type="text">Ovarian Stem Cells Edge Closer to Reality (CME/CE)</title><content type="html">Ovarian Stem Cells Edge Closer to Reality (CME/CE)
(MedPage Today) -- Primitive germline stem cells isolated from human ovaries produced oocytes in vitro, supporting the concept that women continue...&lt;br/&gt;
&lt;br/&gt;
Ovarian Cancer? What You Need to Know&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?a=RPlW2_FbSHw:Nrs4Xb439qs:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?a=RPlW2_FbSHw:Nrs4Xb439qs:63t7Ie-LG7Y"&gt;&lt;img src="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?d=63t7Ie-LG7Y" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?a=RPlW2_FbSHw:Nrs4Xb439qs:4cEx4HpKnUU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?i=RPlW2_FbSHw:Nrs4Xb439qs:4cEx4HpKnUU" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/OvarianCancerAndUs/~4/RPlW2_FbSHw" height="1" width="1"/&gt;</content><link rel="related" href="http://www.medpagetoday.com/HematologyOncology/OvarianCancer/31364" title="Ovarian Stem Cells Edge Closer to Reality (CME/CE)" /><link rel="replies" type="application/atom+xml" href="http://ovariancancerandus.blogspot.com/feeds/4050205144882348925/comments/default" title="Post Comments" /><link rel="replies" type="text/html" href="http://ovariancancerandus.blogspot.com/2012/02/ovarian-stem-cells-edge-closer-to.html#comment-form" title="0 Comments" /><link rel="edit" type="application/atom+xml" href="http://www.blogger.com/feeds/9029913/posts/default/4050205144882348925" /><link rel="self" type="application/atom+xml" href="http://www.blogger.com/feeds/9029913/posts/default/4050205144882348925" /><link rel="alternate" type="text/html" href="http://feedproxy.google.com/~r/OvarianCancerAndUs/~3/RPlW2_FbSHw/ovarian-stem-cells-edge-closer-to.html" title="Ovarian Stem Cells Edge Closer to Reality (CME/CE)" /><author><name>Sandi Pniauskas</name><uri>https://profiles.google.com/104150638679323605960</uri><email>noreply@blogger.com</email><gd:image rel="http://schemas.google.com/g/2005#thumbnail" width="32" height="32" src="//lh3.googleusercontent.com/-pXxp-HXKY6M/AAAAAAAAAAI/AAAAAAAAAek/8dBEqVT6p0I/s512-c/photo.jpg" /></author><thr:total>0</thr:total><feedburner:origLink>http://ovariancancerandus.blogspot.com/2012/02/ovarian-stem-cells-edge-closer-to.html</feedburner:origLink></entry><entry><id>tag:blogger.com,1999:blog-9029913.post-6385541817067968141</id><published>2012-02-26T22:05:00.001-05:00</published><updated>2012-02-26T22:06:06.686-05:00</updated><category scheme="http://www.blogger.com/atom/ns#" term="data collection" /><category scheme="http://www.blogger.com/atom/ns#" term="hospital comparisons" /><title type="text">Medicare's Hospital Web Site Reeks Of The DMV - Forbes</title><content type="html">"....You’d like to know the answer to a simple question. “If I ever have a  heart attack where should I tell the ambulance to take me?”....http://ovariancancerandus.blogspot.com/feeds/posts/default&lt;br/&gt;
&lt;br/&gt;
Ovarian Cancer? What You Need to Know&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?a=CfIj57Gnsf4:LDzqdqUKX30:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?a=CfIj57Gnsf4:LDzqdqUKX30:63t7Ie-LG7Y"&gt;&lt;img src="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?d=63t7Ie-LG7Y" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?a=CfIj57Gnsf4:LDzqdqUKX30:4cEx4HpKnUU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?i=CfIj57Gnsf4:LDzqdqUKX30:4cEx4HpKnUU" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/OvarianCancerAndUs/~4/CfIj57Gnsf4" height="1" width="1"/&gt;</content><link rel="related" href="http://www.forbes.com/sites/davidwhelan/2012/02/26/medicares-hospital-web-site-reeks-of-the-dmv/" title="Medicare's Hospital Web Site Reeks Of The DMV - Forbes" /><link rel="replies" type="application/atom+xml" href="http://ovariancancerandus.blogspot.com/feeds/6385541817067968141/comments/default" title="Post Comments" /><link rel="replies" type="text/html" href="http://ovariancancerandus.blogspot.com/2012/02/medicares-hospital-web-site-reeks-of.html#comment-form" title="0 Comments" /><link rel="edit" type="application/atom+xml" href="http://www.blogger.com/feeds/9029913/posts/default/6385541817067968141" /><link rel="self" type="application/atom+xml" href="http://www.blogger.com/feeds/9029913/posts/default/6385541817067968141" /><link rel="alternate" type="text/html" href="http://feedproxy.google.com/~r/OvarianCancerAndUs/~3/CfIj57Gnsf4/medicares-hospital-web-site-reeks-of.html" title="Medicare's Hospital Web Site Reeks Of The DMV - Forbes" /><author><name>Sandi Pniauskas</name><uri>https://profiles.google.com/104150638679323605960</uri><email>noreply@blogger.com</email><gd:image rel="http://schemas.google.com/g/2005#thumbnail" width="32" height="32" src="//lh3.googleusercontent.com/-pXxp-HXKY6M/AAAAAAAAAAI/AAAAAAAAAek/8dBEqVT6p0I/s512-c/photo.jpg" /></author><thr:total>0</thr:total><feedburner:origLink>http://ovariancancerandus.blogspot.com/2012/02/medicares-hospital-web-site-reeks-of.html</feedburner:origLink></entry><entry><id>tag:blogger.com,1999:blog-9029913.post-7194955987165800886</id><published>2012-02-26T08:00:00.001-05:00</published><updated>2012-02-26T22:01:19.795-05:00</updated><category scheme="http://www.blogger.com/atom/ns#" term="language" /><title type="text">The Language of He’s  ('Cancer-Dancer')</title><content type="html">http://www.cancer-dancer.org/blog-post/2747/the-language-of-hes/


The Language of He’s:


Him: So, uh, how are you. You know?
He: Pretty good.
Him: So, good?
He: Yeah. I guess. You know.
Him:...&lt;br/&gt;
&lt;br/&gt;
Ovarian Cancer? What You Need to Know&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?a=a9hIg4Yznr0:FQH2qOImgxE:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?a=a9hIg4Yznr0:FQH2qOImgxE:63t7Ie-LG7Y"&gt;&lt;img src="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?d=63t7Ie-LG7Y" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?a=a9hIg4Yznr0:FQH2qOImgxE:4cEx4HpKnUU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?i=a9hIg4Yznr0:FQH2qOImgxE:4cEx4HpKnUU" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/OvarianCancerAndUs/~4/a9hIg4Yznr0" height="1" width="1"/&gt;</content><link rel="related" href="http://www.cancer-dancer.org/blog-post/2747/the-language-of-hes/" title="The Language of He’s  ('Cancer-Dancer')" /><link rel="replies" type="application/atom+xml" href="http://ovariancancerandus.blogspot.com/feeds/7194955987165800886/comments/default" title="Post Comments" /><link rel="replies" type="text/html" href="http://ovariancancerandus.blogspot.com/2012/02/language-of-hes.html#comment-form" title="0 Comments" /><link rel="edit" type="application/atom+xml" href="http://www.blogger.com/feeds/9029913/posts/default/7194955987165800886" /><link rel="self" type="application/atom+xml" href="http://www.blogger.com/feeds/9029913/posts/default/7194955987165800886" /><link rel="alternate" type="text/html" href="http://feedproxy.google.com/~r/OvarianCancerAndUs/~3/a9hIg4Yznr0/language-of-hes.html" title="The Language of He’s  ('Cancer-Dancer')" /><author><name>Sandi Pniauskas</name><uri>https://profiles.google.com/104150638679323605960</uri><email>noreply@blogger.com</email><gd:image rel="http://schemas.google.com/g/2005#thumbnail" width="32" height="32" src="//lh3.googleusercontent.com/-pXxp-HXKY6M/AAAAAAAAAAI/AAAAAAAAAek/8dBEqVT6p0I/s512-c/photo.jpg" /></author><thr:total>0</thr:total><feedburner:origLink>http://ovariancancerandus.blogspot.com/2012/02/language-of-hes.html</feedburner:origLink></entry><entry><id>tag:blogger.com,1999:blog-9029913.post-4585215472516599965</id><published>2012-02-26T07:54:00.002-05:00</published><updated>2012-02-26T08:01:43.253-05:00</updated><category scheme="http://www.blogger.com/atom/ns#" term="breast cancer" /><title type="text">abstract: Controlling angiogenesis in breast cancer: A systematic review of anti-angiogenic trials</title><content type="html">Controlling angiogenesis in breast cancer: A systematic review of anti-angiogenic trials

Source: Cancer Treatment Reviews

Purpose
Angiogenesis is critical for tumor growth and a promising...&lt;br/&gt;
&lt;br/&gt;
Ovarian Cancer? What You Need to Know&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?a=pbW6C0nmrXg:6EvNLidUTBk:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?a=pbW6C0nmrXg:6EvNLidUTBk:63t7Ie-LG7Y"&gt;&lt;img src="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?d=63t7Ie-LG7Y" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?a=pbW6C0nmrXg:6EvNLidUTBk:4cEx4HpKnUU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?i=pbW6C0nmrXg:6EvNLidUTBk:4cEx4HpKnUU" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/OvarianCancerAndUs/~4/pbW6C0nmrXg" height="1" width="1"/&gt;</content><link rel="related" href="http://www.sciencedirect.com/science?_ob=GatewayURL&amp;_origin=IRSSCONTENT&amp;_method=citationSearch&amp;_piikey=S0305737211002519&amp;_version=1&amp;md5=ce5fc1239d93ffb2fe5503c47bea1937" title="abstract: Controlling angiogenesis in breast cancer: A systematic review of anti-angiogenic trials" /><link rel="replies" type="application/atom+xml" href="http://ovariancancerandus.blogspot.com/feeds/4585215472516599965/comments/default" title="Post Comments" /><link rel="replies" type="text/html" href="http://ovariancancerandus.blogspot.com/2012/02/controlling-angiogenesis-in-breast.html#comment-form" title="0 Comments" /><link rel="edit" type="application/atom+xml" href="http://www.blogger.com/feeds/9029913/posts/default/4585215472516599965" /><link rel="self" type="application/atom+xml" href="http://www.blogger.com/feeds/9029913/posts/default/4585215472516599965" /><link rel="alternate" type="text/html" href="http://feedproxy.google.com/~r/OvarianCancerAndUs/~3/pbW6C0nmrXg/controlling-angiogenesis-in-breast.html" title="abstract: Controlling angiogenesis in breast cancer: A systematic review of anti-angiogenic trials" /><author><name>Sandi Pniauskas</name><uri>https://profiles.google.com/104150638679323605960</uri><email>noreply@blogger.com</email><gd:image rel="http://schemas.google.com/g/2005#thumbnail" width="32" height="32" src="//lh3.googleusercontent.com/-pXxp-HXKY6M/AAAAAAAAAAI/AAAAAAAAAek/8dBEqVT6p0I/s512-c/photo.jpg" /></author><thr:total>0</thr:total><feedburner:origLink>http://ovariancancerandus.blogspot.com/2012/02/controlling-angiogenesis-in-breast.html</feedburner:origLink></entry><entry><id>tag:blogger.com,1999:blog-9029913.post-4834152696238046793</id><published>2012-02-26T07:38:00.002-05:00</published><updated>2012-02-26T07:54:41.124-05:00</updated><category scheme="http://www.blogger.com/atom/ns#" term="seth's blog" /><title type="text">Seth's Blog: Stick to what you (don't) know</title><content type="html">Stick to what you (don't) knowOne of the dumbest forms of criticism is to shout down an expert in one field who speaks up about something else. The actor with a political point of view, or the...&lt;br/&gt;
&lt;br/&gt;
Ovarian Cancer? What You Need to Know&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?a=qits902IxoY:eDJ0uqqQ_MA:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?a=qits902IxoY:eDJ0uqqQ_MA:63t7Ie-LG7Y"&gt;&lt;img src="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?d=63t7Ie-LG7Y" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?a=qits902IxoY:eDJ0uqqQ_MA:4cEx4HpKnUU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?i=qits902IxoY:eDJ0uqqQ_MA:4cEx4HpKnUU" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/OvarianCancerAndUs/~4/qits902IxoY" height="1" width="1"/&gt;</content><link rel="related" href="http://sethgodin.typepad.com/seths_blog/2012/02/stick-to-what-you-dont-know.html?utm_source=feedburner&amp;utm_medium=feed&amp;utm_campaign=Feed%3A+typepad%2Fsethsmainblog+%28Seth%27s+Blog%29&amp;utm_content=Google+Reader" title="Seth's Blog: Stick to what you (don't) know" /><link rel="replies" type="application/atom+xml" href="http://ovariancancerandus.blogspot.com/feeds/4834152696238046793/comments/default" title="Post Comments" /><link rel="replies" type="text/html" href="http://ovariancancerandus.blogspot.com/2012/02/seths-blog-stick-to-what-you-dont-know.html#comment-form" title="0 Comments" /><link rel="edit" type="application/atom+xml" href="http://www.blogger.com/feeds/9029913/posts/default/4834152696238046793" /><link rel="self" type="application/atom+xml" href="http://www.blogger.com/feeds/9029913/posts/default/4834152696238046793" /><link rel="alternate" type="text/html" href="http://feedproxy.google.com/~r/OvarianCancerAndUs/~3/qits902IxoY/seths-blog-stick-to-what-you-dont-know.html" title="Seth's Blog: Stick to what you (don't) know" /><author><name>Sandi Pniauskas</name><uri>https://profiles.google.com/104150638679323605960</uri><email>noreply@blogger.com</email><gd:image rel="http://schemas.google.com/g/2005#thumbnail" width="32" height="32" src="//lh3.googleusercontent.com/-pXxp-HXKY6M/AAAAAAAAAAI/AAAAAAAAAek/8dBEqVT6p0I/s512-c/photo.jpg" /></author><thr:total>0</thr:total><feedburner:origLink>http://ovariancancerandus.blogspot.com/2012/02/seths-blog-stick-to-what-you-dont-know.html</feedburner:origLink></entry><entry><id>tag:blogger.com,1999:blog-9029913.post-2156291777397438104</id><published>2012-02-25T23:09:00.004-05:00</published><updated>2012-02-25T23:15:04.733-05:00</updated><category scheme="http://www.blogger.com/atom/ns#" term="Canada" /><category scheme="http://www.blogger.com/atom/ns#" term="supplements" /><category scheme="http://www.blogger.com/atom/ns#" term="warnings" /><title type="text">UPDATE: Additional Web sites Selling MMS Sodium Chlorite Solution Not Authorized for Oral Consumption by Humans - Health Canada Advisory 2012-02-23</title><content type="html">......Health Canada would also like to remind Canadians that there are no therapeutic products containing sodium chlorite authorized for oral consumption by humans. MMS may cause serious health...&lt;br/&gt;
&lt;br/&gt;
Ovarian Cancer? What You Need to Know&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?a=J6Rv4WsMvM4:3NdYzHg1QIQ:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?a=J6Rv4WsMvM4:3NdYzHg1QIQ:63t7Ie-LG7Y"&gt;&lt;img src="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?d=63t7Ie-LG7Y" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?a=J6Rv4WsMvM4:3NdYzHg1QIQ:4cEx4HpKnUU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?i=J6Rv4WsMvM4:3NdYzHg1QIQ:4cEx4HpKnUU" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/OvarianCancerAndUs/~4/J6Rv4WsMvM4" height="1" width="1"/&gt;</content><link rel="related" href="http://www.hc-sc.gc.ca/ahc-asc/media/advisories-avis/_2012/2012_27-eng.php" title="UPDATE: Additional Web sites Selling MMS Sodium Chlorite Solution Not Authorized for Oral Consumption by Humans - Health Canada Advisory 2012-02-23" /><link rel="replies" type="application/atom+xml" href="http://ovariancancerandus.blogspot.com/feeds/2156291777397438104/comments/default" title="Post Comments" /><link rel="replies" type="text/html" href="http://ovariancancerandus.blogspot.com/2012/02/update-additional-web-sites-selling-mms.html#comment-form" title="0 Comments" /><link rel="edit" type="application/atom+xml" href="http://www.blogger.com/feeds/9029913/posts/default/2156291777397438104" /><link rel="self" type="application/atom+xml" href="http://www.blogger.com/feeds/9029913/posts/default/2156291777397438104" /><link rel="alternate" type="text/html" href="http://feedproxy.google.com/~r/OvarianCancerAndUs/~3/J6Rv4WsMvM4/update-additional-web-sites-selling-mms.html" title="UPDATE: Additional Web sites Selling MMS Sodium Chlorite Solution Not Authorized for Oral Consumption by Humans - Health Canada Advisory 2012-02-23" /><author><name>Sandi Pniauskas</name><uri>https://profiles.google.com/104150638679323605960</uri><email>noreply@blogger.com</email><gd:image rel="http://schemas.google.com/g/2005#thumbnail" width="32" height="32" src="//lh3.googleusercontent.com/-pXxp-HXKY6M/AAAAAAAAAAI/AAAAAAAAAek/8dBEqVT6p0I/s512-c/photo.jpg" /></author><thr:total>0</thr:total><feedburner:origLink>http://ovariancancerandus.blogspot.com/2012/02/update-additional-web-sites-selling-mms.html</feedburner:origLink></entry><entry><id>tag:blogger.com,1999:blog-9029913.post-8626294902245911538</id><published>2012-02-25T19:25:00.001-05:00</published><updated>2012-02-26T07:00:27.964-05:00</updated><category scheme="http://www.blogger.com/atom/ns#" term="disease drug comparisons" /><category scheme="http://www.blogger.com/atom/ns#" term="drug effectiveness" /><category scheme="http://www.blogger.com/atom/ns#" term="personalized medicine" /><title type="text">Advancing personalized medicine: Tailoring drugs to fit a patient's genetic predisposition</title><content type="html">(note: see chart on website)

Drug effectiveness on common diseases Not all drugs are equally  effective in all patients. Some types of drugs, such as analgesics,
are  effective on almost all...&lt;br/&gt;
&lt;br/&gt;
Ovarian Cancer? What You Need to Know&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?a=R9PfarvRMiE:d5aJQ_EgHXw:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?a=R9PfarvRMiE:d5aJQ_EgHXw:63t7Ie-LG7Y"&gt;&lt;img src="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?d=63t7Ie-LG7Y" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?a=R9PfarvRMiE:d5aJQ_EgHXw:4cEx4HpKnUU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?i=R9PfarvRMiE:d5aJQ_EgHXw:4cEx4HpKnUU" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/OvarianCancerAndUs/~4/R9PfarvRMiE" height="1" width="1"/&gt;</content><link rel="related" href="http://www.sciencedaily.com/releases/2012/02/120224152755.htm?utm_source=feedburner&amp;utm_medium=feed&amp;utm_campaign=Feed%3A+sciencedaily+%28ScienceDaily%3A+Latest+Science+News%29&amp;utm_content=Google+Reader" title="Advancing personalized medicine: Tailoring drugs to fit a patient's genetic predisposition" /><link rel="replies" type="application/atom+xml" href="http://ovariancancerandus.blogspot.com/feeds/8626294902245911538/comments/default" title="Post Comments" /><link rel="replies" type="text/html" href="http://ovariancancerandus.blogspot.com/2012/02/advancing-personalized-medicine.html#comment-form" title="0 Comments" /><link rel="edit" type="application/atom+xml" href="http://www.blogger.com/feeds/9029913/posts/default/8626294902245911538" /><link rel="self" type="application/atom+xml" href="http://www.blogger.com/feeds/9029913/posts/default/8626294902245911538" /><link rel="alternate" type="text/html" href="http://feedproxy.google.com/~r/OvarianCancerAndUs/~3/R9PfarvRMiE/advancing-personalized-medicine.html" title="Advancing personalized medicine: Tailoring drugs to fit a patient's genetic predisposition" /><author><name>Sandi Pniauskas</name><uri>https://profiles.google.com/104150638679323605960</uri><email>noreply@blogger.com</email><gd:image rel="http://schemas.google.com/g/2005#thumbnail" width="32" height="32" src="//lh3.googleusercontent.com/-pXxp-HXKY6M/AAAAAAAAAAI/AAAAAAAAAek/8dBEqVT6p0I/s512-c/photo.jpg" /></author><thr:total>0</thr:total><feedburner:origLink>http://ovariancancerandus.blogspot.com/2012/02/advancing-personalized-medicine.html</feedburner:origLink></entry><entry><id>tag:blogger.com,1999:blog-9029913.post-5519183389734609831</id><published>2012-02-25T19:12:00.001-05:00</published><updated>2012-02-25T19:18:48.384-05:00</updated><category scheme="http://www.blogger.com/atom/ns#" term="second cancers" /><category scheme="http://www.blogger.com/atom/ns#" term="metachronous" /><category scheme="http://www.blogger.com/atom/ns#" term="Japan" /><title type="text">abstract: Incidence of metachronous second primary cancers in Osaka, Japan: update of analyses using population-based cancer registry data</title><content type="html">Incidence of metachronous second primary cancers in Osaka, Japan: update of analyses using population-based cancer registry data: 
(define: metachronous - Two or more cancers appearing at different...&lt;br/&gt;
&lt;br/&gt;
Ovarian Cancer? What You Need to Know&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?a=ikK7ekFy1pU:IPV2MXpQ8hA:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?a=ikK7ekFy1pU:IPV2MXpQ8hA:63t7Ie-LG7Y"&gt;&lt;img src="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?d=63t7Ie-LG7Y" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?a=ikK7ekFy1pU:IPV2MXpQ8hA:4cEx4HpKnUU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?i=ikK7ekFy1pU:IPV2MXpQ8hA:4cEx4HpKnUU" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/OvarianCancerAndUs/~4/ikK7ekFy1pU" height="1" width="1"/&gt;</content><link rel="related" href="http://dx.doi.org/10.1111%2Fj.1349-7006.2012.02254.x" title="abstract: Incidence of metachronous second primary cancers in Osaka, Japan: update of analyses using population-based cancer registry data" /><link rel="replies" type="application/atom+xml" href="http://ovariancancerandus.blogspot.com/feeds/5519183389734609831/comments/default" title="Post Comments" /><link rel="replies" type="text/html" href="http://ovariancancerandus.blogspot.com/2012/02/abstract-incidence-of-metachronous.html#comment-form" title="0 Comments" /><link rel="edit" type="application/atom+xml" href="http://www.blogger.com/feeds/9029913/posts/default/5519183389734609831" /><link rel="self" type="application/atom+xml" href="http://www.blogger.com/feeds/9029913/posts/default/5519183389734609831" /><link rel="alternate" type="text/html" href="http://feedproxy.google.com/~r/OvarianCancerAndUs/~3/ikK7ekFy1pU/abstract-incidence-of-metachronous.html" title="abstract: Incidence of metachronous second primary cancers in Osaka, Japan: update of analyses using population-based cancer registry data" /><author><name>Sandi Pniauskas</name><uri>https://profiles.google.com/104150638679323605960</uri><email>noreply@blogger.com</email><gd:image rel="http://schemas.google.com/g/2005#thumbnail" width="32" height="32" src="//lh3.googleusercontent.com/-pXxp-HXKY6M/AAAAAAAAAAI/AAAAAAAAAek/8dBEqVT6p0I/s512-c/photo.jpg" /></author><thr:total>0</thr:total><feedburner:origLink>http://ovariancancerandus.blogspot.com/2012/02/abstract-incidence-of-metachronous.html</feedburner:origLink></entry><entry><id>tag:blogger.com,1999:blog-9029913.post-497753424127705327</id><published>2012-02-25T18:57:00.002-05:00</published><updated>2012-02-25T18:59:46.312-05:00</updated><category scheme="http://www.blogger.com/atom/ns#" term="CA-125" /><category scheme="http://www.blogger.com/atom/ns#" term="endometriosis" /><category scheme="http://www.blogger.com/atom/ns#" term="CA125" /><title type="text">abstract: Different Levels of Sialyl-Tn Antigen Expressed on MUC16 in Patients With Endometriosis and Ovarian Cancer</title><content type="html">Different Levels of Sialyl-Tn Antigen Expressed on MUC16 in Patients With Endometriosis and Ovarian Cancer

Abstract:

Objective: 
Although CA125 antigen is a useful marker for ovarian cancer, its...&lt;br/&gt;
&lt;br/&gt;
Ovarian Cancer? What You Need to Know&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?a=_EBe1FWzWWQ:ye2otSwsUUU:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?a=_EBe1FWzWWQ:ye2otSwsUUU:63t7Ie-LG7Y"&gt;&lt;img src="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?d=63t7Ie-LG7Y" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?a=_EBe1FWzWWQ:ye2otSwsUUU:4cEx4HpKnUU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?i=_EBe1FWzWWQ:ye2otSwsUUU:4cEx4HpKnUU" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/OvarianCancerAndUs/~4/_EBe1FWzWWQ" height="1" width="1"/&gt;</content><link rel="related" href="http://pdfs.journals.lww.com/ijgc/9000/00000/Different_Levels_of_Sialyl_Tn_Antigen_Expressed_on.99550.pdf" title="abstract: Different Levels of Sialyl-Tn Antigen Expressed on MUC16 in Patients With Endometriosis and Ovarian Cancer" /><link rel="replies" type="application/atom+xml" href="http://ovariancancerandus.blogspot.com/feeds/497753424127705327/comments/default" title="Post Comments" /><link rel="replies" type="text/html" href="http://ovariancancerandus.blogspot.com/2012/02/abstract-different-levels-of-sialyl-tn.html#comment-form" title="0 Comments" /><link rel="edit" type="application/atom+xml" href="http://www.blogger.com/feeds/9029913/posts/default/497753424127705327" /><link rel="self" type="application/atom+xml" href="http://www.blogger.com/feeds/9029913/posts/default/497753424127705327" /><link rel="alternate" type="text/html" href="http://feedproxy.google.com/~r/OvarianCancerAndUs/~3/_EBe1FWzWWQ/abstract-different-levels-of-sialyl-tn.html" title="abstract: Different Levels of Sialyl-Tn Antigen Expressed on MUC16 in Patients With Endometriosis and Ovarian Cancer" /><author><name>Sandi Pniauskas</name><uri>https://profiles.google.com/104150638679323605960</uri><email>noreply@blogger.com</email><gd:image rel="http://schemas.google.com/g/2005#thumbnail" width="32" height="32" src="//lh3.googleusercontent.com/-pXxp-HXKY6M/AAAAAAAAAAI/AAAAAAAAAek/8dBEqVT6p0I/s512-c/photo.jpg" /></author><thr:total>0</thr:total><feedburner:origLink>http://ovariancancerandus.blogspot.com/2012/02/abstract-different-levels-of-sialyl-tn.html</feedburner:origLink></entry><entry><id>tag:blogger.com,1999:blog-9029913.post-1452755696430637660</id><published>2012-02-25T18:42:00.000-05:00</published><updated>2012-02-26T06:23:25.197-05:00</updated><category scheme="http://www.blogger.com/atom/ns#" term="residual disease" /><category scheme="http://www.blogger.com/atom/ns#" term="ovarian cancer surgery" /><category scheme="http://www.blogger.com/atom/ns#" term="history of ovarian cancer surgery" /><category scheme="http://www.blogger.com/atom/ns#" term="treatment outcomes" /><title type="text">abstract: Evolution of surgical treatment paradigms for advanced-stage ovarian cancer: Redefining ‘optimal’ residual disease</title><content type="html">Evolution of surgical treatment paradigms for advanced-stage ovarian cancer: Redefining ‘optimal’ residual disease

Abstract:

Over the past 40 years, the survival of patients with advanced ovarian...&lt;br/&gt;
&lt;br/&gt;
Ovarian Cancer? What You Need to Know&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?a=-zkEVkRjYVs:r-iPbERPaJg:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?a=-zkEVkRjYVs:r-iPbERPaJg:63t7Ie-LG7Y"&gt;&lt;img src="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?d=63t7Ie-LG7Y" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?a=-zkEVkRjYVs:r-iPbERPaJg:4cEx4HpKnUU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?i=-zkEVkRjYVs:r-iPbERPaJg:4cEx4HpKnUU" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/OvarianCancerAndUs/~4/-zkEVkRjYVs" height="1" width="1"/&gt;</content><link rel="related" href="http://www.sciencedirect.com/science?_ob=GatewayURL&amp;_origin=IRSSCONTENT&amp;_method=citationSearch&amp;_piikey=S0090825812001503&amp;_version=1&amp;md5=f2b38fab13b6a7bd9730598bf1fbe839" title="abstract: Evolution of surgical treatment paradigms for advanced-stage ovarian cancer: Redefining ‘optimal’ residual disease" /><link rel="replies" type="application/atom+xml" href="http://ovariancancerandus.blogspot.com/feeds/1452755696430637660/comments/default" title="Post Comments" /><link rel="replies" type="text/html" href="http://ovariancancerandus.blogspot.com/2012/02/abstract-evolution-of-surgical.html#comment-form" title="0 Comments" /><link rel="edit" type="application/atom+xml" href="http://www.blogger.com/feeds/9029913/posts/default/1452755696430637660" /><link rel="self" type="application/atom+xml" href="http://www.blogger.com/feeds/9029913/posts/default/1452755696430637660" /><link rel="alternate" type="text/html" href="http://feedproxy.google.com/~r/OvarianCancerAndUs/~3/-zkEVkRjYVs/abstract-evolution-of-surgical.html" title="abstract: Evolution of surgical treatment paradigms for advanced-stage ovarian cancer: Redefining ‘optimal’ residual disease" /><author><name>Sandi Pniauskas</name><uri>https://profiles.google.com/104150638679323605960</uri><email>noreply@blogger.com</email><gd:image rel="http://schemas.google.com/g/2005#thumbnail" width="32" height="32" src="//lh3.googleusercontent.com/-pXxp-HXKY6M/AAAAAAAAAAI/AAAAAAAAAek/8dBEqVT6p0I/s512-c/photo.jpg" /></author><thr:total>0</thr:total><feedburner:origLink>http://ovariancancerandus.blogspot.com/2012/02/abstract-evolution-of-surgical.html</feedburner:origLink></entry><entry><id>tag:blogger.com,1999:blog-9029913.post-2854244269712048210</id><published>2012-02-25T18:31:00.001-05:00</published><updated>2012-02-25T18:33:21.151-05:00</updated><category scheme="http://www.blogger.com/atom/ns#" term="video-assisted thoracic surgery" /><category scheme="http://www.blogger.com/atom/ns#" term="pleural effusion" /><category scheme="http://www.blogger.com/atom/ns#" term="surgery" /><title type="text">Outcomes of Patients with Gynecologic Malignancies Undergoing Video-Assisted Thoracoscopic Surgery (VATS) and Pleurodesis for Malignant Pleural Effusion</title><content type="html">Outcomes of Patients with Gynecologic Malignancies Undergoing Video-Assisted Thoracoscopic Surgery (VATS) and Pleurodesis for Malignant Pleural Effusion

Background
We evaluated the indications and...&lt;br/&gt;
&lt;br/&gt;
Ovarian Cancer? What You Need to Know&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?a=0S4A0y_k45I:omRndckKHx8:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?a=0S4A0y_k45I:omRndckKHx8:63t7Ie-LG7Y"&gt;&lt;img src="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?d=63t7Ie-LG7Y" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?a=0S4A0y_k45I:omRndckKHx8:4cEx4HpKnUU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?i=0S4A0y_k45I:omRndckKHx8:4cEx4HpKnUU" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/OvarianCancerAndUs/~4/0S4A0y_k45I" height="1" width="1"/&gt;</content><link rel="related" href="http://www.sciencedirect.com/science?_ob=GatewayURL&amp;_origin=IRSSCONTENT&amp;_method=citationSearch&amp;_piikey=S0090825812001552&amp;_version=1&amp;md5=e6dd686568995e31995c34749afd42ad" title="Outcomes of Patients with Gynecologic Malignancies Undergoing Video-Assisted Thoracoscopic Surgery (VATS) and Pleurodesis for Malignant Pleural Effusion" /><link rel="replies" type="application/atom+xml" href="http://ovariancancerandus.blogspot.com/feeds/2854244269712048210/comments/default" title="Post Comments" /><link rel="replies" type="text/html" href="http://ovariancancerandus.blogspot.com/2012/02/outcomes-of-patients-with-gynecologic.html#comment-form" title="0 Comments" /><link rel="edit" type="application/atom+xml" href="http://www.blogger.com/feeds/9029913/posts/default/2854244269712048210" /><link rel="self" type="application/atom+xml" href="http://www.blogger.com/feeds/9029913/posts/default/2854244269712048210" /><link rel="alternate" type="text/html" href="http://feedproxy.google.com/~r/OvarianCancerAndUs/~3/0S4A0y_k45I/outcomes-of-patients-with-gynecologic.html" title="Outcomes of Patients with Gynecologic Malignancies Undergoing Video-Assisted Thoracoscopic Surgery (VATS) and Pleurodesis for Malignant Pleural Effusion" /><author><name>Sandi Pniauskas</name><uri>https://profiles.google.com/104150638679323605960</uri><email>noreply@blogger.com</email><gd:image rel="http://schemas.google.com/g/2005#thumbnail" width="32" height="32" src="//lh3.googleusercontent.com/-pXxp-HXKY6M/AAAAAAAAAAI/AAAAAAAAAek/8dBEqVT6p0I/s512-c/photo.jpg" /></author><thr:total>0</thr:total><feedburner:origLink>http://ovariancancerandus.blogspot.com/2012/02/outcomes-of-patients-with-gynecologic.html</feedburner:origLink></entry><entry><id>tag:blogger.com,1999:blog-9029913.post-6596442938035735263</id><published>2012-02-25T18:17:00.001-05:00</published><updated>2012-02-25T18:24:40.181-05:00</updated><category scheme="http://www.blogger.com/atom/ns#" term="trends" /><category scheme="http://www.blogger.com/atom/ns#" term="Netherlands" /><title type="text">Trends in therapy and survival of advanced stage epithelial ovarian cancer patients in the Netherlands</title><content type="html">Trends in therapy and survival of advanced stage epithelial ovarian cancer patients in the Netherlands


Objective
The aim of this study was to describe trends in survival and therapy in advanced...&lt;br/&gt;
&lt;br/&gt;
Ovarian Cancer? What You Need to Know&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?a=4CQGrocKVcs:CRxaBucCBuE:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?a=4CQGrocKVcs:CRxaBucCBuE:63t7Ie-LG7Y"&gt;&lt;img src="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?d=63t7Ie-LG7Y" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?a=4CQGrocKVcs:CRxaBucCBuE:4cEx4HpKnUU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?i=4CQGrocKVcs:CRxaBucCBuE:4cEx4HpKnUU" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/OvarianCancerAndUs/~4/4CQGrocKVcs" height="1" width="1"/&gt;</content><link rel="related" href="http://www.sciencedirect.com/science?_ob=GatewayURL&amp;_origin=IRSSCONTENT&amp;_method=citationSearch&amp;_piikey=S009082581200159X&amp;_version=1&amp;md5=9ca3b0c9f4a546373dfaf9368a11acf2" title="Trends in therapy and survival of advanced stage epithelial ovarian cancer patients in the Netherlands" /><link rel="replies" type="application/atom+xml" href="http://ovariancancerandus.blogspot.com/feeds/6596442938035735263/comments/default" title="Post Comments" /><link rel="replies" type="text/html" href="http://ovariancancerandus.blogspot.com/2012/02/trends-in-therapy-and-survival-of.html#comment-form" title="0 Comments" /><link rel="edit" type="application/atom+xml" href="http://www.blogger.com/feeds/9029913/posts/default/6596442938035735263" /><link rel="self" type="application/atom+xml" href="http://www.blogger.com/feeds/9029913/posts/default/6596442938035735263" /><link rel="alternate" type="text/html" href="http://feedproxy.google.com/~r/OvarianCancerAndUs/~3/4CQGrocKVcs/trends-in-therapy-and-survival-of.html" title="Trends in therapy and survival of advanced stage epithelial ovarian cancer patients in the Netherlands" /><author><name>Sandi Pniauskas</name><uri>https://profiles.google.com/104150638679323605960</uri><email>noreply@blogger.com</email><gd:image rel="http://schemas.google.com/g/2005#thumbnail" width="32" height="32" src="//lh3.googleusercontent.com/-pXxp-HXKY6M/AAAAAAAAAAI/AAAAAAAAAek/8dBEqVT6p0I/s512-c/photo.jpg" /></author><thr:total>0</thr:total><feedburner:origLink>http://ovariancancerandus.blogspot.com/2012/02/trends-in-therapy-and-survival-of.html</feedburner:origLink></entry><entry><id>tag:blogger.com,1999:blog-9029913.post-9096198485639574977</id><published>2012-02-25T08:37:00.003-05:00</published><updated>2012-02-25T08:39:35.575-05:00</updated><category scheme="http://www.blogger.com/atom/ns#" term="PET/CT" /><category scheme="http://www.blogger.com/atom/ns#" term="MRI" /><title type="text">Diagnostic value of PET/CT is similar to that of conventional MRI and even better for detecting small peritoneal implants in patients with recurrent ovarian cancer.</title><content type="html">CONCLUSION:

The present study revealed that PET/CT is similar to conventional MRI for the detection of recurrent ovarian cancer. PET/CT has greater accuracy in the detection of small-to-medium-sized...&lt;br/&gt;
&lt;br/&gt;
Ovarian Cancer? What You Need to Know&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?a=mmksnWNeCXY:sorquLl_sDM:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?a=mmksnWNeCXY:sorquLl_sDM:63t7Ie-LG7Y"&gt;&lt;img src="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?d=63t7Ie-LG7Y" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?a=mmksnWNeCXY:sorquLl_sDM:4cEx4HpKnUU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?i=mmksnWNeCXY:sorquLl_sDM:4cEx4HpKnUU" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/OvarianCancerAndUs/~4/mmksnWNeCXY" height="1" width="1"/&gt;</content><link rel="related" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?tmpl=NoSidebarfile&amp;db=PubMed&amp;cmd=Retrieve&amp;list_uids=22357440&amp;dopt=Abstract" title="Diagnostic value of PET/CT is similar to that of conventional MRI and even better for detecting small peritoneal implants in patients with recurrent ovarian cancer." /><link rel="replies" type="application/atom+xml" href="http://ovariancancerandus.blogspot.com/feeds/9096198485639574977/comments/default" title="Post Comments" /><link rel="replies" type="text/html" href="http://ovariancancerandus.blogspot.com/2012/02/diagnostic-value-of-petct-is-similar-to.html#comment-form" title="0 Comments" /><link rel="edit" type="application/atom+xml" href="http://www.blogger.com/feeds/9029913/posts/default/9096198485639574977" /><link rel="self" type="application/atom+xml" href="http://www.blogger.com/feeds/9029913/posts/default/9096198485639574977" /><link rel="alternate" type="text/html" href="http://feedproxy.google.com/~r/OvarianCancerAndUs/~3/mmksnWNeCXY/diagnostic-value-of-petct-is-similar-to.html" title="Diagnostic value of PET/CT is similar to that of conventional MRI and even better for detecting small peritoneal implants in patients with recurrent ovarian cancer." /><author><name>Sandi Pniauskas</name><uri>https://profiles.google.com/104150638679323605960</uri><email>noreply@blogger.com</email><gd:image rel="http://schemas.google.com/g/2005#thumbnail" width="32" height="32" src="//lh3.googleusercontent.com/-pXxp-HXKY6M/AAAAAAAAAAI/AAAAAAAAAek/8dBEqVT6p0I/s512-c/photo.jpg" /></author><thr:total>0</thr:total><feedburner:origLink>http://ovariancancerandus.blogspot.com/2012/02/diagnostic-value-of-petct-is-similar-to.html</feedburner:origLink></entry><entry><id>tag:blogger.com,1999:blog-9029913.post-5111179112275891516</id><published>2012-02-25T08:32:00.002-05:00</published><updated>2012-02-25T08:34:15.019-05:00</updated><category scheme="http://www.blogger.com/atom/ns#" term="epimutations" /><category scheme="http://www.blogger.com/atom/ns#" term="Lynch Syndrome" /><title type="text">abstract: Epigenetic epidemiology for cancer risk: harnessing germline epigenetic variation (reference to Lynch Syndrome)</title><content type="html">Abstract
Genetic  epidemiology aims to use the natural variation in the genome, namely  single nucleotide polymorphisms and copy number variants to look for  associations between particular genotypes...&lt;br/&gt;
&lt;br/&gt;
Ovarian Cancer? What You Need to Know&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?a=S-0tuYlzzKM:HvnsZnOjI7s:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?a=S-0tuYlzzKM:HvnsZnOjI7s:63t7Ie-LG7Y"&gt;&lt;img src="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?d=63t7Ie-LG7Y" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?a=S-0tuYlzzKM:HvnsZnOjI7s:4cEx4HpKnUU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?i=S-0tuYlzzKM:HvnsZnOjI7s:4cEx4HpKnUU" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/OvarianCancerAndUs/~4/S-0tuYlzzKM" height="1" width="1"/&gt;</content><link rel="related" href="http://www.ncbi.nlm.nih.gov/pubmed/22359310?dopt=Abstract" title="abstract: Epigenetic epidemiology for cancer risk: harnessing germline epigenetic variation (reference to Lynch Syndrome)" /><link rel="replies" type="application/atom+xml" href="http://ovariancancerandus.blogspot.com/feeds/5111179112275891516/comments/default" title="Post Comments" /><link rel="replies" type="text/html" href="http://ovariancancerandus.blogspot.com/2012/02/abstract-epigenetic-epidemiology-for.html#comment-form" title="0 Comments" /><link rel="edit" type="application/atom+xml" href="http://www.blogger.com/feeds/9029913/posts/default/5111179112275891516" /><link rel="self" type="application/atom+xml" href="http://www.blogger.com/feeds/9029913/posts/default/5111179112275891516" /><link rel="alternate" type="text/html" href="http://feedproxy.google.com/~r/OvarianCancerAndUs/~3/S-0tuYlzzKM/abstract-epigenetic-epidemiology-for.html" title="abstract: Epigenetic epidemiology for cancer risk: harnessing germline epigenetic variation (reference to Lynch Syndrome)" /><author><name>Sandi Pniauskas</name><uri>https://profiles.google.com/104150638679323605960</uri><email>noreply@blogger.com</email><gd:image rel="http://schemas.google.com/g/2005#thumbnail" width="32" height="32" src="//lh3.googleusercontent.com/-pXxp-HXKY6M/AAAAAAAAAAI/AAAAAAAAAek/8dBEqVT6p0I/s512-c/photo.jpg" /></author><thr:total>0</thr:total><feedburner:origLink>http://ovariancancerandus.blogspot.com/2012/02/abstract-epigenetic-epidemiology-for.html</feedburner:origLink></entry><entry><id>tag:blogger.com,1999:blog-9029913.post-299456907514111261</id><published>2012-02-25T07:58:00.002-05:00</published><updated>2012-02-25T08:01:00.069-05:00</updated><category scheme="http://www.blogger.com/atom/ns#" term="Daunorubicin" /><category scheme="http://www.blogger.com/atom/ns#" term="drug shortages" /><title type="text">Drug Shortages &gt; Daunorubicin Hydrochloride Solution for Injection  (updated 2/24/2012)</title><content type="html">"The company cannot estimate a future  release date for more product."http://ovariancancerandus.blogspot.com/feeds/posts/default&lt;br/&gt;
&lt;br/&gt;
Ovarian Cancer? What You Need to Know&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?a=InG8n2K8H5o:CK9Yx_L_TYY:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?a=InG8n2K8H5o:CK9Yx_L_TYY:63t7Ie-LG7Y"&gt;&lt;img src="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?d=63t7Ie-LG7Y" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?a=InG8n2K8H5o:CK9Yx_L_TYY:4cEx4HpKnUU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?i=InG8n2K8H5o:CK9Yx_L_TYY:4cEx4HpKnUU" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/OvarianCancerAndUs/~4/InG8n2K8H5o" height="1" width="1"/&gt;</content><link rel="related" href="http://www.fda.gov/Drugs/DrugSafety/DrugShortages/ucm050792.htm#daunorubicin" title="Drug Shortages &gt; Daunorubicin Hydrochloride Solution for Injection  (updated 2/24/2012)" /><link rel="replies" type="application/atom+xml" href="http://ovariancancerandus.blogspot.com/feeds/299456907514111261/comments/default" title="Post Comments" /><link rel="replies" type="text/html" href="http://ovariancancerandus.blogspot.com/2012/02/drug-shortages-daunorubicin.html#comment-form" title="0 Comments" /><link rel="edit" type="application/atom+xml" href="http://www.blogger.com/feeds/9029913/posts/default/299456907514111261" /><link rel="self" type="application/atom+xml" href="http://www.blogger.com/feeds/9029913/posts/default/299456907514111261" /><link rel="alternate" type="text/html" href="http://feedproxy.google.com/~r/OvarianCancerAndUs/~3/InG8n2K8H5o/drug-shortages-daunorubicin.html" title="Drug Shortages &gt; Daunorubicin Hydrochloride Solution for Injection  (updated 2/24/2012)" /><author><name>Sandi Pniauskas</name><uri>https://profiles.google.com/104150638679323605960</uri><email>noreply@blogger.com</email><gd:image rel="http://schemas.google.com/g/2005#thumbnail" width="32" height="32" src="//lh3.googleusercontent.com/-pXxp-HXKY6M/AAAAAAAAAAI/AAAAAAAAAek/8dBEqVT6p0I/s512-c/photo.jpg" /></author><thr:total>0</thr:total><feedburner:origLink>http://ovariancancerandus.blogspot.com/2012/02/drug-shortages-daunorubicin.html</feedburner:origLink></entry><entry><id>tag:blogger.com,1999:blog-9029913.post-7144482492661824610</id><published>2012-02-25T07:50:00.001-05:00</published><updated>2012-02-25T07:52:51.595-05:00</updated><category scheme="http://www.blogger.com/atom/ns#" term="GOG-0252" /><category scheme="http://www.blogger.com/atom/ns#" term="clinical trials" /><title type="text">Biomarkers in Patients With Previously Untreated Invasive Ovarian Epithelial, Fallopian Tube, or Peritoneal Cancer - Full Text View - ClinicalTrials.gov (GOG-0252)</title><content type="html">Purpose
  RATIONALE: Studying samples of tumor tissue, peritoneal cavity fluid, and blood from patients receiving intraperitoneal chemotherapy may help doctors learn more about the effects of...&lt;br/&gt;
&lt;br/&gt;
Ovarian Cancer? What You Need to Know&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?a=husX2gZdGMQ:wu6B1llMCAg:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?a=husX2gZdGMQ:wu6B1llMCAg:63t7Ie-LG7Y"&gt;&lt;img src="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?d=63t7Ie-LG7Y" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?a=husX2gZdGMQ:wu6B1llMCAg:4cEx4HpKnUU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?i=husX2gZdGMQ:wu6B1llMCAg:4cEx4HpKnUU" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/OvarianCancerAndUs/~4/husX2gZdGMQ" height="1" width="1"/&gt;</content><link rel="related" href="http://clinicaltrials.gov/ct2/show/NCT01295489?term=ovarian+cancer&amp;recr=Open&amp;lup_s=01%2F26%2F2012&amp;lup_d=30" title="Biomarkers in Patients With Previously Untreated Invasive Ovarian Epithelial, Fallopian Tube, or Peritoneal Cancer - Full Text View - ClinicalTrials.gov (GOG-0252)" /><link rel="replies" type="application/atom+xml" href="http://ovariancancerandus.blogspot.com/feeds/7144482492661824610/comments/default" title="Post Comments" /><link rel="replies" type="text/html" href="http://ovariancancerandus.blogspot.com/2012/02/biomarkers-in-patients-with-previously.html#comment-form" title="0 Comments" /><link rel="edit" type="application/atom+xml" href="http://www.blogger.com/feeds/9029913/posts/default/7144482492661824610" /><link rel="self" type="application/atom+xml" href="http://www.blogger.com/feeds/9029913/posts/default/7144482492661824610" /><link rel="alternate" type="text/html" href="http://feedproxy.google.com/~r/OvarianCancerAndUs/~3/husX2gZdGMQ/biomarkers-in-patients-with-previously.html" title="Biomarkers in Patients With Previously Untreated Invasive Ovarian Epithelial, Fallopian Tube, or Peritoneal Cancer - Full Text View - ClinicalTrials.gov (GOG-0252)" /><author><name>Sandi Pniauskas</name><uri>https://profiles.google.com/104150638679323605960</uri><email>noreply@blogger.com</email><gd:image rel="http://schemas.google.com/g/2005#thumbnail" width="32" height="32" src="//lh3.googleusercontent.com/-pXxp-HXKY6M/AAAAAAAAAAI/AAAAAAAAAek/8dBEqVT6p0I/s512-c/photo.jpg" /></author><thr:total>0</thr:total><feedburner:origLink>http://ovariancancerandus.blogspot.com/2012/02/biomarkers-in-patients-with-previously.html</feedburner:origLink></entry><entry><id>tag:blogger.com,1999:blog-9029913.post-3571145020849064709</id><published>2012-02-25T07:47:00.002-05:00</published><updated>2012-02-25T07:48:59.382-05:00</updated><category scheme="http://www.blogger.com/atom/ns#" term="miRNA" /><category scheme="http://www.blogger.com/atom/ns#" term="France" /><category scheme="http://www.blogger.com/atom/ns#" term="clinical trials" /><title type="text">France: Search for Predictors of Therapeutic Response in Ovarian Carcinoma - Full Text View - ClinicalTrials.gov</title><content type="html">Search for Predictors of Therapeutic Response in Ovarian Carcinoma (miRSa)This study is currently recruiting participants.     Verified February 2012 by Centre Francois Baclesse     
First Received...&lt;br/&gt;
&lt;br/&gt;
Ovarian Cancer? What You Need to Know&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?a=E0lq0zd_PzE:gbBPF9UMQiQ:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?a=E0lq0zd_PzE:gbBPF9UMQiQ:63t7Ie-LG7Y"&gt;&lt;img src="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?d=63t7Ie-LG7Y" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?a=E0lq0zd_PzE:gbBPF9UMQiQ:4cEx4HpKnUU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?i=E0lq0zd_PzE:gbBPF9UMQiQ:4cEx4HpKnUU" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/OvarianCancerAndUs/~4/E0lq0zd_PzE" height="1" width="1"/&gt;</content><link rel="related" href="http://clinicaltrials.gov/ct2/show/NCT01391351?term=ovarian+cancer&amp;recr=Open&amp;lup_s=01%2F26%2F2012&amp;lup_d=30" title="France: Search for Predictors of Therapeutic Response in Ovarian Carcinoma - Full Text View - ClinicalTrials.gov" /><link rel="replies" type="application/atom+xml" href="http://ovariancancerandus.blogspot.com/feeds/3571145020849064709/comments/default" title="Post Comments" /><link rel="replies" type="text/html" href="http://ovariancancerandus.blogspot.com/2012/02/france-search-for-predictors-of.html#comment-form" title="0 Comments" /><link rel="edit" type="application/atom+xml" href="http://www.blogger.com/feeds/9029913/posts/default/3571145020849064709" /><link rel="self" type="application/atom+xml" href="http://www.blogger.com/feeds/9029913/posts/default/3571145020849064709" /><link rel="alternate" type="text/html" href="http://feedproxy.google.com/~r/OvarianCancerAndUs/~3/E0lq0zd_PzE/france-search-for-predictors-of.html" title="France: Search for Predictors of Therapeutic Response in Ovarian Carcinoma - Full Text View - ClinicalTrials.gov" /><author><name>Sandi Pniauskas</name><uri>https://profiles.google.com/104150638679323605960</uri><email>noreply@blogger.com</email><gd:image rel="http://schemas.google.com/g/2005#thumbnail" width="32" height="32" src="//lh3.googleusercontent.com/-pXxp-HXKY6M/AAAAAAAAAAI/AAAAAAAAAek/8dBEqVT6p0I/s512-c/photo.jpg" /></author><thr:total>0</thr:total><feedburner:origLink>http://ovariancancerandus.blogspot.com/2012/02/france-search-for-predictors-of.html</feedburner:origLink></entry><entry><id>tag:blogger.com,1999:blog-9029913.post-1393998659489264252</id><published>2012-02-25T07:44:00.001-05:00</published><updated>2012-02-25T07:45:24.483-05:00</updated><category scheme="http://www.blogger.com/atom/ns#" term="oral chemotherapy" /><title type="text">Oral Therapies and Food: To Eat or Not to Eat? - Cancer Network</title><content type="html">"As the treatment of cancer shifts increasingly more toward oral therapies, patients are now partly responsible for when and how they take their medication. Despite the potential for increased...&lt;br/&gt;
&lt;br/&gt;
Ovarian Cancer? What You Need to Know&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?a=AlHyNFfG2aU:TI3vlUpp8T0:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?a=AlHyNFfG2aU:TI3vlUpp8T0:63t7Ie-LG7Y"&gt;&lt;img src="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?d=63t7Ie-LG7Y" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?a=AlHyNFfG2aU:TI3vlUpp8T0:4cEx4HpKnUU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?i=AlHyNFfG2aU:TI3vlUpp8T0:4cEx4HpKnUU" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/OvarianCancerAndUs/~4/AlHyNFfG2aU" height="1" width="1"/&gt;</content><link rel="related" href="http://www.cancernetwork.com/practice/content/article/10165/2037390" title="Oral Therapies and Food: To Eat or Not to Eat? - Cancer Network" /><link rel="replies" type="application/atom+xml" href="http://ovariancancerandus.blogspot.com/feeds/1393998659489264252/comments/default" title="Post Comments" /><link rel="replies" type="text/html" href="http://ovariancancerandus.blogspot.com/2012/02/oral-therapies-and-food-to-eat-or-not.html#comment-form" title="0 Comments" /><link rel="edit" type="application/atom+xml" href="http://www.blogger.com/feeds/9029913/posts/default/1393998659489264252" /><link rel="self" type="application/atom+xml" href="http://www.blogger.com/feeds/9029913/posts/default/1393998659489264252" /><link rel="alternate" type="text/html" href="http://feedproxy.google.com/~r/OvarianCancerAndUs/~3/AlHyNFfG2aU/oral-therapies-and-food-to-eat-or-not.html" title="Oral Therapies and Food: To Eat or Not to Eat? - Cancer Network" /><author><name>Sandi Pniauskas</name><uri>https://profiles.google.com/104150638679323605960</uri><email>noreply@blogger.com</email><gd:image rel="http://schemas.google.com/g/2005#thumbnail" width="32" height="32" src="//lh3.googleusercontent.com/-pXxp-HXKY6M/AAAAAAAAAAI/AAAAAAAAAek/8dBEqVT6p0I/s512-c/photo.jpg" /></author><thr:total>0</thr:total><feedburner:origLink>http://ovariancancerandus.blogspot.com/2012/02/oral-therapies-and-food-to-eat-or-not.html</feedburner:origLink></entry><entry><id>tag:blogger.com,1999:blog-9029913.post-2027272788239730933</id><published>2012-02-25T07:23:00.002-05:00</published><updated>2012-02-25T07:39:04.061-05:00</updated><category scheme="http://www.blogger.com/atom/ns#" term="Canada" /><category scheme="http://www.blogger.com/atom/ns#" term="family practice" /><category scheme="http://www.blogger.com/atom/ns#" term="electronic health records" /><title type="text">open access: Impact of electronic medical record on physician practice in office settings: a systematic review</title><content type="html">Impact of electronic medical record on physician practice in office settings: a systematic review:

The complete article is available as a provisional PDF. The fully formatted PDF and HTML versions...&lt;br/&gt;
&lt;br/&gt;
Ovarian Cancer? What You Need to Know&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?a=MQw0GQALCfg:axOCpbdAsEQ:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?a=MQw0GQALCfg:axOCpbdAsEQ:63t7Ie-LG7Y"&gt;&lt;img src="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?d=63t7Ie-LG7Y" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?a=MQw0GQALCfg:axOCpbdAsEQ:4cEx4HpKnUU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?i=MQw0GQALCfg:axOCpbdAsEQ:4cEx4HpKnUU" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/OvarianCancerAndUs/~4/MQw0GQALCfg" height="1" width="1"/&gt;</content><link rel="related" href="http://www.biomedcentral.com/1472-6947/12/10" title="open access: Impact of electronic medical record on physician practice in office settings: a systematic review" /><link rel="replies" type="application/atom+xml" href="http://ovariancancerandus.blogspot.com/feeds/2027272788239730933/comments/default" title="Post Comments" /><link rel="replies" type="text/html" href="http://ovariancancerandus.blogspot.com/2012/02/open-access-impact-of-electronic.html#comment-form" title="0 Comments" /><link rel="edit" type="application/atom+xml" href="http://www.blogger.com/feeds/9029913/posts/default/2027272788239730933" /><link rel="self" type="application/atom+xml" href="http://www.blogger.com/feeds/9029913/posts/default/2027272788239730933" /><link rel="alternate" type="text/html" href="http://feedproxy.google.com/~r/OvarianCancerAndUs/~3/MQw0GQALCfg/open-access-impact-of-electronic.html" title="open access: Impact of electronic medical record on physician practice in office settings: a systematic review" /><author><name>Sandi Pniauskas</name><uri>https://profiles.google.com/104150638679323605960</uri><email>noreply@blogger.com</email><gd:image rel="http://schemas.google.com/g/2005#thumbnail" width="32" height="32" src="//lh3.googleusercontent.com/-pXxp-HXKY6M/AAAAAAAAAAI/AAAAAAAAAek/8dBEqVT6p0I/s512-c/photo.jpg" /></author><thr:total>0</thr:total><feedburner:origLink>http://ovariancancerandus.blogspot.com/2012/02/open-access-impact-of-electronic.html</feedburner:origLink></entry><entry><id>tag:blogger.com,1999:blog-9029913.post-6327984271500391121</id><published>2012-02-25T06:34:00.001-05:00</published><updated>2012-02-25T06:35:34.009-05:00</updated><category scheme="http://www.blogger.com/atom/ns#" term="grading systems" /><title type="text">abstract: A Binary Histologic Grading System for Ovarian Serous Carcinoma is an Independent Prognostic Factor: A Population-based Study of 4,317 Women diagnosed in Denmark 1978–2006</title><content type="html">A Binary Histologic Grading System for Ovarian Serous Carcinoma is an Independent Prognostic Factor: A Population-based Study of 4,317 Women diagnosed in Denmark 1978–2006

Objective
To evaluate the...&lt;br/&gt;
&lt;br/&gt;
Ovarian Cancer? What You Need to Know&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?a=6EN4_JQ_iqE:xjFjf3pyac0:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?a=6EN4_JQ_iqE:xjFjf3pyac0:63t7Ie-LG7Y"&gt;&lt;img src="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?d=63t7Ie-LG7Y" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?a=6EN4_JQ_iqE:xjFjf3pyac0:4cEx4HpKnUU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?i=6EN4_JQ_iqE:xjFjf3pyac0:4cEx4HpKnUU" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/OvarianCancerAndUs/~4/6EN4_JQ_iqE" height="1" width="1"/&gt;</content><link rel="related" href="http://www.sciencedirect.com/science?_ob=GatewayURL&amp;_origin=IRSSSEARCH&amp;_method=citationSearch&amp;_piikey=S0090825812001540&amp;_version=1&amp;md5=8cc223145231e6a9ed8d3c4c6f38fe91" title="abstract: A Binary Histologic Grading System for Ovarian Serous Carcinoma is an Independent Prognostic Factor: A Population-based Study of 4,317 Women diagnosed in Denmark 1978–2006" /><link rel="replies" type="application/atom+xml" href="http://ovariancancerandus.blogspot.com/feeds/6327984271500391121/comments/default" title="Post Comments" /><link rel="replies" type="text/html" href="http://ovariancancerandus.blogspot.com/2012/02/binary-histologic-grading-system-for.html#comment-form" title="0 Comments" /><link rel="edit" type="application/atom+xml" href="http://www.blogger.com/feeds/9029913/posts/default/6327984271500391121" /><link rel="self" type="application/atom+xml" href="http://www.blogger.com/feeds/9029913/posts/default/6327984271500391121" /><link rel="alternate" type="text/html" href="http://feedproxy.google.com/~r/OvarianCancerAndUs/~3/6EN4_JQ_iqE/binary-histologic-grading-system-for.html" title="abstract: A Binary Histologic Grading System for Ovarian Serous Carcinoma is an Independent Prognostic Factor: A Population-based Study of 4,317 Women diagnosed in Denmark 1978–2006" /><author><name>Sandi Pniauskas</name><uri>https://profiles.google.com/104150638679323605960</uri><email>noreply@blogger.com</email><gd:image rel="http://schemas.google.com/g/2005#thumbnail" width="32" height="32" src="//lh3.googleusercontent.com/-pXxp-HXKY6M/AAAAAAAAAAI/AAAAAAAAAek/8dBEqVT6p0I/s512-c/photo.jpg" /></author><thr:total>0</thr:total><feedburner:origLink>http://ovariancancerandus.blogspot.com/2012/02/binary-histologic-grading-system-for.html</feedburner:origLink></entry><entry><id>tag:blogger.com,1999:blog-9029913.post-3536849322068640936</id><published>2012-02-25T06:27:00.002-05:00</published><updated>2012-02-25T06:28:15.150-05:00</updated><category scheme="http://www.blogger.com/atom/ns#" term="ileus" /><title type="text">abstract: Incidence of and Risk Factors for Postoperative Ileus in Women Undergoing Primary Staging and Debulking for Epithelial Ovarian Carcinoma</title><content type="html">Incidence of and Risk Factors for Postoperative Ileus in Women Undergoing Primary Staging and Debulking for Epithelial Ovarian Carcinoma

Objective
Thorough primary cytoreduction for epithelial...&lt;br/&gt;
&lt;br/&gt;
Ovarian Cancer? What You Need to Know&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?a=D3EdAr3iAxs:e9Rdpv-WAfA:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?a=D3EdAr3iAxs:e9Rdpv-WAfA:63t7Ie-LG7Y"&gt;&lt;img src="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?d=63t7Ie-LG7Y" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?a=D3EdAr3iAxs:e9Rdpv-WAfA:4cEx4HpKnUU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?i=D3EdAr3iAxs:e9Rdpv-WAfA:4cEx4HpKnUU" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/OvarianCancerAndUs/~4/D3EdAr3iAxs" height="1" width="1"/&gt;</content><link rel="related" href="http://www.sciencedirect.com/science?_ob=GatewayURL&amp;_origin=IRSSSEARCH&amp;_method=citationSearch&amp;_piikey=S0090825812001539&amp;_version=1&amp;md5=f83749c9e5ac2e11ac4a936cb2cf7679" title="abstract: Incidence of and Risk Factors for Postoperative Ileus in Women Undergoing Primary Staging and Debulking for Epithelial Ovarian Carcinoma" /><link rel="replies" type="application/atom+xml" href="http://ovariancancerandus.blogspot.com/feeds/3536849322068640936/comments/default" title="Post Comments" /><link rel="replies" type="text/html" href="http://ovariancancerandus.blogspot.com/2012/02/incidence-of-and-risk-factors-for.html#comment-form" title="0 Comments" /><link rel="edit" type="application/atom+xml" href="http://www.blogger.com/feeds/9029913/posts/default/3536849322068640936" /><link rel="self" type="application/atom+xml" href="http://www.blogger.com/feeds/9029913/posts/default/3536849322068640936" /><link rel="alternate" type="text/html" href="http://feedproxy.google.com/~r/OvarianCancerAndUs/~3/D3EdAr3iAxs/incidence-of-and-risk-factors-for.html" title="abstract: Incidence of and Risk Factors for Postoperative Ileus in Women Undergoing Primary Staging and Debulking for Epithelial Ovarian Carcinoma" /><author><name>Sandi Pniauskas</name><uri>https://profiles.google.com/104150638679323605960</uri><email>noreply@blogger.com</email><gd:image rel="http://schemas.google.com/g/2005#thumbnail" width="32" height="32" src="//lh3.googleusercontent.com/-pXxp-HXKY6M/AAAAAAAAAAI/AAAAAAAAAek/8dBEqVT6p0I/s512-c/photo.jpg" /></author><thr:total>0</thr:total><feedburner:origLink>http://ovariancancerandus.blogspot.com/2012/02/incidence-of-and-risk-factors-for.html</feedburner:origLink></entry><entry><id>tag:blogger.com,1999:blog-9029913.post-363125117349581689</id><published>2012-02-25T06:17:00.001-05:00</published><updated>2012-02-25T06:17:29.893-05:00</updated><category scheme="http://www.blogger.com/atom/ns#" term="vitamin D" /><title type="text">abstract: Does vitamin D protect against DNA damage?</title><content type="html">Does vitamin D protect against DNA damage?

Source: Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis

Vitamin D is a secosteroid best known for its role in maintaining bone and...&lt;br/&gt;
&lt;br/&gt;
Ovarian Cancer? What You Need to Know&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?a=6AjOMpvQius:HggDyAk-VQk:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?a=6AjOMpvQius:HggDyAk-VQk:63t7Ie-LG7Y"&gt;&lt;img src="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?d=63t7Ie-LG7Y" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?a=6AjOMpvQius:HggDyAk-VQk:4cEx4HpKnUU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?i=6AjOMpvQius:HggDyAk-VQk:4cEx4HpKnUU" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/OvarianCancerAndUs/~4/6AjOMpvQius" height="1" width="1"/&gt;</content><link rel="related" href="http://www.sciencedirect.com/science?_ob=GatewayURL&amp;_origin=IRSSSEARCH&amp;_method=citationSearch&amp;_piikey=S0027510712000450&amp;_version=1&amp;md5=fbff27eac730a760a94c5feeb9bb3549" title="abstract: Does vitamin D protect against DNA damage?" /><link rel="replies" type="application/atom+xml" href="http://ovariancancerandus.blogspot.com/feeds/363125117349581689/comments/default" title="Post Comments" /><link rel="replies" type="text/html" href="http://ovariancancerandus.blogspot.com/2012/02/does-vitamin-d-protect-against-dna.html#comment-form" title="0 Comments" /><link rel="edit" type="application/atom+xml" href="http://www.blogger.com/feeds/9029913/posts/default/363125117349581689" /><link rel="self" type="application/atom+xml" href="http://www.blogger.com/feeds/9029913/posts/default/363125117349581689" /><link rel="alternate" type="text/html" href="http://feedproxy.google.com/~r/OvarianCancerAndUs/~3/6AjOMpvQius/does-vitamin-d-protect-against-dna.html" title="abstract: Does vitamin D protect against DNA damage?" /><author><name>Sandi Pniauskas</name><uri>https://profiles.google.com/104150638679323605960</uri><email>noreply@blogger.com</email><gd:image rel="http://schemas.google.com/g/2005#thumbnail" width="32" height="32" src="//lh3.googleusercontent.com/-pXxp-HXKY6M/AAAAAAAAAAI/AAAAAAAAAek/8dBEqVT6p0I/s512-c/photo.jpg" /></author><thr:total>0</thr:total><feedburner:origLink>http://ovariancancerandus.blogspot.com/2012/02/does-vitamin-d-protect-against-dna.html</feedburner:origLink></entry></feed>

